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!i!
Summary!
Nuclear! magnetic! resonance! (NMR)! spectroscopy! is! a! powerful! technique! that! allows! non9
invasive!studies!of!biomolecules!at!atomic!resolution.! It!provides! information!on!structure!and!
dynamics!of!biomolecules!and!is!also!broadly!used!in!small!molecule!characterization.!This!thesis!
explores!new!possibilities!of!NMR!spectroscopy!to!characterize!molecular!and!cellular!systems,!
the!chaperone–protein!interactions!in!the!periplasm!of!E.#coli!and!the!metabolism!of!eukaryotic!
cells!upon!external!modifications.!
In!the!first!part!of!this!thesis,!basic!concepts!of!NMR!spectroscopy!are!described,!as!well!as!the!
specific!NMR!experiments!used!in!the!experimental!part.!The!second!part!of!the!thesis!describes!
the!application!of!NMR!spectroscopy!to!characterize!chaperone–protein!complexes.!Site9specific!
intermolecular!short9range!contacts!were!detected!in!a!membrane9protein–chaperone!complex.!
This! was! achieved! by! an! orthogonal! isotope9labeling! scheme! that! permits! the! unambiguous!
detection! of! intermolecular! NOEs! between! the! well9folded! Skp! chaperone! and! the! unfolded!
outer!membrane!protein!A!substrate!ensemble.!The!residues!involved!in!these!contacts!are!part!
of! the! chaperone–substrate! interface.! Furthermore,! the! interaction! between! the! periplasmic!
chaperone! SurA! and! the! BamA9POTRA!domains!was! characterized! by!NMR! spectroscopy.! This!
interaction!is!supposed!to!induce!the!delivery!of!unfolded!outer!membrane!protein!substrates!to!
the! BAM! complex! for! their! insertion! into! the! outer!membrane! of!E.# coli.! The! combination! of!
sequence9specific! assignment! using! triple9resonance! experiments! and! chemical! shift! mapping!
upon! interaction!revealed! the!mechanism!of!SurA! interaction!with!POTRA.!A!destabilization!of!
SurA!and!the!release!of!a!hydrophobic!surface!on!POTRA1!upon!interaction!presumably!lead!to!
the!handover!of!the!OMP!precursor!to!the!Bam!complex.!
The! third! part! of! the! thesis! describes! studies! of! cellular!metabolism!by!NMR! spectroscopy! by!
footprinting! method! and! in! living! cells.! 1D! NMR! experiments,! combined! with! metabolite!
quantification!methods! characterize! the!metabolic! changes! in! cells! infected! by!S.# flexneri! and!
provide! new! insights! into! the! infection! mechanism! of! this! highly! virulent! bacterium.!
Furthermore,!the!potential!of!dissolution!dynamic!nuclear!polarization!(DNP)!NMR!spectroscopy!
in!the!characterization!of!real!time!metabolic!processes! in! living!macrophages!was!successfully!
explored! showing! that!dissolution9DNP!NMR!spectroscopy! can!be!applied! to! a!broad! range!of!
cell!systems,!and!can!become!routinely!applied!for!metabolic!studies!in!the!cell.!
!
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Introduction!
Nuclear!magnetic!resonance!(NMR)!spectroscopy!was!first!reported!in!bulk!material!by!Bloch!et#
al.[1]!and!Purcell!et#al.[2]! in!1946,!and!was!recognized!by!the!1952!Nobel!Prize! in!Physics.!Since!
then,!NMR!spectroscopy!has!become!a!major!tool!in!analytical!chemistry!and!molecular!biology.!
Application! of! nuclear!magnetic! resonance! (NMR)! spectroscopy! to! biomolecules! was! strongly!
facilitated!by!the!development!of!Fourier!transform!NMR!spectroscopy!by!Ernst!and!Anderson[3]!
in!1966!and! the!conception!of!multidimensional!NMR!spectroscopy!by! Jeener! in!1971[4].! Since!
the!eighties,!methods!have!become!available! to!obtain! complete! sequence9specific! resonance!
assignments!of! small! proteins,!DNA!and!RNA! fragments.! Since! then,! the!number!of! structures!
solved!by!NMR!spectroscopy!grew!exponentially!to!reach!an!approximate!of!11,000!nowadays[5].!
Together!with!X9ray!crystallography!and!electron!microscopy,!NMR!spectroscopy!is!one!of!three!
techniques!capable!of!determining!three9dimensional!structures!of!biological!macromolecules!at!
atomic! resolution! and!provides,! readily,! information!on!dynamic! processes.!Main! obstacles! to!
the!development!of!NMR!spectroscopy!of!biomolecules!are!its! inherent! low!sensitivity!and!the!
complexity!of!the!measured!spectra.!NMR!spectroscopy!of!proteins!in!solution!also!suffers!from!
a! “size! limitation”! occurring! from! increased! transverse! relaxation.! As! a! consequence,! only! 2!
percent! of! protein! structures! solved! by!NMR! spectroscopy! comprise!more! than! 200! residues.!
However,! the!development!of! stronger!magnets! and!more! sensitive!NMR!spectrometers!push!
the! sensitivity.! Advances! in! sample! preparation,! through! the! selective! use! of! 13C! and! 15N!
isotopes[6]! combined! with! multidimensional! heteronuclear! NMR! spectroscopy! techniques[7]!
allowed! to! convert! the! spectral! complexity! into! significant! advantage! providing! crucial!
information! in! distances[8],! connectivity,! structures[9,! 10].! The! development! of! specific! protein!
labeling!patterns[11],!the!use!of!perdeuteration[12]!as!well!as!new!spectroscopic!techniques!such!
as! TROSY[13]! and!more! recently! the! development! of! reverse!micelles[14],[15]! raise! this! limitation!
towards! large! systems,! in! favorable! cases! up! to! 1! MDa[16,! 17].! Recently! the! development! of!
dissolution!dynamic!nuclear!polarization!(DNP)!NMR!spectroscopy!has! increased!the!sensitivity!
of! certain! NMR! experiment! up! to! 10,000! fold[18].! DNP! proves! to! be! relevant! in! the! study! of!
various! cell!metabolites[19923]! and,! thanks! to! its! continuous!development,! could!become!a! very!
powerful!tool!in!molecular!biology.!
!
!
!
!
!
!
!
!
!
!
!
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!
1.1 Basic!Principles!of!Nuclear!Magnetic!Resonance!
Spectroscopy!
Spin!Theory!
NMR!spectroscopy!exploits!the!fact!that!nuclei!possess!a!spin!angular!momentum!characterized!
by!the!nuclear!spin!quantum!number!I.!The!nuclear!spin!angular!momentum!is!a!vector!quantity!! !that,! because! of! the! laws! of! quantum! mechanics,! can! have! 2I! +! 1! possible! orientations,!
described!by! the!magnetic!quantum!number!m!=! (9I,! 9I!+!1,!…,! I91,! I).!The!value!of! the!nuclear!
spin!quantum!number!I!is!the!combination!of!the!individual!spins!½!of!each!proton!and!neutron!
in!the!nucleus!(Table!1.1).!Among!them,!only!non9zero!spins! interact!with!the!magnetic!B9field!
and!are!observable!by!NMR!spectroscopy.!These!nuclei!possess!a!nuclear!magnetic!moment!!!
defined!by!Eq.!1!where!γ!is!the!gyromagnetic!ratio,!a!characteristic!constant!for!a!given!nucleus!
(Table!1.1),!determining!its!sensitivity!in!NMR!spectroscopy.!
! = !!!! = !!ℏ!!!!!!!!!!(1)!
Liquid! state! NMR! spectroscopy! uses! mainly! nuclei! possessing! a! spin! ½,! as! the! quadrupolar!
moment!displayed!by!spins!I!>!½!leads!to!broad!NMR!signals.!The!nuclei,!1H,!13C,!15N,!19F!and!31P!
are!thus!the!most!commonly!used!in!biomolecular!NMR!spectroscopy.!
!
Nucleus! 1H! 2H! 13C! 14N! 15N! 19F! 31P!! !"!!!" ∙ !!! ! 42.6 ∙ 10!! 6.5 ∙ 10!! 10.7 ∙ 10!! 3.1 ∙ 10!! −4.3 ∙ 10!! 40.1 ∙ 10!! 17.2 ∙ 10!!
I! 1/2! 1! 1/2! 1! 1/2! 1/2! 1/2!
Table!1.1!Gyromagnetic!ratios!and!nuclear!spin!quantum!numbers!for!nuclei!of!particular! importance! in!
biological!NMR!spectroscopy.!
!
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In!the!absence!of!an!external!field,!the!quantum!states!corresponding!to!the!2I!+!1!values!of!m!
have! the! same! energy! and! the! nuclear! spin! vector! does! not! have! preferred! orientation.!
However,! placed! in! an! external! magnetic! field,! the! different! spin! states! acquire! different!
energies!given!by!Eq.!2!in!which!!!is!the!magnetic!field!vector.!
! = ! ∙ !!!!!!!!!!!!!!(!2)!
In!an!NMR!spectrometer,!this!static!external!magnetic!field!is!directed!along!the!z9axis,!and!the!
energies! of! the! m! spin! states! are! obtained! by! multiplying! the! projections! of! the! angular!
moments!onto!the!z!axis!by!the!magnetic!field!shown!in!Eq.!3!where!ℏ!is!the!Planck!constant!and!!!!the!static!magnetic!field!strength.!!!! = !!!! = !−!ℏ!!!!!!!!!(3)!
The!interaction!results!in!2I!+!1!energy!levels,!equally!spaced!by!energy!gaps!Δ! = ℏ!!!,!known!
as! the! Zeeman! levels.! In! the! case! of! a! nucleus!with! a! spin! quantum!number! I! =!½! in! a! static!
magnetic!field!B0,!the!spin!states!can!take!two!orientations,!parallel!(m!=!+1/2)!denoted!α!and!
antiparallel! (m!=!91/2)!denoted!β!at!the!energies!!! = ! !!ℏ!!!!and!!! = − !!!ℏ!!!!respectively!
(Fig.!1.1).!!
!
!
!
Figure! 1.1! Energy! levels! |α>! and|β>! of! the! two! possible! orientations! of! a! nucleus! possessing! a! spin!
quantum!number!I!=!½!in!a!static!magnetic!field!B0!oriented!along!the!z!axis.!
!
At! thermal! equilibrium,! these! different! energy! levels! are! unequally! populated,! as! the! lower!
energy!orientation!of!the!nuclear!spins!is!more!favorable!according!to!Boltzmann!equations.!The!
difference! of! population! between! two! consecutive! states! is! called! polarization! (Eq.! 4)! and!
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determines!the!sensitivity!of!an!NMR!experiment.!In!the!case!of!a!1H!nucleus,!possessing!a!spin!
½,!the!population!difference!between!the!α!and!β!states!in!a!static!magnetic!field!of!800!MHz!at!
temperature! of! 273! K! it! is! equal! to! about! 0.999872.! This! small! population! difference! is!
responsible!for!the!sensitivity!of!NMR!spectroscopy.!!!
!!!! = exp − ℏ!!!!!! !!!!!!!!!!!(4)!
!
The!OneCPulse!NMR!Experiment!
An!NMR!experiment! is!performed!by!stimulating!transitions!between!two!consecutive!Zeeman!
levels! allowing! net! transitions! of! the! excess! of! spins! from! the! higher! populated! state! to! the!
consecutive! one.! Transitions! are! stimulated! by! applying! an! electromagnetic! wave! of! energy!
corresponding!to!the!difference!between!the!levels!Δ! = ℏ!!!!to!the!system.!!
In! a! simple! semiclassical! vector!model[1],! ! the! small! population! excess! in! the! lower! spin! state!
gives! rise! to! a! net! macroscopic! magnetization!! !resulting! from! the! superposition! of! the!
microscopic!moments!(Eq.!5).!!!
! = !! − !! !!!"#$%& !!!!!!!!!(5)!
At! thermal! equilibrium,! this! bulk! magnetization! denoted! !!is! parallel! to! the! static! magnetic!
field.! An! application! of! a! radiofrequency! (rf)! pulse! to! the! system! with! energy! equal! to! the!
difference!Δ!!between! two! consecutive! spin! states! (on9resonance! pulse)!will! deviate! the! bulk!
magnetization! vector! from! the! z9axis! (Fig.! 1.2a).! In! the! ideal! one9pulse! experiment,! the! on9
resonance!pulse!B1!achieves!a!rotation!of!the!magnetization!by!90°!into!the!x,y9plane!where!the!
maximum!magnetization!is!detected.!Once!in!the!x,y9plane,!the!magnetization!starts!to!precess!
around!the!z9axis!at! its!Larmor!frequency!(Eq.!6)!during!an!acquisition!period!t,!generating!the!
signal!recorded!by!the!NMR!spectrometer,!the!free!induction!decay!(FID)!(Fig!1.2b).!
!! = !!! = 2!!!!!!!!!(6)!
Due!to!relaxation!(detailed!in!section!1.2)!the!magnetization!does!not!precess!freely!in!the!x,y9
plane!forever,!but!returns!to!the!equilibrium!state!along!the!z9axis,!leading!to!a!decay!of!the!FID.!
The! time9domain! FID! is! then! Fourier! transformed! to! produce! a! frequency9domain! spectrum!
displaying!a!resonance!peak!at!frequency! !!(Fig.!1.2c).!
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!
!
Figure!1.2!One9pulse!NMR!experiment.!The!vector!quantities!are!highlighted!in!bold.!a)!Evolution!of!the!
magnetization! during! a! one9pulse! experiment.! b)! Free! induction! decay! (FID)! recorded! in! a! one9pulse!
experiment! and! c)! its! Fourier! transformed! NMR! spectrum! displaying! an! NMR! peak! at! the! Larmor!
frequency! !.!
!
!
Chemical!Shift!
Distinction!between!the!different!nuclei!in!an!NMR!spectrum!is!made!possible!as!the!resonance!
frequency!of! a! given!nucleus! slightly! differs! from! their! Larmor! frequency! !!(Eq.! 7)! due! to! its!
interaction!with! the! local! environment.! This! difference,! called! chemical! shift,! is! caused!by! the!
motion!of! the!electrons!surrounding!each!spin,!generating!a! second!magnetic! field!acting!as!a!
chemical!shield!around!the!nuclei.!Thus,!the!magnetic!field!experienced!by!nuclei!is!attenuated!
by!a!factor!!!!,!where!!!represents!the!shielding!constant.!This!chemical!shielding!is!very!small!
in!magnitude! compare! to! the! external!magnetic! field,! with! typical! values! of! a! few! or! several!
parts!per!million!(ppm).!Thus!the!resonance!frequency!observed!for!a!nucleus!is!defined!by!Eq.!7!
and!variations!in!chemical!shielding!due!to!different!electronic!environments! leads!to!different!
resonances!frequencies!of!nuclei.!
! = −! 1 − ! !!!!!!!!!!(7)!
For!practical!reasons,!the!chemical!shift! is!defined!relative!to!a!resonance!signal!of!a!reference!
molecule! (Eq.!8),!where!ωref! is! the! resonance! frequency!of! the! reference!substrate,!defined!as!
δ =! 0! ppm.! In! biomolecular! NMR! of! protons,! the! reference! substrate! is! typically! the! methyl!
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resonance!of! 2.29dimethyl929silapentane959sulfonic! acid[24]! (DSS),!which!has! a! lower! resonance!
frequency!than!most!protons!in!other!molecules.!
! = − !!"#!!!!"# ∙ 10!!!"!!!!!(8)!
The!chemical!shift!of!a!nucleus!depends!on!the!electron!distribution!in!its!molecular!orbitals!and!
thus!also!on!the!local!geometry!(neighboring!atoms,!angles!between!bonds,!bond!lengths).!As!an!
example,! the! proton! chemical! shift! strongly! depends! on! the! electronegativity! of! the! bound!
nucleus,! influencing!the!local!electron!density!at!the!proton.!In!the!case!of!proteins,!secondary!
chemical! shifts! are! also! observed,! dependent! on! dihedral! angles! and! the! type! of! secondary!
structure!elements.!Thus,!the!chemical!shift!contain!contributions!of!the!secondary!and!tertiary!
structure! of! proteins! and! its! variation! can! be! related! to! even! small! structural! modifications.!
Therefore,! chemical! shift! perturbation! (CSP)! studies! allow! to! monitor! changes! in! protein!
structure,!such!as!unfolding[25],!where!the!chemical!shifts!of!the!residues!change!towards!their!
random9coil! chemical! shift! values.! CSP! mapping! is! also! a! powerful! technique! to! characterize!
protein9protein! interactions[26].! There,! changes! in! chemical! shifts,! for! example! of! the! amide!
moiety,! are! induced! by! the! changes! in! local! environment! upon! binding.! The! changes! are!
quantified!by!Eq.!9,!where!Δδ(1H)!and!Δδ(15N)!are!the!chemical!shift!changes!of!the!1H!and!15N!
nuclei,!respectively.!
!"# = ∆! !!! ! + !!∆! !!!" !        (9) 
!
Scalar!Coupling!
In!an!isolated!spin!system,!the!nucleus!gives!rise!to!one!peak!in!the!NMR!spectra!at!its!chemical!
shift! position.! However,! interactions! between! covalently! attached! nuclei,! mediated! by! the!
electrons! forming! the! chemical! bonds,! cause! the! splitting! of! the! resonance! signals! into!
multiplets[27].! This! spin–spin! coupling!or! scalar! coupling! is! characterized!by! the! scalar! coupling!
constant!n!!"!(in!Hertz),!whose!strength!depends!on!the!number!of!covalent!bonds!(n)!separating!
the! two! nuclei! I! and! S,! as! well! as! the! nuclei! type.! For! protons,! detectable! scalar! coupling!
interaction! typically!have!! = 1!to!4.! In!a! two!spin!½!system! I!and!S,!described!by! four! states,!
αα, αβ, βα!and!ββ, corresponding!to!the!two!possible!magnetic!quantum!numbers! ! ± 1 2 !
(Fig.! 1.3a),! the! allowed! transitions! occur! between! |αα> and! |αβ> and! between |βα> and!
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|ββ> at!the! resonance! frequency! of! the! spin! S! !,! and! between|αα>! and! |βα>! and! between!
|αβ>!and!|ββ> at!the!resonance!frequency!of!the!spin!I,! !.!If!the!spins!are!scalar!coupled,!the!
scalar! coupling!!!"!modifies! the! energy! levels! of! the! four! spin! states! by! a! factor!± !!!!ℏ!!"!and!
thus,! according! to! Eqs.! 3! and! 6,! the! resonance! frequencies! by! a! factor!± !!!!"!" .! As! a!
consequence,!the!NMR!spectrum!will!display!two!peaks!for!each!spin!centered!on!the!resonance!
frequencies!!! !and!!! ,! and! different! by!!"!" !(Fig.! 1.3b).! The! scalar! coupling! is! used! in!
multidimensional!NMR!experiments!to!transfer!magnetization!between!spins.!
!
!
!
Figure! 1.3! Two! spin!½! system;! adapted! from!Cavanagh,! J.!et# al.[28].! a)! Energy! levels! |αα>,! |αβ>,! |βα>!
and|ββ>! of! two! non! scalar! coupled! spins! ½! and! corresponding! NMR! spectrum!where! each! non! scalar!
coupled! spin!½! gives! rise! to! one! peaks! at! its! resonance! frequency.! b)! Energy! levels! |αα>,! |αβ>,! |βα>!
and|ββ>!of!two!scalar!coupled!spins!½!and!corresponding!NMR!spectrum!where!each!scalar!coupled!spin!
½!gives!rise!to!two!peaks!at!its!resonance!frequency!± !!!!"!".!
!
!
Chemical!Exchange!
A! modification! of! the! chemical! shift! of! a! given! nucleus! can! happen! via! perturbation! of! its!
environment.!Such!change!can!be!caused!by! internal!motion!such!as!conformational!exchange!
or! by! interaction! with! another! molecule! during! complex! formation.! There,! the! chemical!
exchange! rate! constant! k! is! defined! as! the! rate! of! interconversion! between! these! different!
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conformations[29].! For! a! nucleus! exchanging! between! two! conformations! A! and! B,! each!
conformation!is!giving!rise!to!a!distinct!resonance!with!chemical!shift!values!δA!and!δB,!and!with!
distinct! frequencies! νA! and! νB,! distant!of Δν.! Possible! exchange! regimes! between! these!
conformations,!equally!populated,!are!displayed!in!Figure!1.4.!
!
!
!
!
Figure!1.4.!Possible!chemical!exchange!regimes!of!a!nucleus!interconverting!between!two!conformations!
A!and!B,!with!distinct!chemical!shift!value!δA!and!δB.!k!is!the!chemical!exchange!rate!and!Δν!the!difference!
between!the!resonance!frequencies!of!the!nucleus!in!conformations!A!and!B.!
!
If! the! exchange! rate! is! smaller! than! the! difference! in! resonance! frequencies!
Δν, the!system!is!on!slow!exchange! in! the! NMR! time! scale! (millisecond! regime)! and! the! two!
different! conformations! of! the! nucleus! are! observed! during! the!measurement! time.! Basically,!
while! the!NMR!experiment! is! recorded,!half!of! the!molecules!are! in!conformation!A!while! the!
other!half! is! in!conformation!B.!As! the! rate!of!exchange! increase,! the!molecule!starts! to!swap!
between!conformations!A!and!B!multiple!times!during!the!NMR!time!scale!and!the!two!original!
resonance! frequencies! of! the! nucleus! therefore! modulates! each! other.! This! causes! a! loss! of!
coherence!and! thus!a!peak!broadening,!as!well! as!a!movement!of! the!peaks,!as! the!nuclei!no!
longer! have! the! chemical! shifts! δA! and! δB! but! !! − !! !!!and!(!! − !!)!!!where!!!!and!!!!
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are! the! proportion! of! time! spent! in! conformations! A! and! B! respectively.! The! intermediate!
exchange!or!coalescence!is!reached!when!Δ! ≈ !,!where!the!extreme!broadening!prevents!the!
distinction!of!the!peak!in!the!NMR!spectra.!Finally,!if!the!exchange!rate!is!very!large!compared!to!
the!frequency!difference!between!the!two!conformations,!the!system!is!in!fast!exchange!on!the!
NMR! time! scale! and! one! single! peak! is! observed! at! the! average! chemical! shift! of! the! two!
conformations.!There,!while!the!NMR!experiment!is!recorded,!the!nucleus!spends!half!of!its!time!
in!each!conformation.!!
1.2 Spin!Relaxation!!!!!!
Introduction!to!Spin!Relaxation!
Relaxation!is!the!process!by!which!spins!return!to!their!equilibrium!state!where!the!population!
of!the!energy!levels!are!those!given!by!the!Boltzmann!distribution.!For!a!spin!½,!a!transition!from!
the!α!to!the!β!states!is!induced!by!an!electromagnetic!wave,!perturbing!the!spin!population!at!a!
transition!rate!W!modulated!by!the!population!of!the!α!state.!Then,!relaxation!is!happening!at!
the!same!transition!rate!W!between!the!β! to!the!α!states!modulated!by!the!population!of!the!
β state! (Fig.!1.5a).!Thus,! the! rates!of!change!of! the!population!of! the!α!and!β! states[30]! can!be!
described!by!Eq.!10!where!(!! − !!!)!and!(!! − !!!)!are! the!populations!of! the!α!and!β! states!
deviated!form!equilibrium!ones!!!! !and!!!! .!
!!!!" = −!(!! − !!!) !+!(!! − !!!)!
!!!!" = −!(!! − !!!) +!(!! − !!!)!!
!
The!net!magnetization! !!along!the!z!axis!being!equal!to!the!population!difference!between!the!
two! states! (Eq.! 5),! its! evolution! with! time! is! defined! by! Eq.! 11! where! ! = (!!! − !!!)!is! the!
equilibrium!magnetization.!!
(10)!
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!!!!! = ! !!!!!!" != −2! !! −!! !!!!!!!!!!(11)!
!! ! = !! 0 −!!! !! !!! +!!!!!!!!!!!!!(12)!
Integration!of!Eq.!11!(Eq.!12)!shows!that!the!evolution!of!the!z9magnetization!Mz!with!time!due!
to! spin! relaxation! follows! an! exponential! law! (Fig.! 1.5b,! where! ! 0 !is! the!magnetization! at!
time!zero,!!! = !!! = !!!!is!the!longitudinal!or!spin9lattice!relaxation!time!and!R1!the!longitudinal!
relaxation! rate.! This! longitudinal! relaxation! characterizes! the! process! through! which! the!
magnetization!goes!back!to!its!equilibrium!position!along!the!z!axis!through!interaction!with!the!
environment,!called! lattice.!Typical!T1! values! for! 1H!are!between!hundreds!of!milliseconds!and!
tens!of!second!while!they!are!generally!twice!longer!for!13C!nuclei.!!
!
!
!
!
!Figure!1.5.!Relaxation!in!a!spin!½!system;!adapted!from!Keeler,!J.[31].!a)!Transitions!between!the!α!and!β!
states!in!a!spin!!½!system!where!the!transition!from!α!and!β!decreases!the!population!of!the!α!state!and!a!
transition! form! β! to! α! increase! the! population! of! the! α! state.! b)! Plot! of! the! evolution! of! the! z9
magnetization! (Mz)! with! time,! following! an! exponential! law,! where! Mz
0! is! the! z9magnetization! at!
Boltzmann!equilibrium!and!Mz!(0)!the!magnetization!at!t!=!0.!
!
!
T1#depends!on!the!transition!rate!constant!W!influenced!by!the!type!of!nuclei,!the!source!of!the!
relaxation! mechanism! and! the! magnetic! field! fluctuations! happening! in! the! sample.! Indeed,!
spontaneous!spin!relaxation!in!the!absence!of!external!influences!is!essentially!absent!and!for!it!
to! occur! there! must! be! magnetic! field! fluctuations! in! resonance! with! the! energy! difference!
between!the!spin!states!involved!in!the!transition.!Each!nucleus!has!a!local!magnetic!field!whose!
direction! is! changing! with! molecular! motion,! giving! rise! to! magnetic! field! fluctuations.! These!
fluctuations! create!electromagnetic! fields!with!wide! ranges!of! frequencies!due! to! the! random!
nature!of! the!molecular!rotation.!The!spectral!density!! ! !describes!the!amount!of!molecular!
motion!at!the!frequency! [32]!(Eq.!13).!
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! ! = !!!!!!!!!! ∝ !!!!(13)!!!! !depends! on! τc,! the! molecular! rotational! correlation! time! of! the! molecule! determined! by!
different!factors!among!which!the!molecular!weight!of!the!molecule!is!the!most!important.!The!
larger! is! a! molecule,! the! slower! is! its! reorientation! and! the! longer! is! its! τc.! The! correlation!
between!τc!and!!! = 1 2! !is!displayed!in!Figure!1.6,!showing!the!influence!of!the!molecular!
size!on!the!relaxation!time.! In!addition!to!molecular!motions,!the!source!of!the! local!magnetic!
fields!inducing!relaxation!influences!the!relaxation!rate!W!of!the!nuclear!spins.!
!
!
!
!
Figure! 1.6.! Longitudinal! (!!)! and! transverse! (!!)! relaxation! time! function! of! the! molecular! rotational!
correlation!time!!!!displayed!in!orange!and!blue!respectively.!Adapted!from!Reich,!H.!J.[33].!
!
!
Sources!of!Relaxation!
For!spin!½!in!proteins,!the!relevant!sources!of!relaxation!are!the!chemical!shift!anisotropy,!the!
dipolar! coupling! and! the! paramagnetic! effect.! The! chemical! shift! anisotropy! (CSA)!mechanism!
arises! from!the! fact! that! the!electronic!environment!around!a!nucleus! is!generally!anisotropic.!
Thus,! the! magnitude! and! the! direction! of! the! additional! magnetic! field! created! by! electrons!
surrounding! the! nucleus! depends! on! the! orientation! of! the! molecule! relative! to! the! static!
magnetic!field!and!modification!of!these!fields!by!molecular!motion!induces!relaxation.!In!NMR!
spectroscopy!of!biological!molecules,!while!13C,!15N!and!31P!have!significant!CSA!contributions!to!
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relaxation,!it!is!usually!not!a!dominant!factor!for!protons[28].!The!dipolar!relaxation!mechanism!is!
happening! between! pairs! of! dipolar9coupled! spins! I! and! S[34]! where! the! fluctuations! from! the!
spin! I! will! induce! relaxation! of! the! spin! S! and! vice# versa.! This! dipole–dipole! relaxation! is!
proportional! to! the! square! of! the! dipolar! coupling! constant! DIS! (Eq.! 14),! implying! strong!
dependence!in!the!distance!!!"!between!the!two!nuclei.!As!well!it!depends!on!the!gyromagnetic!
ratio!where!nuclei!with!high!γ!relax!faster.!!
!!" ∼ !!!!ℏ!!!!!"! !!!!!!!!!!(14)!
In!small!molecules!in!solution,!since!the!proton!has!the!highest!γ value!of!the!common!nuclei,!it!
causes! also! the! strongest! dipole–dipole! relaxation.! Thus,! dipolar! relaxation! is! the! principal!
relaxation!pathway!for!protons!as!well!as!carbon!and!nitrogen!directly!attached!to!protons.!In!a!
dipolar!coupled!1H9X!spin!system,!the!dipolar!relaxation!rate!of!a!nucleus!X!by!its!nearby!protons!
is!given!by!Eq.!15.!
!!!(!!) = !!!!(!!) = 2!!"! ∙ !!(!!") = 2 ∙ !!! ∙ !!! ∙ ℏ! !!!"! ! ∙ !!(!!")!!!!!(15)!
As!an!example,!the!T1!values!of!a!13C!nuclei!directly!bound!to!a!proton!vary!typically!between!0.1!
and! 10! seconds! but! longer! values! typically! between! 10! and! 300! seconds! are! observed! for!
quaternary! carbons[35].! Thus,! deuteration! of! molecules! are! commonly! used! to! increase! T1!
values[36]!as!the!gyromagnetic!ratio!of!deuteron!is!7!times!lower!than!the!one!of!proton.!
Finally,! the! paramagnetic! effect[37]! occurs! between! a! spin! and! a! paramagnetic! center.! As! the!
presence! of! an! unpaired! electron! is! required! for! the! effect,! it! is! happening! only! in! specific!
systems.!
!
!
Nuclear!Overhauser!effect!(NOE)!
The!nuclear!Overhauser!effect! (NOE),!named!after! its!discoverer!Albert!Overhauser! in!1953[38],!
consists!in!the!transfer!of!magnetization!between!two!dipolar!coupled!spins!via!cross!relaxation.!
A!NOE!occurs! in!a! two!spin!½!system!I!and!S!by!dipolar,!and!not!scalar,!coupling!described!by!
Figure!1.7.!In!such!system,!relaxation!can!happen!between!all!energy!levels!and!the!transitions!
can! be! classified! into! three! groups.! Transition! at! rate! constant!W1,! between! two! consecutive!
energy! levels,! involves! a! spin! flip! of! only! one! of! the! spins! and! corresponds! to! previously!
described#T1!relaxation.!Transition!at!rate!constant!W0!involves!a!simultaneous!α!to!β!flip!for!one!
Chapter!1! Nuclear!Magnetic!Resonance!Spectroscopy!!
15!
spin!and!β!to!α!flip!for!the!other!spin,!corresponding!to!a!zero9quantum!transition.!Finally,!the!
transition!at!rate!constant!W2! involves!a!simultaneous!flip!of!both!spins! in!the!same!direction,!
corresponding!to!a!net!double!quantum!transition.!
!
!
!
!
Figure! 1.7.! Energy!diagram!of!a! two!spin!½!systems!dipolar!coupled! in!a!magnetic! field.!The! transitions!
displayed! as! solid! lines! correspond! to! the! T1# relaxation! and! the! transitions! displayed! in! dashed! lines!
correspond!to!the!cross9relaxation!through!dipolar!coupling.!
!
!
Thus,!by!analogy!to!Eq.!10,!the!rate!of!change!of!the!populations!of!the!different!states!can!be!
described!here!for!the|αα>!state!(Eq.!16).!!
!!!|!!!!" = −!! ! !|!!! −!! ! !|!!! −!!!|!!! +!! ! !|!"! +!! ! !|!!! +!!!|!!!!!!!(16)!
In!this!system,!the!net!magnetizations!!! !and!!!!of!the!spins!I!an!S!along!the!z9axis!are!described!
as! the!population!difference!across! the! two! I!and!S! spins! transition! respectively,!by!Eq.!17.!As!
well!as!a!third!combination!of!the!population,!2!!!!!is!described.!!! = !|!!! − !|!"! + !|!"! − !|!!!!!! = !|!!! − !|!"! + !|!"! − !|!!!!!!!!!!!!!!!!!!!!!!!(17)!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!2!!!! = !|!!! − !|!"! − !|!"! + !|!!!!!!
Thus,!by!analogy!to!Eq.!11,!the!evolutions!of!the!spin!magnetizations!with!time!can!be!described,!
by!combination!of!Eq.!16!and!17,!by!the!Solomon!equations[39]!(Eq.!18)!where!the!populations!!!!
and!!!,!are!the!derivation!from!their!equilibrium!values!!!!!and!!!!.!!
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!!!!" = − 2!! ! +!! +!! !! − !! −!! !! − 2!! ! !2!!!!!!!!!!" = − !! −!! !! − 2!! ! +!! +!! !! − 2!! ! !2!!!!!!!!!!!!!(18)!!!!!!!" = −2!! ! !! − 2!! ! !! − (2!! ! + 2!! ! )2!!!!!!
It! shows! that! the! rate! of! change!of! each! spin!magnetization!depends!on! self9relaxation! (!! =2!! ! +!! +!! !for! spin! I! and!!! = 2!! ! +!! +!! !for! spin! S)! equivalent! to! the!
above9described! T1! as! well! as! on! cross! relaxation! between! the! two! spins! described! by!!!" =!! −!! ,! through! double! quantum! and! zero! quantum! transitions[40].! Thus,! the! NOE! effect!
between!two!dipolar!coupled!nuclei! I!and!S,!depends!on!the!cross9relaxation!rate!constant!!!"!
that,!using!Eq.!15,!can!be!written!as!
!!" = !! −!! != 2. !!!. !!!.ℏ! !!!"! ! !!! − ! !!! !!!!(19)!
The!frequency!necessary!to!induce!the!transition!at!W2!rate!constant,! !! !is!equal!to!the!sum!of!
the! resonances! frequencies! for! the! two! spins,! ! + !!!and! the! frequency!necessary! to! induce!
the!transition!at!W0!rate!constant,! !! !is!equal!to!the!difference!of!the!resonances!frequencies!
for!the!two!spins,! ! − !!.!Thus,!in!the!case!of!two!identical!nuclei,!with!resonances!frequencies!!!!the!cross9relaxation!rate!constant!is!!
!!" ∝ 6! 2!! − ! 0 !!!"! = 6! 2!! − 2!! !!!"! !!!!!(20)!
It! indicates! that! for!6! 2!! > ! 0 !or!2!! ,! the! cross! relaxation! rate! constant! is! positive.!
Therefore! a! short!!! !leads! to! a! positive! NOE! effect.! On! the! other! hand,! for! long!!! !the! NOE!
effect! is!negative.!The!crossing!point! is!at! !!! = !! ≈ 1,!where!the!W0!and!W2!effects!cancel!
each! other’s! and! there! is! no! NOE! is! observable! (Fig! 1.8).! The! NOE! contains,! via! the! cross!
relaxation!rate!constant! information!about!molecular!size!as!well!as! the!distance!between!the!
two! dipolar! coupled! nuclei! through! the! r96! dependence.! This! strong! distance! dependence!
prevents!the!detection!of!the!NOE!effect!between!spins!far!from!each!other.!Basically,!a![1H,1H]!
NOE!typically!occurs!with!distances!below!6!Å!in!small!proteins.!Thus,!the!NOE!effect!is!broadly!
used! to! measure! intermolecular! distances,! where! the! intensity! of! the! cross9relaxation! rate!
constant!is!used!as!a!constraint!to!calculate!protein!structures[41].!The!NOE!can!also!be!used!in!a!
qualitative! way.! In! protein! assignment! the! NOE! effect! measured! on! the! amide! proton! (1HN)!
allows!to!detect!the!surrounding!protons,!thus!providing!information!on!the!amino9acid!position!
within!the!protein!and!in!unfolded!ensembles,!where!the!NOE!effect!contains!the!contribution!
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from!different!conformations!of!the!structural!ensemble!(NOE!measurement!detailed!in!section!
1.3).!
!
!
!
Figure!1.8.!Variation!of!the!sign!of!the!NOE!effect!function!of!the!molecular!rotational!correlation!time!τc,!
related! to! the! size! of! the!molecule! and! the! resonance! frequency!ω0,! for! two! equivalent! spin!½! dipolar!
coupled.!Adapted!from!Gemmecker,!G.[42].!
!
!
Transverse!Relaxation!
In! addition! to! the! previously! described! spin9lattice! relaxation,! a! decrease! of! NMR! coherence!
over!time!also!arises!from!the!interaction!of!spins!with!their!environment,!including!other!spins.!
This! effect! is! called! transverse! or! spin9spin! relaxation! and! determines! the! evolution! of! the!
transverse!magnetization! !"!with!time.!By!analogy!to!Eq.!12,!transverse!relaxation!follows!an!
exponential!decay! law!described!by!Eq.!21!where! !" 0 !is!the!magnetization!at!time!zero,!!!!
the!transverse!relaxation!time!constant!and!!! = !!!!the!transverse!relaxation!rate!constant.!
!!"(!) = !!" 0 !! !!! !!!!(21)!
As! for! the! longitudinal! relaxation,! this! process! occurs! by! random! fluctuations!of! the!magnetic!
field!at!the!nucleus,!triggering!transitions!of!the!spins!between!energy!levels.!The!most!relevant!
relaxation! mechanisms! in! protein! NMR! arise! from! dipolar! interaction! and! chemical! shift!
anisotropy.! Similar! to! the! longitudinal! relaxation,! the! transverse! relaxation! time! constant!!!!
depends!on!the!spectral!density!function!! ! !(Eq.!22),!where!for!biomolecules!displaying!a!long!!! !(> !!),! the! term!! 0 !is! dominant.! Thus,! in! first! order! approximation,! the! relaxation! time!
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constant!!! !for! dipolar! relaxation! in! a! two9spin! system! is! proportional! to! the! molecular!
rotational!correlation!time!!! !and!large!molecules!thus!feature!very!rapid!transverse!relaxation!
(Fig.!1.6).!
!!! ∝ ! 0 + ! 2!! + 2!! !! = 2!! + !!!!!!!!!!!! + !!!!!!!!!!! !!!!!!!!(22)!
The! linewidth! of! an! NMR! experiment !Δ! ,! defined! as! the! full! width! at! half! height! of! the!
resonance! peak,! is! proportional! to! the! relaxation! time! constant!!! !(Eq.! 23).! For! an! ideal!
Lorentzian!line!shape!the!linewidth!is!given!by!
Δ! = !!!!!!!!!!!!(23)!
Thus,! the! resonances! become! broader! for! large! molecules,! displaying! long!!! !(Eq.! 22).! As!
relaxation! is! affecting! both! resolution! and! signal9to9noise! ratio,! an! increase! in! molecular! size!
leads!to!an!overall!decrease!in!spectral!quality.!This!leads!to!a!“size!limitation”!for!solution!state!
NMR!spectroscopy.!Several!techniques!allow!to!push!this!limit!higher,!such!as!perdeuteration!of!
the!protein[12,!36],!specific! labeling!schemes[11]!to!minimize!dipolar! interactions,!or!optimal!pulse!
sequences!managing! relaxation! losses[13].!As!a! consequence,! functional! studies!of!proteins!can!
be!performed!on!large!systems!up!to!1!MDa[16,!17].!
1.3 Heteronuclear!NMR!Experiments!Applied!to!Proteins!
Amino!acids,!the!constituent!of!proteins,!are!composed!of!proton,!carbon,!nitrogen,!oxygen!and!
sulfur,! connected! together! intra–residually! through! atomic! bonds,! or! inter–residually! via!
secondary!structure!or!macromolecular!interactions.!Thus,!atomic!resolution!studies!of!proteins!
and! protein! complexes! require! the! characterization! of! distances,! connections! and! angles!
between!these!different!nuclei.!As!discussed!in!section!1.1,!the!proton!possess!spin!½!and!is!thus!
well!suited!for!liquid!state!NMR!spectroscopy.!13C!and!15N!possess!a!spin!½!as!well!but!their!low!
natural! abundance!of! 1.11! and!0.36!%,! respectively,! prevents! their! detection! in!NMR! spectra.!
However,!these!heteronuclei!can!be!specifically!enriched!towards!100!%!13C!and!15N!labeled!by!
commonly! used!methods[6],!making! them! suited! for!NMR! spectroscopy.! Thus,! it! is! possible! to!
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correlate! heteronuclear! resonances! with! protons! using! NMR! experiments,! transfering!
magnetization! through! bond! or! through! space! between! these! nuclei[43].! In! heteronuclear!
experiments,!the!application!of!a!radiofrequency!pulse!will!rotate!the!spin!magnetization!to!the!
x,y9plane! followed! by! coherence! transfer! between! the! different! coupled! spins! and! then!
detection!during!an!acquisition!period.!The!heteronuclear!NMR!experiments!generally!used!are!
heteronuclear! multiple! quantum! coherence! (HMQC)[44,! 45]! or! heteronuclear! single! quantum!
coherence! (HSQC)[7]! mechanisms! to! transfer! coherence! between! the! spins.! The! sensitivity! of!
heteronuclear! experiments,! calculated! as! the! signal! to! noise! ratio! !! ,! depends! on! the!
gyromagnetic!ratios!of!the!different!nuclei!as!well!as!on!the!spin9lattice!relaxation!described!in!
Eq.! 24! where!!!" !and!!!"# !corresponds! to! the! gyromagnetic! ratios! of! the! exited! and! the!
detected! nucleus,!!! !to! the! recycle! time! of! the! NMR! experiment! and!!!,!"!to! the! spin! lattice!
relaxation! rate! of! the! exited! nucleus.! Thus,! to! increase! sensitivity,! indirect! detection! through!
proton!is!favored[46,!47].!
!! ∝ !!"!!"#!/! 1 − !"# !!,!"!! !!!!!!(24)!
Heteronuclear! experiments! are! commonly! used! in! protein! studies! to! control! sample! quality,!
measure!distances!between!nuclei,!assign!proteins,! calculate! structures!and! their! large! variety!
allows!obtaining!all!necessary!information!for!macromolecule!characterization.!In!addition,!they!
increase! the! NMR! spectral! dimensionality,! thus! provide! better! resolution,! necessary! for! large!
macromolecules!where!the! large!number!of!resonances!prevents!their!unambiguous!detection!
in!the!highly!overlapping!one!or!multi–dimensional!homonuclear!NMR!spectra.!
!
!
2D![15N,1H]CHSQC,!the!Protein!Fingerprint!
The!2D![15N,1H]9HSQC!pulse!sequence!displayed!in!Figure!1.9,!correlates!scalar!coupled!15N!and!
1H! nuclei! and! can! be! divided! in! four! periods:! the! insensitive! nuclei! enhanced! by! polarization!
transfer! (INEPT)! element[48],! transferring! the! polarization! form! the! sensitive! proton! to! the! 15N!
nuclei!through!one–bond!scalar9coupling!(1!!"),!the!evolution!period,!where!the!chemical!shift!
of!the!15N!nuclei!is!encoded,!the!reverse!INEPT,!transferring!the!polarization!back!to!the!proton!
and!the!acquisition,!encoding!the!proton!chemical!shift.!!
!
!
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Figure! 1.9.! 2D! [15N,1H]9HSQC!pulse! sequence!where! thin!bars! represents!90°!pulses!and! thick!bars!180°!
pulses.! The! dashed! blocks! represents! the! elements! added! to! HSQC! to! decouple! proton! and! nitrogen!
nuclei.!
!
!
During! the! first! INEPT! block,! the! equilibrium! Hz! magnetization! is! converted! to! transverse!
magnetization! 9Hy! by! a! proton! 90°! pulse.! The! 180°! pulse! in! the!middle! of! the!1 2!!" !time!
period!allows!evolution!of!the!one–bond!scalar!coupling!constant!between!the!two!nuclei!while!
preventing!proton!chemical!shift!evolution.!An!antiphase!1H!magnetization!with!respect!to!15N!is!
obtained! (9HxNz).!At! the!end!of! the! INEPT!block,! the! two! simultaneous!90°!pulses! transfer! the!
polarization!from!proton!to!nitrogen!to!obtain!an!antiphase!15N!magnetization!with!respect!to!1H!
(9HzNy).!Then,! the! 15N!magnetization!evolves!during! the! t1! time!period,!where! the!detection!of!
the!15N!resonance!frequencies!is!achieved!by!recording!a!series!of!experiments!incrementing!t1.!
Finally,! the!magnetization! is! converted!back! into! in9phase! 1H!magnetization! (9Hx)! by! a! reverse!
INEPT!block!and!the!1H!resonance!frequencies!are!recorded!during!the!acquisition!time!t2.!The!
proton!and!nitrogen!resonance!frequencies!recorded!during!t1!and!t2!evolution!times!give!rise!to!
four! peaks! in! the! 2D! [15N,1H]9HSQC! NMR! spectrum! for! each! 1H915N! moiety! at! frequencies!!! ± !!!" 2!and! ! ± !!!" 2,!separated!in!each!dimension!by!the!one–bond!scalar!coupling!
constant!!!" ≈ 92! " !(Fig.! 1.10a).! In! order! to! simplify! the! 2D! [15N,1H]9HSQC! spectrum,! the!
heteronuclei! can! be! decoupled,! suppressing! the! evolution! of! the! one–bond! scalar! coupling!
constant! during! t1! and! t2.! The! decoupling! of! proton! during! 15N! evolution! is! achieved! by!
application!of!a!180°!proton!pulse!in!the!middle!of!the!evolution!period!that!refocuses!the!!!"!
coupling,!and!the!decoupling!of!15N!during!proton!acquisition!is!achieved!by!applying!a!series!of!
15N!pulses!continuously!inverting!the!direction!of!the!spin!(Fig!1.9,!dashed!elements).!Thus,!the!
NMR!spectrum!displays!a!single!resonance!for!each!1H915N!moiety!at!the!resonance!frequency!of!
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the!proton! !,!in!the!direct!dimension,!and!nitrogen! !,!in!the!indirect!dimension!(Fig.!1.10b).!
In!general,!the!HSQC!is!run!in!decoupled!mode,!unless!measurement!of!!!"!is!desired.!
!
!
!
!
Figure! 1.10.! Schematic! HSQC! spectra;! adapted! from! Pascal,! S.! M.[49]! a)! Zoom! of! a! 2D! [15N,1H]9HSQC!
spectrum! of! protein! on! a! region! showing! peaks! arising! from! two! 1H915N! moieties! of! resonances!
frequencies! !!,!,!!,! !and! !!,!,!!,! .! The! dashed! box! contains! peaks! arising! form! one! amino! acid.!
The!TROSY!peak!described! in! the! following!section! is!highlighted! in! red.!b)!2D!decoupled9[15N,1H]9HSQC!
spectrum!on!the!same!system!than!a).!!
!
In! protein! studies,! 2D! [15N,1H]9HSQC! is! one! of! the! simplest! and!more! useful! two9dimensional!
pulse!sequence.!Each!amino!acid!except!proline!contains!an!amide!proton!bound!to!a!nitrogen.!
Thus,!the!2D![15N,1H]9HSQC!spectrum!displays!a!peak!for!each!amino!acid,!providing!a!fingerprint!
of! the!protein.! In!addition,! it!also!contains!peaks!corresponding! to! the!NH2!groups!of! the!side!
chains!of!asparagine!and!glutamine!and!the!indole!moieties!of!tryptophan,!appearing!in!specific!
regions! of! the! spectrum.! Indeed,! each! 1H915N! moiety! display! a! characteristic! chemical! shift,!
containing! a! random! chemical! shift! part,! specific! for! each! amino! acid[50],! and! a! secondary!
chemical! shift! dependent! on! the! protein! structure.! Thus,! 2D! [15N,1H]9HSQC! spectra! provide!
information! on! the! protein! secondary! structure! elements!where! amino! acids! involved! in! a!β9
sheet!experience!downfield!shift!(higher!ppm!value)!compared!to!random!proton!chemical!shift!
value[51],!while! amino! acids! involved! in!α9helix! experience! upfield! shift[52].! Residues! located! in!
loops!or!unfolded!protein! regions!display! random!coil! chemical! shift! values,! typically!between!
7.5!and!8.5!ppm.!2D![15N,1H]9HSQC!experiments!are!broadly!used!to!characterize!protein!folding!
or!unfolding,!following!the!proton!chemical!shift!changes!of!the!residues!away!from!or!towards!
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random! chemical! shift! as! well! as! protein! interactions,! following! chemical! shift! changes! upon!
titration!with!a!binding!partner.!!
!
Transverse!RelaxationCOptimized!Spectroscopy!(TROSY)!
HSQC!spectra!of!large!macromolecules!(>!10!kDa)!suffer!from!fast!transversal!relaxation!due!to!
the! longer!molecular!rotational!correlation!time!τc,! leading!to!poor!sensitivity! (Eq.!22).!At!high!
magnetic!field!strengths,!the!major!sources!of!relaxation!in!the!amide!moiety!are!chemical!shift!
anisotropy!(CSA)!and!dipolar!interactions.!Dipolar!interaction!to!remote!protons!can!be!reduced!
by!complete!or!partial!deuteration!of! the!proteins.!To! further! reduce!T2! relaxation,! transverse!
relaxation9optimized! spectroscopy! (TROSY)! uses! constructive! interference! between! the! N–H!
dipolar!interactions!and!the!15N!CSA[13,!53].! In!a!sample,!the!direction!of!the!z9component!of!the!
local!magnetic!field!caused!by!dipolar! interaction! is!either!positive!or!negative! if! the!two!spins!
involved!in!the!interaction!are!in!a!parallel!or!antiparallel!orientation!respectively.!On!the!other!
hand,! the! direction! of! the! z! component! of! the! local!magnetic! field! caused! by! CSA! is! positive,!
irrespectively!of!the!spins!orientation.!Thus,!these!two!local!magnetic!fields!partially!cancel!in!an!
antiparallel! orientation! of! the! spins.! In! a! non9decoupled! 2D! [15N,1H]9HSQC! spectrum,! this!
orientation! corresponds! to! the! peak! located! at! the! bottom! right! position! of! the! 1H–15N!
quadruplet!(highlighted! in!red! in!Fig.!1.10a).!The!TROSY!experiment!selects!this!TROSY!peak!to!
become! the! only! one! to! be! displayed! in! the! NMR! spectrum,! extending! the! size! limitation! of!
proteins!above!1!MDa!in!functional!studies[17,!54956].!!!
3D!NOESYCTROSY!experiment!!
The! above! described!HSQC!or!HMQC!pulse! sequences! as!well! as! their! TROSY! versions! can! be!
further!combined!with!hetero9!or!homonuclear!pulse!sequences!towards!heteronuclear9edited!
NMR! experiments[57,! 58].! Such! experiments! yield! additional! information! on! proteins,! such! as!
relaxation! parameters,! distances! or!!9correlations! between! amino! acids.! The! heteronuclear9
edited!3D!NOESY9HSQC[8]!(or!HMQC)!experiment!is!highly!useful!to!facilitate!assignments!of!the!
[1H–1H]!NOE!cross!peaks!even!in!crowded!spectral!regions!by!adding!an!indirect!dimension.!The!
heteronuclear9edited! 3D! [1H,1H]9NOESY915N9TROSY! consists! of! a! two9dimensional! nuclear!
Overhauser! enhancement! spectroscopy! (NOESY)! experiment[59,! 60]! combined! with! a! TROSY!
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version!of!the!HSQC!pulse!sequence.!The!NOESY!experiment!correlates!protons!that!are!close!in!
space.!Its!pulse!sequence!(Fig.!1.11a)!is!composed!of!a!first!90°9t1990°!block!that!encodes!the!1H!
resonance!frequencies!and!returns!the!magnetization!to!the!z9axis.!Then,!the!z9magnetization!is!
transferred!by!the!NOE!effect!to!all!dipolar!coupled!protons!during!a!defined!mixing!time! !! .!
Finally,! the! magnetization! is! converted! into! a! detectable! in9phase! 1H!magnetization! by! a! 90°!
pulse!and!the!1H!resonance!frequencies!are!recorded!during!the!acquisition!time!t2!(Fig.!1.11b).!!
!
!
!
!
Figure! 1.11.! NOESY! experiment;! adapted! from! Higman,! V.! A.[61].! a)! 2D! [1H,1H]9NOESY! pulse! sequence!
where! thin! bars! represents! 90°! pulses.! b)! Polarization! transfer! during! a! 2D! [1H,1H]9NOESY! experiment!
where!the!resonance!frequencies!of!the!protons,!highlighted!in!green,!are!encoded!during!the!90°9t1990°!
and!acquisition!block!(highlighted!in!green)!and!the!magnetization!transfer!represented!by!orange!arrows!
is!happening!during!the!mixing!period!highlighted!in!orange!on!the!corresponding!pulse!sequence.!
!
!
Thus!for!each!proton! !,!the!2D![1H,1H]9NOESY!spectrum!contains!a!diagonal!peak!at!frequency!!!!!,!!! !and!n!cross!peaks!at!frequencies! !!!!,!!!" !arising!from!the!interaction!of! ! !with!
its!n!dipolar!coupled!protons.!The!NOE!cross!peaks!can!be!negative!or!positive!according!to!the!
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molecular! size! (Fig.! 1.8)! and! their! intensities,! which! are! proportional! to! the! dipolar! cross9
correlation!rate!constants!!!!!!",!contain!distance!information!between!the!two!coupled!spins,!!!!!!" !(Eq.!20).!Thus,! intra9!and! inter9proton!distances!can!be!approximated,! from!a! reference!
distance!!!"#!known!by!covalent!geometry,!using!Eq.!25!where!!!"#!and!!!!!!" !are!the!integrated!
cross!peak!intensities.!!
!!!!!" = !!"# !!"#!!!!!" !!!(25)!
Importantly,! the! quantitative! conversion! of! NOE! cross! peaks! into! interspin! distances! benefits!
from! the! use! of! short! mixing! times! that! avoid! spin! diffusion! effects.! Indeed,! for! long! mixing!
times,! the! magnetization! transferred! between! two! spins! is! further! relayed! to! other! nuclei,!
modifying! the! intensity–distance! correlation.! Importantly,! the! conversion! of! NOE! cross! peaks!
into!interspin!distances!can!be!performed!correctly!only!for!a!single!structural!conformation.!In!a!
dynamic!ensemble,!the!NOE!cross!peaks!will!contain!contributions!from!different!conformations,!
thus!prohibiting!their!quantitative!use.!!
In! the! 3D! [1H,1H]9NOESY915N9TROSY! pulse! sequence,! the!magnetization! transferred! by! dipolar!
coupling!between!1H!spins!is!then!going!through!the!HSQC!pulse!sequence!(Fig!1.9),!where!it!is!
transferred!to!15N9bound!nuclei!by!an!INEPT!element!through!scalar!coupling!to!encode!the!15N!
resonance! frequency! and! brought! back! to! the! bound! proton! for! detection.! The! 3D! [1H,1H]9
NOESY915N9TROSY!spectrum!thus!displays!for!each!amide!proton! ! !a!diagonal!peak!at!frequency!!!!!,!!! ,!!! ,!where! !! !is!the!resonance!frequency!of!the!15!! !nucleus!of!the!1!!915!! !amide!
group,! and! n! cross! peaks! at! frequencies! !!!" ,!!! ,!!!! !corresponding! to! the! interaction! of!
the!1!!915!! !amide!group!with! its!n!dipolar!coupled!protons.! In!order!to!obtain! information!on!
protein!side!chains,!the!15N!heteronucleus!can!be!substituted!by!13C!and!the!spectrum!obtain!will!
display! cross! peaks! between! protons! and! 13C! bound! protons.! Besides! providing! distance!
measurements!between!dipolar! coupled!protons,! the!3D! [1H,1H]9NOESY915N9TROSY!experiment!
is!commonly!used!for!protein!assignment,!where!NOE!cross9peaks!are!observed!between!amide!
protons! (!!)! and! neighboring! protons! with! sufficiently! short! 1H91H! distance[41].! Indeed,! cross!
peaks!can!often!be!observed!between! !!of!residues!i!and!i±1.!As!well,!cross!peaks!between! ! !
and!!! !can! often! be! observed! between! residues! i! and! i+3! or! i+4! in! α9helical! secondary!
structures,!as!well!as!between!residues!i!and!the!facing!residue!in!β9sheets!and!i!and!i+2!in!tight!
turns.!However,!the!increasing!number!of!amide!moieties!in!large!molecules!can!lead!to!strong!
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chemical! shift! overlap! preventing! sequential! assignment! of! protein! backbone! residues! and!
alternative!strategies!have!to!be!applied.!
!
!
The!HNCACB!as! an!Example!of! TripleCresonance!Experiments! for!Protein!
Assignment!
As! a! method! for! sequential! resonance! assignment,! a! large! number! of! three9! and! four9
dimensional!heteronuclear! triple9resonance!experiments!correlating!backbone!1!!,! 15!,! 1!!,!,!
13!!,! !and!13!!!nuclei!using!scalar!coupling!have!been!developed[9,!10].!Some!are!based!on!15!–
13!!!transfer,! connecting! the! amide! group! of! residue! i! to! 13!!!of! residue! i91! as! such! as! the!
HNCO[62]!or!involve!15!–13!!,! !transfer!between!the!amide!group!and!13!!,! !of!residue!i!and!i91!
such!as! the!HNCA!or! the!HNCACB[8].! In! standard!nomenclature,! the!name!of! an!experiment! is!
formed! by! the! nuclei! involved! in! the! coherence! transfer! in! the! order! following! the! transfer!
pathway!from!the!proton.!Nuclei!are!given!in!brackets!if!their!chemical!shifts!do!not!evolve.!!
The! HNCACB! experiment! (Fig.! 1.12),! is! a! very! useful! triple9resonance! experiment! for! protein!
assignment!as!it!provides!sequential!information,!connecting!the!1N–15H!moieties!of!residue!i!to!
13!! !and! 13!! !of! residues! i! and! i91.! The! HNCACB! experiment! consists! of! an! INEPT! block!
transferring! the! magnetization! from! 1!! !to! the! scalar! coupled! nucleus! 15! !via! 1!!" .! Using!
another!INEPT!block,!the!magnetization!is!then!transferred!from!15!!to!13!! !via!2!!!!.!Then,!part!
of!the!magnetization!is!transferred!on!13!! !using!an!INEPT!block!followed!by!an!evolution!period!
where! the! 13!!,! !resonance! frequencies! are! encoded! by! t1! increments.! The! magnetization! is!
transferred! back! to! 13!! !and! then! to! 15! !using! reverse! INEPTs! where! the! 15! !resonance!
frequency!is!recorded!during!the!time!period!t2.!Finally,!magnetization!is!transferred!back!to!the!
scalar! coupled! amide! proton! for! detection! during! the! acquisition! time! t3! (Fig.! 1.12a).! The!
resulting!3D!HNCACB!spectrum!features!for!each!1N–15H!amide!moiety!up!to!four!cross!peaks!at!
positions! !!!,! ,!!!,! ,!!! ,! !!!,! ,!!!,! ,!!! ,! !!!,!!! ,!!!,! ,!!! !and! !!!,!!! ,!!!,! ,!!! !
(Fig!1.12b).!As!each!spectral!strip!displays!the!13!! !and!13!! !chemical!shifts!of!residues!i!and!i91,!
multiple! strips! can! be! linked! together! allowing! sequential! connection! of! amino! acids! (dashed!
lines!on!Fig.!1.12b).!In!addition,!characteristic!13!! !and!13!! !chemical!shifts!of!alanine,!threonine,!
serine!and!glycine!residues!allow!their! identification! form!the!HNCACB!strips.!This! information!
coupled!with!the!alignment!of!sequentially!connected!spin!systems!with!the!known!amino!acid!
sequence!thus!allows!unambiguous!sequential!assignment.!
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Figure! 1.12.! HNCACB! experiment,! adapted! from! Higman,! V.! A.[61].! a)! Polarization! transfer! during! a! 3D!
HNCACB!pulse!sequence!b)!Schematic!strips!of!1N915H!amide!moieties!of!a!3D!HNCACB!spectrum,!where!
the!cross!peaks!of! the!amide!moiety!with! 13!!!are!displayed! in!blue!and! 13!!!in!green.!The! less! intense!
cross!peaks!with!nuclei!of!residue!i91!are!represented!with!smaller!circles.!The!dashed!lines!represent!the!
sequence!connectivity!between!the!stripes.!The!three!last!strips!contain!the!typical!13!!!and!13!!!chemical!
shifts!of!alanine,!serine!and!glycine.!!
!
!
!
!
!
!
!
!
!
!
!
Chapter!1! Nuclear!Magnetic!Resonance!Spectroscopy!!
27!
!
!
!
!
!
1.4 Dissolution!Dynamic!Nuclear!Polarization!NMR!
Spectroscopy!
Despite!the!powerful!information!provided!by!NMR!spectroscopy,!the!technique!suffers!from!a!
limited!sensitivity,!narrowing!its!application!to!samples!with!high!concentration!of!active!nuclei!
and!requiring!labeling!strategies!for!biomolecular!application.!The!thermal!polarization!of!nuclei!
is! very! low! and,! even! when! using! the! highest! available! external! magnetic! fields,! can! not! go!
greater! than! 0.01! percent.! However,! the! sensitivity! of! NMR! spectroscopy! has! dramatically!
increased!since!its!discovery!by!Bloch!et#al.[1]!and!Purcell!et#al.[2]! in!1946,!through!instrumental!
innovations!as!well!as!methodological!developments!such!as!Fourier!transformation[3],!improved!
polarization! transfer!schemes[48]!and! is!now!broadly!used!to!study!biomolecules.!An!additional!
approach! to! increase! NMR! sensitivity! is! the! use! of! hyperpolarization,! producing! a! spin!
population!difference!greater!than!the!one!obtained!at!thermal!Boltzmann!equilibrium.!Several!
hyperpolarization!techniques!have!been!developed!such!as!para9hydrogen!induced!polarization!
(PHIP)[63],! optical! pumping[64]! and! dynamic! nuclear! polarization! (DNP)[65],! each! of! which! can!
increase! the! NMR! sensitivity! by! several! orders! of! magnitude.! PHIP! generates! hyperpolarized!
states!by!particular!chemical!addition!reactions,!while!optical!pumping!is!limited!to!certain!noble!
gases.!DNP!however!can!be!applied!to!any!sample!containing!molecules!with!unpaired!electron,!
broadening! its! use! to! a! large! range! of! biological! systems.! DNP! was! first! discovered! by!
Overhauser!in!1953[38]!and!was!soon!experimentally!applied!in!conducting!solid!metals!by!Carver!
and! Slichter[66],! then! later! in! solution[67].! DNP! is! achieved! by! applying! continuous! high9power!
microwave! irradiation! at! or! near! the! electron! Larmor! frequency! to! drive! polarization! transfer!
from!the!large!electron!spin!polarization!to!the!nuclear!system[65].!DNP!application!to!solid!state!
NMR! spectroscopy! was! developed! in! the! eighties[68,! 69]! and! expanded! to! a! large! range! of!
biological! systems! by! the! development! of! improved! instrumentation,! such! as! high9power!
microwave!sources,!as!well!as!by!chemical!advancements!with!the!development!of!biradicals!as!
electron! source.! Besides! its! application! to! solid! systems,! dissolution! DNP! was! developed,! for!
applications! in! solution! first! for! in# vivo! MRI! purposes[18,! 70].! Dissolution! DNP! enables! close! to!
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complete! polarization! of! organic! molecules! in! a! liquid! solution! allowing! tracing! of! a!
hyperpolarized! marker# in# vivo! and! its! metabolic! products.! Dissolution! DNP! was! successfully!
applied! to! systems! in# vitro,! in! combination!with! the! use! high9resolution! NMR! spectrometers,!
were! the!metabolisms!of! several! cell! systems,! such!as!E.# coli! or!S.# cerevisiae!were! followed! in!
real!time[19923].!
!
!
Principle!of!Dynamic!Nuclear!Polarization!
The! sensitivity! of! an! NMR! experiment! is! proportional! to! the! equilibrium! polarization,! the!
population! difference! between! the! basic! energy! states,! described! in! Eq.! 4! for! a! spin! ½! in! an!
external! magnetic! field.! Proton! spin! polarization! in! a! static! magnetic! field! of! 800! MHz! at!
temperature!near!273!K!is!about!1.28 ∙ 10!!,!and!this!polarization!can!be!significantly!increased!
by!lowering!the!temperature!or! increasing!the!magnetic!field!strength.!Furthermore!spins!with!
high!gyromagnetic!ratio!have! increased!polarization,!such!as!the!electron!spin!!! !that!features,!
compared! to! nuclear! spin!!!,! a! signal! enhancement! of! the! order! of! !!! !! !corresponding! to! a!
factor!660!for!1H!and!2600!for!13C.!Furthermore,!by!decreasing!temperature!to!1!K,!the!electron!
spin!virtually!reaches!its!maximum!polarization!!!~1.!The!DNP!principle!consists!of!transferring!
this! high! electron! spin! polarization! to! the! nuclear! spins! at! low! temperature.! This! polarization!
transfer!can!occur!through!two!different!mechanisms:!the!solid!effect!and!the!thermal!mixing[65].!
The!solid!effect[71]!is!happening!in!a!system!where!electrons!are!diluted!(<!1!mM)!in!an!abundant!
nuclear! spin! matrix,! leading! to! a! one9to9one! electron–nucleus! dipole–dipole! interaction.! The!
transfer! of! the! electron! spin! polarization! to! the! dipolar! coupled! nucleus! I! is! induced! by!
microwave! irradiation! at! frequency!! = !! ± !! !where!!! !is! the! electron! spin! resonance!
frequency! and! !! !the! nuclear! spin! resonance! frequency! (Fig.! 1.13).! These! transitions,!
corresponding!to!the!W0!and!W2!transitions!described!for!two!dipolar!coupled!nuclear!spins!(Fig!
1.7),! are! followed!by!electron! relaxation!!!!,!bringing!back! the!electron! spin! to! its!equilibrium!
state,! thus! leading! to! high! polarization! PI! of! the! nucleus.! The! nuclear! polarization! decay,!
described!by!the! longitudinal!spin!relaxation!!!! !of! the!nucleus,! typically!happens!on!the!order!
of!an!hour.!
In!a!sample!containing!higher!than!~1!mM!radical!concentration,!the!thermal!mixing!effect[72]!is!
predominant.!There,!the!ensemble!of!electrons!and!nuclear!spins!behave!like!energy!reservoirs!
and!can!be!described!using!a!thermodynamic!model[73].!The!application!of!microwave!irradiation!
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to! the! system! cools! down! the! electron! reservoir! to! a! temperature!!!.! Thus,! the! nuclear! spin!
reservoir! tends! to! equilibrate! his! temperature! by! thermal! contact! to! the! electron! reservoir!
temperature!and!the!final!nuclear!polarization!is!given!by!Eq.!4!where!the!sample!temperature!is!
replaced!by!!!.!!
!
!
!
!
Figure!1.13.!Solid!effect!in!a!system!composed!of!one!nuclear!spin!½!and!one!electron!spin;!adapted!from!
Bornet,!A.!et!al.[74]!a)!Electron9spin!dipolar!coupled!energy! levels.!The!red!balls!represent!the!amount!of!
spins! in! each! level.! b)! Microwave! of! energy!!! − !! !applied! to! electron9spin! dipolar! coupled! energy!
levels,!leading!to!the!transfer!of!spin!electron!polarization!to!nuclear!spin!polarization!(highlighted!in!red).!
The!red!balls!represent!the!amount!of!spins!in!each!level.!PI!corresponds!to!the!nuclear!spin!polarization!
obtained.!
!
!
Dissolution!dynamic!nuclear!polarization!NMR!spectroscopy!
Application! of! DNP! in! solution,! by! transferring! electron! polarization! to! organic!molecules! in! a!
liquid! solution! was! first! desribed! by! Arednkjaer9Larsen! et# al.! in! 2003[18].! ! Typically,! the!
hyperpolarization!is!generated!at!temperatures!between!1!and!4.2!K!and!at!high!static!magnetic!
fields!of!e.g.!3.4!T[18,!75].!The!hyperpolarized!samples!are!glass9forming!solutions!containing!the!
target!molecule!as!well!as!an!organic!stable!free!radical.!As!dissolution!DNP!relies!on!the!thermal!
mixing!effect,!radicals,!such!as!TEMPO,!are!used!to!fulfill!the!DNP!conditions.!Subsequently,!the!
hyperpolarized!sample!is!rapidly!dissolved!by!a!burst!of!hot!D2O!vapor!to!obtain!a!dilute!solution!
at! room! temperature! while! preserving! the! enhanced! nuclear! spin! polarization.! This!
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hyperpolarized! solution! can! be! transferred! to! a! high9resolution! NMR! spectrometer.! The!
polarization!enhancements!of!the!dissolved!samples!can!increase!the!sensitivity!of!certain!NMR!
experiments!up!to!10,000!fold[18].!However,!the!dissolution!DNP!method!is!limited!by!the!short!
lifetime!of!the!hyperpolarization!in!solution,!of!the!order!of!!!.!Thus,!high!sensitive!protons!with!
short!!!!values!are!difficult!to!detect!and!low9γ!nuclei!like!13C!are!favored.!In!addition,!the!length!
of!the!measurement!window!is!limited,!allowing!detection!of!fast!processes!only.!However,!the!
development! of! new! polarization! transfer! schemes[76],! progress! in! radical! design! as! well! as!
hyperpolarized! molecules! exhibiting! longer! lifetime[77]! could! partially! overcome! this! issue.!
Hence,! dissolution!DNP,! by! increasing! the! sensitivity! of!molecular! probes! of! several! orders! of!
magnitude[78980],!opens!a!broad!range!of!in#vitro!applications!such!as!metabolic!cells!studies[19923].!
! !
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$
2.1 Introduction$
!
A(molecular(chaperone(is(a(protein(necessary(for(the(correct(fold(and(assembly(of(a(polypeptide(
substrate,(but( it( is(not(part(of( the( final( stable(and( functional( fold[1].(Molecular(chaperones(are(
found(in(all(cell(compartments(where(they( interact(with(unfolded(polypeptide(chains,(ensuring(
their(correct(folding(and(transport[2].(They(assist(a(large(variety(of(protein(maturation(processes(
in( an( ATPGdependent( or( independent( manner( and( can( be( classified( in( different( functional(
groups[3].( Chaperones( assist( translocation( of( unfolded( polypeptide( across( cell( membranes(
(translocases),(transport(of(substrates(to(prevent(misfolding((holdases),(insertion(of(proteins(into(
a( membrane( in( a( functional( state( (insertases),( and( support( the( folding( of( soluble( proteins(
(foldases).(Despite(their(common(functionality,(chaperones(share(little(sequence(specificity(but(
often( act( on( a( broad( range( of( substrates.( These( substrate( interactions( happen( in( a( highly(
dynamic( manner( due( to( the( inherent( disordered( nature( of( the( unfolded( and( partially( folded(
polypeptide(substrates.(Although(XGray(elucidated(a(number(of(chaperone(structures(in(their(apo(
form,( the( flexibility( of( the( substrate( usually( prevents( its( use( to( obtain( information( on( their(
bound( state.( NMR( spectroscopy( is( a( powerful( technique( to( provide( structural( information( of(
transient( and( dynamic( protein–protein( interactions( at( atomic( resolution[4,( 5].( Different( NMR(
techniques( have( successfully( been( employed( for( characterizing( structures( of( chaperones( and(
chaperoneGprotein( complexes.(Chemical( shift(perturbation( (CSP)(was( successfully(employed( to(
characterize(substrates(bound(to(the(chaperone(GroEL(and(GroEL/ES(complex[6G8],(Hsp90[9,(10](and(
Hsp70[11],(where(the(interaction(surface(was(mapped(for(a(classical(protein–substrate(interaction(
where( the( chaperone( recognizes( a( certain( segment( of( the( substrate( and( binds( it( in( a( single(
defined( conformation.( The( nuclear( Overhauser( effect( (NOE),( providing( information( on( atomic(
distances,( was( successfully( applied( to( characterize( intraG( and( interGmolecular( contacts( in(
complexes(and(allowed(solving(chaperone–substrate(structures,(among(which(Trigger(Factor[12].(
Paramagnetic( relaxation(enhancement( (PRE)(was(used( to(measure( intermolecular( distances( in(
classical( chaperone–substrate( complexes( as( Hsp90[9,( 13]( as( well( as( in( a( dynamic( conformation(
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ensemble( as( the( SkpGOmp( complex[14].( Furthermore,( several( other( NMR( techniques( such( as(
hydrogen/deuterium( exchange[15,( 16]( or( spin( relaxation[14]( brought( essential( information( on( a(
broad(range(of(chaperone–substrate(complexes.((
Among( the( large( number( of( chaperone–substrate( complexes( in( the( cell,( this(work( focuses( on(
further( investigation( of( the( periplasmic( chaperones( of( E.# coli,( the( outer( membrane( protein(
(OMP)(holdases(Skp(and(SurA,(for(which(the(molecular(basis(and(the(functional(details(of(their(
mechanism( at( the( atomic( level( remains( only( partly( understood.( Previous( NMR( interaction(
studies( of( Skp( with( its( OMP( substrate( revealed( that( the( unfolded( polypeptide( binds( the(
chaperone( in( a( compact( ensemble( of( rapidly( interconverting( conformations( devoid( of( regular(
secondary(structure(elements,( the(“fluid(globule”[14],(providing( for( the( first( time(structural(and(
dynamic( information( at( the( atomic( level( of( the( chaperone:substrate( interplay.( Furthermore,(
NMR( studies( of( substrates( bound( to( the( SurA( chaperone( indicate( that( the( outer( membrane(
protein( A( (OmpA)( interacts( in( a( similar( fluidic( conformation( state( ensemble[14],( pointing( to( a(
general( fluid( globuleGlike( state( for( the( OMP(within( the( chaperone.( The( understanding( of( this(
energyGindependent(chaperoneGassisted(transport(and(delivery(mechanism(at(the(atomic(level(is(
fundamental( as( they(play(an(essential( role( in( the( cell,( preventing(aggregation(of( the(unfolded(
OMP(during( transport( from( the( inner(membrane( (IM)( to( the(outer(membrane( (OM)(of(GramG
negative(bacteria.(In(E.#coli,(OMPs,(located(in(the(lipidic(OM,(display(βGbarrel(structure(consisting(
of(antiparallel(amphipathic(βGstrands[17].(They(are(synthesized(in(the(cytoplasm(by(the(ribosome,(
as( precursors( with( NGterminal( signal( sequence,( required( for( translocation( across( the( inner(
membrane.( These( precursors( are( initially( bound( by( the( chaperone( trigger( factor( and(
subsequently(handed(over(to(the(chaperone(secretoryGtranslocase(B((SecB),(which(prevent(their(
aggregation( during( their( transport( through( the( cytoplasm[18].( The( NGterminal( signal( sequence(
target( the( OMP( precursor( to( the( Sec( machinery,( embedded( in( the( inner( membrane,( for( its(
translocation( across( the( membrane( into( the( periplasm( where( the( signal( sequence( is( cleaved(
off[18,(19].(There,(the(nascent(OMPs(are(accessible(to(the(periplasmic(chaperones(Skp((seventeen(
kilodalton( protein),( DegP( and( SurA( (survival( factor( A),( ensuring( their( transport( to( the( outer(
membrane( and( their( delivery( to( the( βGbarrel( assembly( machinery( (Bam( complex).( The( main(
component( of( the( Bam( complex,( BamA( is( composed( of( a( sixteenGstranded( βGbarrel( and( five(
periplasmic(polypeptide( transport(associated( (POTRA)(domains.(The(Bam(complex(ensures( the(
insertion(of( the(OMPs( into(the(OM((Fig.(2.1)[20].(The(exact( roles(of( the(periplasmic(chaperones(
are( not( yet( clear,( as( individual( knockouts( of( these( proteins( do( not( show( lethal( phenotypes.(
Lethality(was(however(observed(in(cells(lacking(both(Skp(and(SurA(as(well(as(DegP(and(SurA,(but(
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not(DegP(and(Skp[21].(These(data(suggest(a(parallel(pathway(where(SurA(may(act(as(the(primary(
periplasmic( chaperone( and( the( Skp/DegP( path( as( an( alternative( rescue( for( off–pathway(OMP(
polypeptides[22].((
(
(
$
Figure$ 2.1.( Schematic( representation(of( the(OMP(biogenesis( in(E.# coli# [23](where( the(OMP( is(depicted( in(
red.(
(
(
In(this(chapter,(the(interaction(between(the(Skp(chaperone(and(its(OMP(substrate(characterized(
at(atomic( resolution( (section(2.2)(as(well( as( the( investigation(of( the( interaction(between(SurA(
and(POTRA(domains( (section(2.3)( allowed( to( take(a( step( forward( in( the(understanding(of( this(
essential(chaperone(mechanism.(! (
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Structural Mapping of a Chaperone–Substrate Interaction Surface**
Morgane Callon, Bjçrn M. Burmann, and Sebastian Hiller*
Abstract: NMR spectroscopy is used to detect site-specific
intermolecular short-range contacts in a membrane–protein–
chaperone complex. This is achieved by an “orthogonal”
isotope-labeling scheme that permits the unambiguous detec-
tion of intermolecular NOEs between the well-folded chaper-
one and the unfolded substrate ensemble. The residues
involved in these contacts are part of the chaperone–substrate
contact interface. The approach is demonstrated for the 70 kDa
bacterial Skp-tOmpA complex.
Molecular chaperones play an essential role in the biogen-
esis of proteins in all kingdoms of life.[1,2] As a general mode
of function, they interact with unfolded protein substrates,
prohibiting their progression on non-native aggregation
pathways.[3] Still, the molecular basis of chaperone–substrate
interactions is not well understood at the atomic level.
NMR spectroscopy is a powerful technique to provide
structural information of transient and dynamic protein–
protein interactions at atomic resolution.[4,5] It has been
successfully employed for the direct observation of substrates
bound to the chaperones GroEL,[6–10] Hsp90,[11–13] Hsp70,[14]
and Skp.[15,16] Furthermore, long-range spatial correlations
between substrates and chaperones have been detected for
Skp,[16] Hsp90,[11] and GroEL[10] by the use of paramagnetic
relaxation enhancement (PRE). However, for a full descrip-
tion of the molecular interactions, the identification of direct
contact interfaces in the unperturbed chaperone–substrate
complex is necessary. Thereby, chemical shift perturbations
do not necessarily yield the true interaction surface, because
they are ensemble averages of the dynamic systems and can
contain significant contributions of allosteric effects. Addi-
tional experimental approaches are thus required.
Herein, we use the nuclear Overhauser effect (NOE) to
detect site-specific intermolecular short-range contacts in
a membrane-protein–chaperone complex. We measure these
contacts in the 70 kDa complex of the chaperone Skp with its
bound substrate tOmpA. Skp is a homotrimeric, 51 kDa
chaperone from the Gram-negative bacterium Escherichia
coli (E. coli) that prevents outer membrane proteins from
aggregation during their transport across the periplasm.[17,18]
Its apo-form features three long a-helical “arms” forming
a central cavity.[19] The 19 kDa transmembrane domain of the
outer membrane protein A, tOmpA, is a natural substrate of
Skp.[20] Previous solution NMR studies have shown that
tOmpA and the alternative substrate OmpX, when bound to
Skp, adopt the conformational state of a “fluid globule”,
a compacted ensemble of rapidly interconverting conforma-
tions devoid of regular secondary structure elements, but with
non-random backbone dynamics.[16]
The interpretation of intermolecular cross-relaxation
events between the folded Skp and the unfolded tOmpA
has to consider that the 1H–1H cross-relaxation rate constant
sjk between a proton j on the chaperone and a proton k on the
substrate is an ensemble average (Supporting Information,
Figure 1), similar to intramolecular NOEs in unfolded protein
ensembles.[21–24] The amplitude of an NOE cross-peak
between spin j and k thus contains contributions from
different conformations of the structural ensemble, and
importantly, owing to the r!6 dependence of sjk, it is biased
by conformations with short interspin distances r. Further-
more, as the dynamic ensemble features a narrow chemical
shift dispersion, the observed cross-peaks in 3D NOESY
spectra are typically a superimposition of multiple substrate
spins with similar chemical shifts. These features generally
prohibit a quantitative conversion of NOESY cross-peak
amplitudes into interspin distances.
However, measurements of the NOE can be used to
identify those residues of the chaperone that feature a sig-
nificantly populated amount of conformations in close spatial
Figure 1. Random-coil-like averaging of tOmpA side chain conforma-
tions in the Skp-bound state. a) 2D [13C,1H]-HSQC spectrum of 200 mm
[U-2H,15N, Ile-d1-13CH3, Leu,Val-
13CH3]-tOmpA in NMR buffer with 8m
urea at 37 8C. The number of detected and expected resonances for
each methyl moiety type are indicated. b) 2D [13C,1H]-HMQC spectrum
of 550 mm [U-2H,15N, Ile-d1-13CH3, Leu,Val-
13CH3]-tOmpA in NMR
buffer with 150 mm DPC at 37 8C. c) 2D [13C,1H]-HMQC spectrum of
560 mm [U-2H,15N, Ile-d1-13CH3, Leu,Val-
13CH3]-tOmpA bound to [U-
2H]-
Skp in NMR buffer at 37 8C.
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contact with spin probes in the substrate. These residues are
part of the chaperone–substrate contact surface. For mapping
of these residues, we use an “orthogonal” side-chain labeling
scheme, that is, a combination of amino acid side-chain
moieties with non-overlapping 1H chemical shift dispersion.
These are the methyl groups of isoleucine, leucine, and valine
for the unfolded substrate (ILV-tOmpA) and the methyl
groups of alanine residues for the chaperone (A-Skp), which
were introduced in 13CH3-labeled form on a deuterated
background using established techniques.[25,26] Formation of
the complex was accomplished by rapid dilution of purified,
denatured tOmpA into separately produced Skp solution and
subsequent buffer exchange. The integrity of the complex, its
homogeneous 3:1 Skp:tOmpA stoichiometry, and the folding
competence of tOmpA from the complex was assessed as
described previously.[16]
A set of 2D [13C,1H]-correlation spectra of ILV-labeled
tOmpA in three different preparational states serves as an
initial characterization of the substrate side chains (Figure 1).
In 8m urea aqueous solution, tOmpA adopts a fast exchang-
ing random-coil ensemble and accordingly, the ILV side chain
moieties feature narrow 1H and 13C chemical shift dispersions
of 0.22 ppm and 0.2–0.6 ppm, respectively (Figure 1a). In the
folded state of tOmpA in DPCmicelles, the protein populates
an 8-stranded b-barrel structure as the single, stable con-
formation. Therein, the ILV side chains are involved in
specific contacts, resulting in 1H and 13C chemical dispersions
about four times larger than in denaturant (Figure 1b).
Bound to the chaperone Skp, the methyl moieties of ILV-
tOmpA feature again narrow chemical shift dispersions,
closely resembling the random-coil spectrum and thus
indicating that the tOmpA side-chains in Skp lack a well-
defined structure (Figure 1c). The observation of a single set
of resonances confirms the presence of a conformational
ensemble in the fast exchange regime, that is, with individual
lifetimes below 1 ms, validating the use of an ensemble model
as the basis of the data interpretation.
The alanine CH3 resonances in Skp feature a large
dispersion, both in the apo and the holo form, in accordance
with the adoption of a well-defined secondary and tertiary
structure (Figure 2a). Intermolecular cross-peak amplitudes
were measured by 3D 13C-resolved [1H,1H]-NOESY experi-
ments. Importantly, the orthogonal side-chain labeling pat-
tern ensures the absence of spectral overlap between the
intermolecular cross-peaks and the strong diagonal peaks, as
well as between inter- and intramolecular cross-peaks (Fig-
ure 2b). The observation of a cross-peak in the isoleucine,
leucine, and valine 1H chemical shift range 0.55–0.9 ppm in
the holo- relative to the apo-spectrum can thus be directly
assigned to intermolecular NOE contacts between a specific
site on Skp and the ILV methyl spins in the tOmpA ensemble
(Figure 2c,d). The integration of alanine NOE cross-peaks
shows non-zero cross-peak amplitudes for residues A34, A75,
A78, and A86, all of which have their side-chains pointing into
the central part the Skp cavity (Supporting Information,
Table S1). Alanine residues located at the trimer interface, as
well as at the bottom of Skp, did not show a detectable NOE
to the spin probes in the substrate ensemble. The contact
surface mapping thus shows that tOmpA is bound in the
central part of the Skp cavity (Figure 3). Notably, these
intermolecular cross-peaks have the same sign as the diagonal
peaks, indicating an overall negative NOE for the ensemble
average and thus the existence of the slowmotion limit for the
chaperone–substrate contacts.[27,28] The local lifetimes of
segments of the substrate bound to the chaperone thus have
a lower limit of ti@w0
!1" 1 ns. A comparison to cross-peaks
with known intramolecular distances within Skp in the same
spectrum shows that the ensemble-averaged intensities cor-
respond to fully populated distances in the range 5–6 !
(Supporting Information, Table S2). Since the intermolecular
NOE peaks are a superposition of individual signals from up
to 45 spin probes in tOmpA, we estimate that, on average,
conformations with a given Skp–tOmpA 1H–1H spin pair in
close contact are populated by about 0.5–2%.
Figure 2. Measurement of intermolecular methyl–methyl NOEs
between Skp and tOmpA. a) 2D [13C,1H]-HMQC spectrum of 700 mm
[U-2H,15N, Met-13CH3, Ala-
13CH3]-Skp (A-Skp; light blue) in NMR buffer
at 37 8C. The sequence-specific resonance assignments are indicated.
b) Overlay of 1H projections of a 2D [13C,1H]-HMQC spectrum of
560 mm [U-2H,15N, Ile-d1-13CH3, Leu,Val-
13CH3]-tOmpA (ILV-tOmpA)
bound to [U-2H]-Skp in NMR buffer at 37 8C (purple) and of a 2D
[13C,1H]-HMQC spectra of 700 mm A-Skp in NMR buffer at 37 8C (blue).
c) 2D strips from 3D 13C-edited-[13C,1H]-NOESY spectra taken at the
positions of Ala 34 and Ala 80 of 700 mm A-Skp in its apo form (light
blue) and 250 mm A-Skp with bound ILV-tOmpA (holo form, dark blue)
in NMR buffer at 37 8C. Spectra were recorded with a NOESYmixing
time of 200 ms. The dashed horizontal lines indicate the 1H chemical
shift dispersion of ILV residues in tOmpA bound to Skp (0.55–
0.9 ppm). d) Overlay of a 1H projection of a 2D [13C,1H]-HMQC
spectrum of 560 mm ILV-tOmpA bound to Skp (purple) and 1D cross
sections from the 3D 13C-edited-[13C,1H]-NOESY spectra shown in (c),
taken at the position of Ala 34.
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Finally, we compare the result from the NOE-based
mapping with previous measurements of intermolecular
PREs from a paramagnetic spin label attached to OmpX
and detected on the individual amide moieties of Skp.[16]
Overall, the positions of the Omp substrate in the center of
the Skp cavity determined by the two different spin-inter-
action methods PRE and NOE are in excellent agreement
(Figure 3a). Importantly, however, the NOE mapping distin-
guishes residues A46 and A80, which are located in the Skp
arms at the mid-height of the cavity, but with their side-chains
pointing outside, from residues A34 and A78, which have
both close contacts to tOmpA. The PRE, in turn, is similar for
all four residues with G2-values in the range 70–130 s
!1. The
NOE-based contact interface mapping thus shows that the
helical arms of Skp do not twist from their canonical position
in the crystal structure and that they have a distinct substrate
interaction surface on their inside.
In summary, measurements of intermolecular NOE in
combination with a suitable orthogonal methyl group labeling
strategy enabled the structural mapping of the Skp–tOmpA
contact interface at the atomic level. Structurally meaningful
intermolecular NOEs in the slow motion
limit were detected in a folded–unfolded
protein–protein complex. In particular,
and compared to the long-ranged PREs,
the short-ranged NOEs allow the dis-
tinction of residues according to their
side-chain orientation. The approach can
be tailored to a system of interest by
suitable orthogonal combinations of
methyl-group side chains. For example,
methionine CH3 moieties with proton
signals from 1.95 to 2.25 ppm could be
readily integrated in the present setup.
Since methyl groups on a deuterated
background are highly sensitive and
since sequence-specific resonance
assignments are known for molecular
sizes larger than 150 kDa,[29,30] we esti-
mate that with 70 kDa, the size limita-
tion of the approach has not been
reached in the present study. The
approach thus opens new perspectives
for the investigation of molecular inter-
actions in protein biogenesis.
Experimental Section
Details on protein biochemistry, isotope label-
ing and NMR spectroscopy are given in the
Supporting Information. Sequence-specific
side-chain resonance assignments of apo-
and holo-Skp have been deposited to the
BMRB data base with accession codes 19733
and 19730, respectively.
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 Supplementary Figure 
 
 
 
 
Supplementary Figure 1. Conformational averaging of intermolecular NOEs in a chaperone–substrate complex. 
Schematic model of six conformations of a chaperone protein (blue) in complex with its unfolded substrate 
(purple) in fast chemical equilibrium. Eight protons H1–H8 are highlighted. For each substrate conformation, 
pairs of protons involved in short-range contacts, corresponding to strong intermolecular NOEs, are connected 
with dashed lines. 
  
 Supplementary Tables 
 
Supplementary Table 1. Integrals of intermolecular NOE cross-peak volumes between alanine methyl groups 
of Skp and ILV methyl groups in tOmpA  
Skp 
Residue Iapo (AU) Iholo (AU) Iholo–Iapo (AU) (Iholo–Iapo)/Iapo 
A1 no assignment 
A5 46'100 45'000 -1100 -0.02 
A17 no assignment 
A34 17'000 43'900 26'900 1.58 
A46 41'300 53'000 11'700 0.28 
A56 12'500 2'000 -10'500 -0.84 
A69 no assignment 
A75 8'000 39'400 31'400 3.93 
A78 2'900 21'000 18'100 6.24 
A80 14'200 4'300 -9'900 -0.70 
A86 1'400 26'300 24'900 17.79 
A103 44'000 37'000 -7'000 -0.16 
A108 * * * * 
A119 21'700 19'000 -2'700 -0.12 
A121 4'300 no assignment 
A123 30'000 52'400 22'400 0.75 
A134 17'500 12'100 -5'400 -0.31 
 
*: δH (A108) = 0.793 ppm. This resonance overlaps with the ILV methyl groups of tOmpA. Intermolecular 
cross-peaks between A108 and ILV-tOmpA are thus masked by the strong diagonal cross-peak of A108. 
 
Supplementary Table 2. Integrals of intramolecular NOE cross-peak volumes between protons with known 
distance in Skp. 
 
  Proton pair Iholo–Iapo (AU) 
Distance in  
crystal structure (Å) 
HN(K98) – Hβ(A96) 56’200 5.2 
 Supplementary Methods 
Protein biochemistry: Skp and tOmpA were expressed and purified as described.[1] In brief, Skp lacking its 
signal sequence and with cleavable N-terminal His6-tag was expressed in E.coli BL21 (λ DE3) cells and purified 
by Ni2+-affinity twice, in aqueous solution and in a 6M Gdm/HCl solution. The transmembrane domain of 
OmpA (residues 1–177; tOmpA) lacking its signal sequence was expressed in E.coli BL21 (λ DE3) cells. The 
inclusion body pellet was washed twice, solubilized in 6 M Gdm/HCl and rebuffered into 8 M urea solution, 
applied to a HiTrap Q HP column and rebuffered into 6 M Gdm/HCl solution. The Skp–tOmpA complex was 
assembled by adding an excess of denatured tOmpA to Skp in NMR buffer (25 mM MES, 150 mM NaCl, pH 
6.5) in a dropwise fashion under continuous stirring at room temperature. After centrifugation for 20 min at 
4000xg, the supernatant was concentrated by ultrafiltration. 
 
Isotope labeling: [U-2H,15N, Ile-δ1-13CH3, Leu,Val-13CH3]-tOmpA (ILV-tOmpA) was obtained by growing E. 
coli in D2O-based M9-minimal medium containing (15NH4)Cl and [U-2H,12C]-glucose as the sole nitrogen and 
carbon sources, respectively. 100 mg of 3-[2H], [13CH3]-ketoisovalerate and 75 mg of [2H], 3,3-[13CH3]-
ketobutyrate were added to the medium 1 h prior to induction.[2] [U-2H,15N, Met-13CH3, Ala-13CH3]-Skp (MA-
Skp) was obtained by growing E. coli in M9 minimal medium containing (15NH4)Cl, [U-2H,12C]-glucose, 2% of 
bioexpress rich medium (Cambridge Isotope Laboratories) and D2O. 100 mg of 2-[2H], 3-[13C] L-alanine and 
250 mg of [13CH3] methionine were added to the medium 1 h prior to induction.[3] Besides bioexpress, all 
isotopes were purchased from Sigma Aldrich. 
 
NMR spectroscopy: NMR spectra were recorded at 37°C for the Skp apo and holo forms on a Bruker AscendII-
700 spectrometer equipped with a cryogenic triple-resonance probe. The proton chemical shifts were referenced 
to internal DSS[4] and those for carbon-13 were indirectly referenced. The 2D [13C,1H]-HSQC of urea-denatured 
ILV-tOmpA was recorded in a total experiment time of 1 h 30 min. The 1H carrier was centered on the water 
resonance, the 13C carrier at 16.5 ppm. The interscan delay was set to 1 s. In the direct dimension, 2048 complex 
points were recorded in an acquisition time of 182 ms, multiplied with a 75°-shifted sine bell, zero-filled to 4096 
points and Fourier transformed. In the indirect dimension, 1024 complex points were measured with a maximal 
evolution time of 363 ms, multiplied with a 75°-shifted sine bell, zero-filled to 2048 points and Fourier 
transformed. The 2D [13C,1H]-HMQC were recorded in a total experiment time of 13 h for ILV-tOmpA in 
detergent micelles, in 20 h for ILV-tOmpA in Skp and in 6 h 30 min for Skp in its apo form. The 1H carrier was 
 centered on the water resonance, the 13C carrier at 20 ppm. The interscan delay was set to 1 s. In the direct 
dimension, 2048 complex points were recorded in an acquisition time of 182 ms, multiplied with a 75°-shifted 
sine bell, zero-filled to 4096 points and Fourier transformed. In the indirect dimension, 300 complex points were 
measured with a maximal evolution time of 49 ms, multiplied with a 75°-shifted sine bell, zero-filled to 1024 
points and Fourier transformed. The 3D [13C,1H]-NOESY were recorded in a total experiment time of 102 h for 
Skp in its apo form and in 87 h for Skp-tOmpA. The 1H carrier was centered on the water resonance, the 13C 
carrier at 17.5 ppm. The interscan delay was set to 0.97 s. In the direct dimension, 1024 complex points were 
recorded in an acquisition time of 91 ms, multiplied with a 75°-shifted sine bell, zero-filled to 2048 points and 
Fourier transformed. In the carbon indirect dimension, 130 complex points were measured with a maximal 
evolution time of 43 ms for Skp in its apo form (122 points and 36 ms for Skp-tOmpA), multiplied with a 75°-
shifted sine bell, zero-filled to 256 points and Fourier transformed. In the proton indirect dimension, 136 
complex points were measured with a maximal evolution time of 16 ms for Skp in its apo form (124 points and 
14 ms for Skp-tOmpA), multiplied with a 75°-shifted sine bell, zero-filled to 512 points for Skp in its apo form 
(256 points for Skp-tOmpA) and Fourier transformed. For all spectra polynomial baseline correction was applied 
in all dimensions.  
 
Data analysis: NMR data were processed using PROSA[5] and analyzed with CARA (cara.nmr.ch) and 
XEASY.[6] Alanine residues of Skp were assigned sequence-specifically from previously established 13Cβ 
assignments,[1] in combination with an analysis of 3D 15N-resolved-[1H,1H]-NOESY and 3D 13C-resolved-
[1H,1H]-NOESY spectra. NOESY spectra were integrated using XEASY.[6] Spectral intensities in 3D 13C-
resolved-[1H,1H]-NOESY spectra of apo and holo Skp were measured by integration at the 1H chemical shift 
position of ILV residues (0.55–0.9 ppm), using a cuboid integration volume in three dimensions, and resulting in 
the integrals Iapo and Iholo, respectively. Intermolecular NOE peaks with significant signal-to-noise ratio are 
detected, if (Iholo–Iapo)/Iapo > 1. 
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$
2.3 Atomic$Details$of$the$SurA–POTRA$
Interaction:$Insights$into$the$Delivery$
Mechanism$of$unfolded$Outer$Membrane$
Protein$to$the$Bam$Complex$
Abstract$
In(E.#coli,(the(periplasmic(chaperone(SurA(interacts(with(the(soluble(BamAGPOTRA(domains.(This(
interaction(plays(a(role( in(delivering(the(unfolded(OMP(to(the(Bam(complex(for( its( insertion( in(
the( OM,( as( part( of( OMP( biogenesis.( So( far,( no( structural( details( are( known( about( this(
interaction.(Here,(we(used(NMR(spectroscopy(to(determine(the(binding(site(between(SurA(and(
POTRA(in#vitro.(Different(constructs(were(tested(to(define(the(minimal(constructs(exhibiting(the(
SurA–POTRA( interaction( for( further( structural( characterization.( Using( a( chemical( shift(
perturbation( approach,( the( binding( site(was(mapped( on( the( first( domain( of( POTRA.(On( SurA,(
partial( sequenceGspecific( resonance( assignments( of( the( protein( were( established( to( map( the(
interaction(site.(The(assignments(indicate(an(interaction(with(POTRA(on(the(antiGparallel(βGsheet(
formed(by(βGstrands(located(at(the(beginning(and(at(the(end(of(the(NG(and(CGterminal(domains,(
respectively.( The( possible( role( of( arginine( 64,( located( within( the( α2( helix( of( POTRA1,( was(
investigated( revealing( a( potential( OMP( delivery( mechanism,( by( inducing( the( formation( of( a(
possible(OMP–specific(receiving(surface(on(POTRA1.(Based(on(our(findings,(a(mechanism(of(SurA(
interaction( with( POTRA( inducing( the( OMP( substrate( delivery( is( suggested,( where( the(
destabilization(induced(on(the(SurA(chaperone(and(hydrophobic(interactions(on(POTRA(are(the(
critical(features(of(the(process.((
(
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Introduction$
The(E.# coli( SurA( gene(was( first( discovered( in( a( screen(designed( to( identify( genes( required( for(
survival(of(E.# coli( during( stationary(phase[1G3].( Subsequently,( it(was( shown( to(be( located( in( the(
periplasm(and(assist( the( folding(of(OMP(polypeptides[4].( SurA( is(a(47(kDa(protein(belonging( to(
the( class( of( transport( chaperones( composed(of( four( domains:( the(NGterminal( domain( (N),( the(
peptidylGprolyl(isomerase(domain(1((PPIase1)(and(the(CGterminal(domain((C)(form(a(core(module(
while(the(peptidylGprolyl(isomerase(domain(2((PPIase2)(is(a(satellite(domain(linked(to(the(core(of(
the(protein(by(a(long(flexible(linker((Fig.(2.2a)[5].(The(chaperone(activity(of(SurA(is(carried(out(by(
the( NG( and( CGterminal( domains( alone,( the( two( PPIase( domains( being( dispensable( for( SurA(
function[6].(The(function(of(these(two(PPIase(domains(is(still(unclear,(as(only(PPIase2(domain(was(
shown( to( exhibit( peptidylGprolyl( isomerase( (PPIase)( activity.( It( was( suggested( that( the( first(
domain(can(be(a(selectivity(filter(for(unfolded(OMPs[7],(while(the(second(domain(could(act(as(a(
trap(to(close(the(substrate( inside(the(core(domain,(be(a(second(peptideGbinding(site(or(exhibit(
PPIase(activity[5].(The(NG(and(CGterminal(domains(bind(OMP(polypeptides(carrying(preferentially(
an(aromaticGpolarGaromaticGnonpolarGproline((ArGΠGArGnonΠGP)(motif.(The(ArGXGAr((where(X(can(
be( any( residue)( motif( is( found( with( high( frequency( in( OMP( sequences( suggesting( that( SurA(
selectively(recognize(these(specific(substrates[8].(This(selection(could(also(involve(the(side(chain(
orientation(along(two(faces(of(the(peptide,(consistent(with(the(βGstrand(secondary(structure(of(
the(OMP[9].(Atomic(details(on(the(interaction(of(these(selected(substrates(with(SurA(is(not(known(
but(the(crystal(structure(suggests(an(interaction(of(the(OMP(in(a(crevice(formed(by(the(NG(and(CG
terminal(domains[5,(7].(
The(delivery(of(the(OMPs(to(the(Bam(complex,(for(their(folding(in(the(OM(is(happening(through(
the( polypeptide( transport( associated( (POTRA)( domains[10].( POTRA( domains( are( NGterminal(
periplasmic( soluble( domains( of( BamA,( followed( by( the( βGbarrel( protein( at( the( CGterminus,(
assisting(the(refolding(of(the(unfolded(OMP(inside(the(OM.(They(are(present(in(all(Omp85(family(
proteins(essential(for(biogenesis(and(assist(polypeptide(transport[11].(The(crystal(structure(of(the(
soluble(BamAGPOTRAs( (Fig.(2.2b)[12]( shows(a( fishhook(shape(with( successive( individual(POTRAs(
rotated(in(a(right(handed(direction,(each(domain(sharing(low(sequence(similarities(but(a(similar(
fold(of(2(helices(and(3(βGstrands(ordered(as(β−α−α−β−β.( In(2010,(Topalova(et#al.(showed(that(
POTRA(domains( could(also(adopt( an(extended( conformation(by( SAXS,( that(may(bridge( the( IM(
and(the(OM(across(the(periplasm,(suggesting(an(additional(transport(pathway(for(the(unfolded(
OMP[13].(NMR(studies(of(POTRAGOMP(interaction(indicate(a(weak(binding(in(fast(exchange(on(the(
NMR( timescale( (>( 1ms)( located( on( the( first( βGstrand( of( POTRA1( and( the( second( βGstrand( of(
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POTRA2[14].( Based( on( this( observation( it( was( proposed( that( the( transport( of( the( OMP( to( the(
barrel( is( achieved( by( βGaugmentation( where( the( unfolded( peptide( will( use( the( βGstrands( of(
POTRA( as( a( folding( template[13].( To( date,( no( structural( data( could( confirm( or( infirm( this(
hypothesis.(Furthermore,(no(functional(details(are(known(on(the(interaction(between(SurA(and(
POTRA( besides( mutagenesis( experiments,( showing( that( the( interaction( is( taking( place( in( the(
vicinity(of(Arginine(64((R64)(located(on(the(second(helix(of(POTRA1(and(that(an(alteration(of(this(
helix( leads(to(an(Omp(biogenesis(defect(as(well(as(a(reduced( interaction(with(SurA[15,(16].(Here,(
we(used(NMR(spectroscopy,(combined(with(complementary(biophysical(tool(to(characterize(the(
interaction(between(POTRA(and(SurA(at( atomic( resolution,( indicating(a(possible(OMP(delivery(
and(transport(mechanism(along(POTRA(domains.(
(
(
(
$
$
Figure$ 2.2.(Crystal( structures(of(periplasmic(chaperones( in(E.#Coli.( a)(Crystal( structure(of( the(chaperone(
protein( SurA( where( the( different( domains( are( depicted( with( a( blue( shade( (PDB:( 1M5Y)[5].( b)( Crystal(
structure(of(the(first(four(POTRA(domains(of(BamA(where(the(different(domains(are(depicted(with(a(red(
shade((PDB:(2QDF)[12].(
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Results$
Characterization$of$the$periplasmic$chaperone$SurA!in!vitro$
To( assess( the( state( and( suitability( of( SurA( for( in# vitro( NMR( studies,( 2D( [15N,( 1H]GTROSYGHSQC(
spectra(of(the(protein(in(two(different(buffers(and(at(four(different(temperature(conditions(were(
recorded.(All(spectra(featured(a(wide(chemical(shift(dispersion(as(well(as(a(single(and(coherent(
set(of(the(amide(resonances,(characteristic(of(a(folded(protein(in(a(single(conformation.(Among(
these(conditions,(the(protein(gave(the(best(spectral(characteristics(at(a(temperature(of(37°C(and(
in( a( buffer( containing( 20( mM( KPi,( 100( mM( KCl,( pH( 6.5( and( 0.5( mM( EDTA,( chosen( as( NMR(
conditions(for(all(subsequent(experiments((Fig(2.3a).(
One( of( the(most( important( aspect( for( the(mechanism( by(which( chaperone( proteins(maintain(
their( OMP( substrate( in( an( unfolded( folding( competent( state( during( transport( through( cell(
compartments,( was( proposed( to( be( the( formation( of( a( cavity( by( chaperone( oligomerization,(
therefore(providing(a(protective(environment(for(the(aggregationGprone(substrate[6].(In(the(case(
of(SurA,(Xu(et#al.(proposed(the(formation(of(the(cavity(through(dimerization(of(the(core(domain,(
upon(substrate(binding(on(the(basis(of(coGcrystallization(studies(with(model(peptides[7].(To(test(
whether(the(dimerization(is(also(happening(in(the(absence(of(substrate,(2D([15N,1H]GTROSYGHSQC(
spectra( of( [UG15N,2H]GSurA( at( increasing( concentrations( of( 300 µM,( 600( µM( and( 1( mM( were(
recorded( (data( not( shown).( The( comparison( of( the( normalized( spectra( showed( a( decrease( of(
intensity(of(the(resonances(with(increasing(concentration.(Interestingly,(the(resonances(located(
in( the( spectral( region( typical( for(βGstrand( secondary( structure( (8.5(<(δ(1H)(<(10(ppm)(undergo(
larger(intensity(decrease(than(the(peaks(in(the(randomGcoil(region(of(the(spectrum((7.5(<(δ (1H)(<(
8.5( ppm),( corresponding( to( amide( moieties( in( loops( or( unfolded( regions.( This( indicates( an(
oligomerization( of( the( protein,( where( the( increase( in( size( of( the( molecule( causes( a( general(
increase(of(the(width,(and(decrease(of(intensity,(of(the(resonances(with(a(weaker(effect(on(the(
loops( or( unfolded( regions( due( to( their( flexibility.( To( characterize( this( aspect( further,( SurA(
oligomerization( in( a( concentration( range( from( 15.7( to( 500 µM( was( quantified( by( analytical(
ultracentrifugation.(The(protein(sedimentation(coefficient(c(s),(directly(related(to(particles(size(in(
solution(was( fitted,( showing(an( increase(of( size( from(the(SurA(monomer,(at(4.6(S,( towards( its(
dimer,( at( 6.2( S( (Fig( 2.3b).( Thus,( to( determine( SurA( dimerization( constant( (!!),( the( weight(
averaged(sGvalues((sW)(calculated(form(the(AUC(curves(were(fitted(to(a(monomerGdimer(model(
(Eq.(6,(Material(and(Methods(section)((Fig(2.3c)(giving(a(!!(value(of(1.2(mM(for(the(full( length(
SurA.((
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Figure$ 2.3.( SurA( characterization.( a)( Overlay( of( 2D( [15N,1H]GTROSYGHSQC( spectra( of( 300(µM( [UG15N,2H]G
SurAfl( in(NMR(buffer( at( 37°C( (dark(blue)( and(300(µM([UG15N,( 2H]GSurAΔP2( in(NMR(buffer( at( 37°C( (light(
blue).( b)( AUC( titration( curve( of( SurAfl( at( 15.7,( 31.3,( 62.5,( 125,( 250( and( 500(µM( (green( color( gradient)(
where(the(x(axis(represents(the(sedimentation(coefficient(S(and(the(y(axis(the(normalized(sedimentation(
coefficient(distribution(c(s).(c)(Weight(averaged(sGvalues((sW)(calculated(from(the(c(s)((distribution(for(each(
concentration((b)((crosses)(fitted(to(monomerGdimer(model((Eq.(6,(Material(and(Methods(section)(shown(
as(solid( line.(d)(Overlay(of(1H(projections,(of(2D([15N,1H]GTROSYGHSQC(spectra(of(300µM((dark(blue),(600(
µM((pink)(and(1(mM((green)([UG15N,2H]GSurAΔP2(in(NMR(buffer(at(37°C.(The(projections(are(normalized(to(
the(lowest(concentration(using(the(following(formula:( !"#$%& = ! !"# ∙ !" ∙ !!!!"#$%& !!!!"#.(e)(Ratio(
between(the(integrals(at(8.5(to(10(and(at(7.5(to(8.5(ppm(of(the(1H(projections(at(300,(600(µM(and(1(mM(
(d)(vs.( concentration( (crosses).( The(data(were( compared( to( fits(of( a(monomerGdimer(model(using(Eq.(2(
(Material( and(Methods( section)( using(!!(of( 20,( 100,( 500(µM(and(2.5(mM( (left( to( right)( shown(as( solid(
lines.(
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To(determine(whether(the(dimer(interface(is( located(in(the(core(module(of(the(protein,(similar(
2D( [15N,1H]GTROSYGHSQC( experiments( were( recorded( on( a( SurA( construct( lacking( its( PPIase( 2(
domain( (SurAΔP2).( As( for( the( fullGlength,( the( spectra( displayed(wide( chemical( shift( dispersion(
and(a(single(and(coherent(set(of( resonances( (Fig.(2.3a).(Furthermore,(a(similar(oligomerization(
behavior(was(observed(with(concentration( (Fig(2.3d).(Measurements(of( the( ratio(between( the(
integrals( at( 8.5( to( 10( and( at( 7.5( to( 8.5( ppm( of( the( 1H( projections( give( an( estimate( of( the(
monomeric( fraction( !! (of(SurAΔP2(at(each(concentration.(This( rough(assumption(was(made(
assuming(a(ratio(of(1(for(the(monomer(only( !! = 1 (and(0(for(the(dimer(only( !! = 0 (as(the(
2D( [15N,1H]GTROSYGHSQC( spectra( could( not( be( directly( compared( due( to( different( acquisition(
parameters((number(of(complex(points(and(carrier(position(in(both(dimensions,(acquisition(and(
evolution( times).( Plot( of( these( ratio( vs.( the( total( concentration( were( compared( to( fits( of( a(
monomerGdimer(model(using(Eq.(2((Material(and(Methods(section)(with(!!(of(20,(100,(500(µM(
and(2.5(mM((Fig(2.3e).(This(approach(estimates(the(dimerization(constant(for(SurAΔP2(between(
100(and(500(µM,(smaller(than(for(the(fullGlength(protein.(However,(the(!!(calculated(from(AUC(
data( for( SurAfl( could( be( overestimated( due( to( the( possible( increase( in( frictional( ratio( at( high(
concentration(used(to(measure(the(sedimentation(coefficient(distribution.(Thus,(both(AUC(and(
NMR( measurements( have( to( be( repeated( in( order( to( better( estimate( the(!!(and( determine(
whereas(the(binding(interface(is(located(in(the(core(module(or(in(the(PPIase2(domain(of(SurA.(
(
(
POTRA$interacts$with$the$NK$and$CKterminal$domains$of$SurA$
During(OMP(biogenesis,(SurA(chaperone(activity(is(carried(out(by(its(NG(and(CGterminal(domains,(
while( the( PPIase( domains( are( dispensable( for( the( interaction[4].( To( further( investigate( which(
domains(of( SurA(are( involved( in( the( interaction(with(POTRA,( the( two(PPIase(domains(of( SurA(
were( expressed( independently( (SurA( PPIase1( and( SurA( PPIase2)( and( 2D( [15N,1H]GTROSYGHSQC(
spectra(were(recorded((Fig.(2.4).(The(2D([15N,1H]GTROSYGHSQC(spectrum(of(SurA(PPIase2(showed(
wellGdispersed(resonances(overlaying(with(the(peaks(of(the(SurAfl(spectrum,(indicating(a(similar(
fold(of( this(domain(alone(and(within( the(protein( (Fig.(2.4a).(Conversely,(while( the(2D( [15N,1H]G
TROSYGHSQC(spectrum(of(SurA(PPIase1(features(wide(chemical(shift(dispersion,(characteristic(of(
a(structured(domain,(a(large(number(of(resonances(did(not(overlay(with(the(peaks(of(the(SurAfl(
spectrum((Fig.(2.4b).(This(is(consistent(with(previous(observations(showing(that(within(the(core(
module,(a(part(of(the(PPIase1(domain(is(occluded(by(the(N(and(CGterminal(domains(and(displays(
Chapter(2(( Molecular(Chaperones(and(their(Complexes((!
(57(
a(displaced(βGstrand(compared(to(the(typical(PPIase(structures[5].(
(
(
Figure$ 2.4.( Individual( domains( of( SurA.( a)( Overlay( of( 2D( [15N,1H]GTROSYGHSQC( spectra( of( 300( µM( [UG
15N,2H]GSurAfl( (blue)( and( of( 300( µM( [UG15N,2H]GSurA( PPIase2( (green)( in( NMR( buffer.( b)( Overlay( of( 2D(
[15N,1H]GTROSYGHSQC(spectra(of(300(µM([UG15N]GSurAfl((blue)(and(of(400(µM([UG15N]GSurA(PPIase1((pink)(in(
NMR(buffer.((
(
Interaction( of( these( singles( domains( with( POTRA( was( further( analyzed,( using( a( construct(
containing(the(two(first(domains(only((POTRA12)(as(we(show(below(that(they(are(sufficient(for(
the( interaction( with( SurA.( 2D( [15N,1H]GTROSYGHSQC( spectra( of( apoG[UG15N]–POTRA12( and( in(
presence(of( the( individual( PPIase( domains( at( a( 1:0.5( and(1:1.5( POTRA12:SurAPPIase2( and(1:1(
POTRA12:SurAPPIase1( ratio( were( recorded( (Fig( 2.5a( and( b( respectively).( No( chemical( shifts(
changes( were( observed( upon( SurAPPIase1( and( SurAPPIase2( titration,( indicating( that( these(
individual(domains(do(not(have(a(detectable(affinity(for(POTRA.(
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Figure$2.5.( Identification(of(the(SurA(binding( interface(for(POTRA.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of(
220(µM([U(G15N]GPOTRA12(in(NMR(buffer((red)(upon(addition(of(0.5(molar((orange)(and(1.5(molar((green)(
equivalent(of( SurAPPIase2.( For(a( clear(visualization( the( resonances(of( the( titrated(POTRA(are(arbitrarily(
shifted.( b)( 2D( [15N,1H]GTROSYGHSQC( spectra( of( 300( µM( [UG15N]GPOTRA12( in( NMR( buffer( (red)( upon(
addition( of( 1(molar( equivalent( of( SurAPPIase1( (orange).( For( a( clear( visualization( the( resonances( of( the(
titrated( POTRA( are( arbitrarily( shifted.( c)( Chemical( shift( perturbations( of( POTRA12( residues,( in( the(
presence(of(SurAfl( (top)(and(SurAΔP2( (bottom)(plotted(vs.( the(amino(acid( residue(number(of(POTRA12.(
The(secondary(structure(of(the(POTRA(domains(is(indicated(above.(d)(2D([15N,1H]GTROSYGHSQC(spectra(of(
400( µM( [UG15N,2H]GSurAΔP2( in( NMR( buffer( (dark( blue)( upon( addition( of( 1( molar( (blue),( and( 2( molar(
(green)(equivalent(of(POTRA12.(
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These(finding(were(confirmed(by(analyzing(2D([15N,1H]GTROSYGHSQC(spectra(of([UG15N]GPOTRA12(
(Fig( 2.5c),( displaying( similar( changes( in( chemical( shifts( upon( SurAfl( and( SurAΔP2( titration.( As(
well,(similar(resonances(were(affected(on(the(2D([15N,1H]GTROSYGHSQC(spectra(of(15NGSurAfl(and(
15NGSurAΔP2,(displayed(in(Figure(2.5d,(upon(POTRA12(titration.(
To( further( confirm( that( the(NG( and( CGterminal( domains( alone( are( required( for( the( interaction(
with( POTRA,( a( SurA( construct( lacking( the( two( PPIase( domains( (SurANC)( was( designed,( but(
studies(on(this(construct(were(not(pursued(due(to(its(low(expression(yield(and(precipitation.(As(
well,( the(expression(of( the(NG(and(CGterminal(domains( independently(was(not( tested(as( it(had(
previously(been(shown(that(these(domains(alone(are(not(stable(and(functional[4].(
(
(
The$NK$and$CKterminal$βKstrands$of$SurA$are$involved$in$the$OMP$delivery$mechanism$
To( characterize( the( interaction( surface( on( SurA( upon( POTRA( binding,( sequenceGspecific(
resonance(assignments(had(to(be(obtained(for(the(NMR(spectra(of(the(SurAΔP2(construct.(NMR(
sequenceGspecific(backbone(assignment(was(carried(out(recording(3D(TROSYGHNCA,(3D(TROSYG
HNCACB[17],(3D(TROSYGHNCO[18],(3D(TROSYGHNCACO[19](and(3D([1H,1H]GNOESYG15NGTROSY[20](on(a(
600(µM([UG15N,2H]GSurAΔP2(sample.(With(these(data,(about(40(%(of(the(backbone(resonances(of(
the( protein( could( be( assigned( in( a( sequenceGspecific( manner( (Fig( 2.6).( The( chemical( shift(
perturbations( (CSP)( between( the( 2D( [15N,1H]GTROSYGHSQC( spectra( of( [UG15N,2H]GSurAΔP2( apo(
and( in( complex( with( POTRA12( at( a( 1:1( ratio( were(measured( (Fig( 2.7a)( and,( for( the( assigned(
residues,( transferred( on( SurA( crystal( structure( (PDB:( 1M5Y)( (Fig( 2.7b( and( c).( As( observed(
previously,( SurAPPIase( 1( domain( is( not( playing( a( role( in( the( interaction( with( POTRA( as( no(
chemical(shift(changes(could(be(observed(for(its(residues.(The(largest(CSP(were(measures(on(the(
amino(acids(constituting(the(NG(and(CGterminal(βGstrands(of(the(protein,(forming(an(antiGparallel(
βGsheet,(as(well(as(on(α1,(α2(and(α3(helices(of(the(NGterminal(domain.(The(antiGparallel(βGsheet(
formed(by(βGstrands( located(at(the(beginning(and(at(the(end(of(the(NGterminal(and(CGterminal(
domains(respectively(was(shown(to(act(as(a(structural(support(of(the(protein[21].(Observation(of(
major(chemical(shift(changes(on(these(residues(can(indicate(that((1)(they(are(part(of(the(binding(
interface(with(POTRA(or(that((2)(the(interaction(of(POTRA(at(an(allosteric(site(induce(an(opening(
of( the( antiGparallel(βGsheet( leading( to( a( partial( destabilization( of( the( protein( structure( which(
could(be(the(release(mechanism(of(the(bound(OMP(substrate,(in(absence(of(external(energy.(
(
(
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(
$
$
Figure$ 2.6.( SequenceGspecific( resonance( assignment( of( SurAΔP2.( a)( 2D( [15N,1H]GTROSYGHSQC( spectra( of(
400(µM([UG15N,2H]–SurAΔP2(in(NMR(buffer(and(zoom(of(the(central(part(of(the(spectrum(indicated(with(a(
dashed(box.( Selected( sequenceGspecific( resonance( assignments( are( indicated.( b)( Strips( from(3D( TROSYG
HNCACB(spectrum(of(700(µM([UG15N,2H]–SurAΔP2(in(NMR(buffer.(Resonances(belonging(to(!!(atoms(are(
displayed(in(blue(and(Resonances(belonging(to(!! !atoms(are(displayed(in(yellow.(
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$
Figure$2.7.(SurAΔP2(binding( interface(with(POTRA12.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of(400(µM([UG
15N,2H]–SurAΔP2( in(NMR(buffer( (dark( blue)( upon( addition( of( 1(molar( equivalent( of( POTRA12( (blue).( b)(
Ribbon(representation(of(SurAΔP2((PDB:(1M5Y),(where(changes(upon(POTRA12(interaction(are(indicated(
by( a( cyan( gradient( for( CSP( values( between( 0( and( 0.13.( Amino( acid( resonances( disappearing( upon(
interaction(with(POTRA12(are( indicated( in( red.( c)(Amino(acid( sequence(of( SurAΔP2(where( the(assigned(
residues( are( highlighted( in( green.( The( secondary( structure( elements( of( the( NGterminal( domain( (blue),(
PPIase1(domain((dark(blue)(and(CGterminal(domain((light(blue)(are(indicated(above.#
(
(
Interaction$between$SurA$and$the$first$two$domains$of$POTRA$in!vitro$
In(the(cell,(the(interaction(between(the(BamAGPOTRA(domains(and(SurA(is(supposed(to(result(in(
the( handover( of( SurAGbound( OMPs( to( the( POTRA( domains( for( subsequent( assembly( and(
insertion( into( the( outer(membrane.( In# vitro,( the( complex( of( fullGlength( SurA( (SurAfl)(with( [UG
15N,2H]–labeled( POTRA( containing( the( 5( domains( (POTRA15)( was( assembled( at( a( 1:1( ratio( by(
mixing( the(two(proteins( in(NMR(buffer(and(a(2D([15N,1H]GTROSYGHSQC(spectrum(was(recorded(
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for(comparison(with(the(spectrum(of(the(apo(form(of(POTRA15.(The(apo(state(appeared(to(be(
consistent(with(previous(NMR(studies(of(POTRA(and(assignments(were(achieved( (B.(Burmann,(
unpublished(data).((
(
(
(
$
Figure$2.8.(POTRAGSurA(interaction.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of([UG15N,2H]GPOTRA15(at(400(µM(
in(NMR(buffer((red)(and(in(interaction(with(1(molar(equivalent(of(SurAfl((gold).(b)(Cartoon(representation(
(top)(and(surface(representation((bottom)(of(POTRA15((PDB:(2QDF)(where(changes(upon(interaction(with(
SurA( are( indicated( by( a( red( gradient( for(
!!"!!!!"!(values( between( 1( (red)( and( 0( (brown).( c)( Overlay( of( 2D(
[15N,1H]GTROSYGHSQC( spectra( of( [UG15N,2H]GPOTRA15( at( 400( µM( in( NMR( buffer( (red)( and( 2D( [15N,1H]G
TROSYGHSQC(spectra(of([U(G15N,2H]GPOTRA12(at(270(µM(in(NMR(buffer((orange).(
(
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Large(chemical( shift(changes(between(the(apo(and(the(holo( [UG15N,2H]–POTRA15(NMR(spectra(
were( detected( as( well( as( disappearance( of( several( resonances( (Fig( 2.8a)( (B.( Burmann,(
unpublished( data).( The( mapping( of( these( changes( on( the( crystal( structure( of( POTRA15( (PDB(
2QDF)(reveals(that(mainly(the(first(two(POTRA(domains(are(affected(upon(SurA(interaction((Fig(
2.8b).(Additional(effects(in(the(other(POTRAs(are(located(in(the(interfaces(between(the(individual(
domains.(Through(the(localization(of( its(binding(interface(with(SurA,(a(construct(containing(the(
two(first(POTRA(domains(was(designed((POTRA12).(2D([15N,1H]GTROSYGHSQC(spectrum(recorded(
on([UG15N]–POTRA12(overlaid(with(the(corresponding(POTRA15((Fig(2.8c),(indicating(that(the(two(
domains( alone( have( the( same( structure( than( within( the( fullGlength( construct( and( that( the(
truncation( of( domains( 3( to( 5( did( not( affect( the( structure( of( the( individual( domains.( The( 2D(
[15N,1H]GTROSYGHSQC(spectrum(of([UG15N]–POTRA12(at(a(1:1(ratio(of(POTRA:SurA(display(similar(
changes( in( chemical( shifts( as( observed( for( the( fullGlength( POTRA( (data( not( shown).( On( SurA,(
both(2D([15N,1H]GTROSYGHSQC(spectra(of([UG15N]–SurAfl(at(1:1(SurA:POTRA15(and(SurA:POTRA12(
equivalents(display(chemical(changes(compared(to(the(apo(spectrum(of(SurAfl(and(the(chemical(
shift( perturbations(observed( are( comparable( upon( addition(of( the(different( POTRA( constructs(
(data(not(shown),(showing(that(these(two(domains(are(sufficient(for(the(interaction.(
$
(
SurA$interacts$with$the$first$domain$of$POTRA$
The( interaction( between( SurA( and( POTRA( was( suggested( previously,( on( the( basis( of( in# vivo(
crosslinking(experiments,(to(be(located(in(the(α2(helix(of(the(first(POTRA(domain[16],(consistent(
with( our( results( obtained( by( NMR( spectroscopy.( To( confirm( the( interaction( site( and( obtain(
details(at(the(atomic(level,(the(two(first(POTRA(domains(were(expressed(independently((POTRA1(
and( POTRA2)( and( 2D( [15N,1H]GTROSYGHSQC( spectra( with( increasing( amounts( of( SurA( were(
recorded.((
The( 2D( [15N,1H]GTROSYGHSQC( spectra( of( [UG15N]–POTRA1( and( [UG15N]–POTRA2( showed( wellG
dispersed( resonances(overlaying(with( the(POTRA12(NMR(spectrum,( indicating(a( similar( fold(of(
these(domains(alone(and(linked(together((Fig.(2.9a).(Only(the(amine(resonances(of(residues(Q35(
and(R36(located(in(the(loop(between(β1(and(α1,(residues(N71(to(V75(in(the(loops(between(α2(
helix(and(β2(strand(of(POTRA(1,(K89,(E90,(R91(and(T93( located( in( the( linker(between(the( two(
domains( and( the( residues( E123( to( I130( located( in( the( loop( between( α1( and( α2( helices( of(
POTRA2( showed( important( changes( in( chemical( shifts( (Fig.( 2.9a( and( b).( Their( changes( in(
chemical( shifts( confirms( that( these( residues( are( part( of( the( domain( interface.( From( the(NMR(
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spectrum(of(POTRA12(all(the(assignments(could(be(transferred(to(POTRA1(and(POTRA2.((
(
(
(
$
Figure$2.9.(Individual(POTRA(domains.(a)(Overlay(of(2D([15N,1H]GTROSYGHSQC(spectra(of(300(µM([U(G15N]G
POTRA12((red),(270(µM([UG15N]GPOTRA1((orange)(and(270(µM([UG15N]GPOTRA2((green)(in(NMR(buffer.(The(
sequenceGspecific(resonance(assignment(of(the(residues(undergoing(chemical(shift(change(in(the(isolated(
POTRA( domains( is( indicated.( b)( Ribbon( representation( of( the( first( and( second( POTRA( domains( (PDB:(
2QDF),(where(the(residues(undergoing(chemical(shift(change(in(the(isolated(POTRA(domains(are(indicated(
in(red.(
#
Upon( addition( of( 0.5( to( 8(molar( equivalent( of( [UG2H]–SurAΔP2,( no( changes( in( chemical( shifts(
were(observed(in(15NGPOTRA2(NMR(spectra((Fig(2.10a).(This(indicates(that(this(individual(domain(
does( not( have( a( detectable( affinity( for( SurA.( However( it( is( worth( noting( that( POTRA( 2(
resonances( within( the( biGdomain( construct( POTRA12( experience( chemical( shift( changes( upon(
SurA(addition(that(are(most(likely(triggered(by(POTRA1((data(not(shown).(These(changes(indicate(
an(indirect(interaction(with(SurA.(The(same(experiments(on(the(isolated(POTRA1(revealed(large(
chemical(shift(perturbations(of(the(resonances(upon(addition(of(SurA((Fig(2.10b),( in(agreement(
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to( the( ones( observed( for( the( POTRA12( construct.( POTRA1( was( thus( used( as( the( minimal(
construct(of(interaction(for(all(further(studies.(
#
#
$
$
Figure$2.10.(SurA(interaction(with(single(POTRA(domains.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of(270(µM(
[UG15N]GPOTRA2(in(NMR(buffer((red)(and(in(interaction(with(1((orange)(and(4(molar(equivalent((green)(of(
[UG2H]GSurAΔP2.(b)(2D([15N,1H]GTROSYGHSQC(spectra(of(270(µM([UG15N]GPOTRA1(in(NMR(buffer((red)(upon(
addition(of(1((orange)(and(4((green)(molar(equivalent(of([U(G2H]–SurAΔP2.#
(
(
Surface$ plasmon$ resonance$ confirms$ that$ POTRA1–SurAΔP2$ is$ a$ suitable$ minimal$
construct$for$interaction$studies$
Surface( plasmon( resonance( (SPR)( measurements( were( performed( to( measure( the( affinity(
between( the( different( POTRA( and( SurA( constructs.( POTRA1,( POTRA2( and( POTRA12( were(
immobilized(on(SPR(chips(by(covalent(coupling(of(their(amine(groups(to(the(carboxymethylated(
dextran( matrix.( Then,( SurAfl( and( SurAΔP2( constructs( were( loaded( on( the( chip( and( the(
dissociation(constants((KD)(were(measured(using(the(kinetic/affinity(method[22].(The(dissociation(
constant(measured(between(POTRA12(and(SurAΔP2(domains(is(equal(to(12(±(6(µM,(comparable(
to( the( KD( of( POTRA12–SurAfl( interaction( of( 16( ±( 1(µM( (Fig.( 2.11( and( Table( 2.1),( in( excellent(
agreement( with( the( observed( behavior( in( the( NMR( titrations( (Fig( 2.5d).( As( well,( the( specific(
interaction(of(POTRA1(with(SurA(was(confirmed(by(affinity(measurements,(as(POTRA2(did(not(
show( any( detectable( interaction(with( SurA,(while( POTRA1( and( POTRA12( did.( The( dissociation(
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constants((KD)(between(POTRA1(and(SurAΔP2(and(POTRA12(and(SurAΔP2(are(equal(to(12(±(4(µM(
and( 12( ±( 6(µM( respectively,( indicating( a( similar( affinity( for( SurA,( mediated( through( the( first(
POTRA(domain((Fig.(2.11(and(Table(2.1).(These(results(corroborate(that(SurA(interacts(with(the(
first(POTRA(domain(only. 
(
( POTRA12$ POTRA1$ POTRA2$ POTRA1R64A$
SurAfl$ 16(±(1(µM( 13.4(±(1(µM( >(100(µM( 210(±(44(µM(
SurAΔP2$ 12(±(6(µM( 12(±(4(µM( >(100(µM( >(500(µM(
Table$ 2.1.( Interaction(constants( (KD)(between( the(different( constructs(of(POTRA(and(SurA(measured(by(
surface(plasmon(resonance((SPR)(using(the(kinetic/affinity(method.(
(
(
!
Figure$ 2.11.(Determination(of(dissociation(constants( (KD)(between(SurA(and(POTRA(by( surface(plasmon(
resonance((SPR).(a)(Affinity(curve(of(POTRA12(titrated(with(increasing(amounts(of(SurAfl.(b)(Affinity(curve(
of( POTRA( 12( titrated( with( increasing( amounts( of( SurAΔP2.( c)( Affinity( curve( of( POTRA1( titrated( with(
increasing(amounts(of(SurAΔP2.(The(different(POTRA(constructs(were( immobilized(by(amine(coupling(to(
the(dextran(matrix,(then(the(different(SurA(constructs(were(loaded(on(the(chip.(The(data(points((crosses)(
were(measured(using(the(kinetic/affinity(method[22].(The(solid(lines(correspond(to(the(fitted(curves.(
(
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The$hydrophobic$core$of$POTRA1$is$affected$upon$interaction$with$SurA$
The( large( and( numerous( chemical( shifts( changes( observed( in( the( 2D( [15N,( 1H]GTROSYGHSQC(
spectrum(of( [UG15N]–POTRA1(upon(addition(of(SurAΔP2( (Fig.(2.12a)( indicate(a(major(structural(
rearrangement(of(the(protein(upon(interaction.((
(
(
$
$
Figure$2.12.(Changes(on(POTRA1(upon(addition(of(SurAΔP2.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of(270(µM(
[UG15N]GPOTRA1(in(NMR(buffer((red)(and(upon(addition(of(1(molar(equivalent(of([UG2H]–SurAΔP2((orange).(
The(sequenceGspecific(resonance(assignment(of(the(residues(disappearing(upon(interaction(with(SurAΔP2(
is( indicated.(b)(Ribbon(representation(of(POTRA1( (PDB:(2QDF)(where(changes(upon(addition(of(1(molar(
equivalent(of(SurAΔP2(are(indicated(by(a(pink(gradient(for(CSP(values(between(0(and(0.2(ppm(and(amino(
acid( resonances( disappearing( are( indicated( in( red.( The( residues( disappearing( upon( interaction( with(
SurAΔP2(are(indicated.(
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In(order( to(map( the( interaction( surface(of(SurA(on(POTRA1(at( the(atomic( level,( chemical( shift(
perturbations((CSP)(were(calculated(between(the(NMR(spectra(of(the(apo(form(of(POTRA1(and(
after( addition( of( 1( molar( equivalent( of( [UG2H]–SurAΔP2.( The( CSP( value( were( plotted( on( the(
crystal(structure(of(POTRA(1((PDB(2QDF),(shown(in(Figure(2.12b,(were(the( intensity(of(the(CSP(
are(depicted(with(a(pink(gradient.(The(major(perturbations(are(located(in(the(α2(helix(as(well(as,(
to(a( lesser(extend,( in( the(β1(and(β3(strands,(while( the(α1(helix( is( less(affected.( In(addition( to(
these(changes,(residues(from(N71(to(R79(constituting(the(β2(strand(K89(in(the(β3(strands(as(well(
as(N55(and(E57,(and( I59(and(F67( located( in( the(α2(helix(of(POTRA1,( facing( the(β2(strand,(are(
lineGbroadened(below(the(detection( limit,(already(after(addition(of(0.5(molar(equivalent(of( [UG
2H]–SurAΔP2((Fig.(2.12b).(The(chemical(shift(perturbations(observed(on(POTRA(indicate(changes(
on( α2( helix( as( well( as( β1( and( β3( strands,( due( to( direct( or( indirect( interaction( with( SurA,(
consistent( with( previous( cysteineGspecific( in# vivo( crossGlinking( experiments( proposing( that( an(
interaction(of(SurA(with(the(α2(helix(of(POTRA1[16].(Workman(et#al(also(showed(that(the(deletion(
of(a(residue(of(the(α2(helix(of(POTRA1(leads(to(severe(defect(in(the(OMP(biogenesis(that(can(be(
partially(recovered(by(the(insertion(of(an(amino(acid(that(restores(its(wildGtype(helical(turn.(This(
functional(defect(can(be(due(to(the(disruption(of(the(hydrophobic(core(formed(between(residues(
of(the(α2(helix(and(β2(strand,(which(can(be(crucial(for(POTRA1(stability(and(function.(This(is(also(
consistent(with(the(conservation(of(the(residues(I59,(D74,(V75(and(V77,(forming(a(hydrophobic(
cluster[12].( The( disappearance( of( resonances( from( residues( forming( this( hydrophobic( core,(
observed( in( our( 2D( [15N,1H]GTROSYGHSQC( NMR( spectra( of( [UG15N]–POTRA1( upon( addition( of(
SurAΔP2,(supports(their(importance(in(POTRA(function.(It(reflects(a(chemical(exchange(of(these(
moieties( between( two( environments( in( the( intermediate( range( of( the(NMR( time( scale(where(
their(kinetic(constant(of(exchange((kex)(about(the(order(of(the(frequency(difference(between(the(
resonances(of(these(two(states,(prevents(its(detection.(This(exchange,(observed(in(the(presence(
of( SurAΔP2,( can( be( intermolecular,( between( the( hydrophobic( residues( and( SurA,( upon(
interaction(or( intramolecular,( induced(by(an(allosteric( SurA(binding,(where( these( residues(will(
exchange( between( a( bound( conformation,( forming( the( hydrophobic( core( and( a( free(
conformation(at(an(intermediate(rate.(This(suggests(a(possible(mechanism(for(the(transfer(of(the(
unfolded(OMP(from(SurA( to(POTRA(where( the(hydrophobic( residues(created(a( rim(acting(as(a(
receptor(for(the(unfolded(substrate.(
(
(
(
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The$first$POTRA$domain$undergoes$major$structural$rearrangements$upon$interaction$
with$SurA$
Analysis( of( the( 2D( [15N,1H]GTROSYGHSQC( spectra( of( [UG15N]–POTRA1( in( presence( of( 8( molar(
equivalents(of(SurAΔP2(also(revealed(the(presence(of(new(resonances,(appearing(in(the(randomG
coil( region(of( the(spectrum((7.5(<(δ (1H)(<(8.5(ppm)( (Fig.(2.13a).(Their(position(corresponds( to(
resonances(of(amide(groups(in(a(randomGcoil(conformation,(lacking(defined(secondary(structure,(
indicating( an( unfolding( of( POTRA1( amino( acids( upon( addition( of( SurA.( This( “unfolding”( effect(
appeared( to( be( specific,( as( it( was( observed( only( for( POTRA1.( The( 2D( [15N,1H]GTROSYGHSQC(
spectra(of([UG15N]–POTRA2(alone(do(not(display(this(set(of(new(resonances(when(titrated(with(
SurA( (data(not( shown).( To( investigate( the(origin(of( this( “unfolding”( effect,( the( stability( of( the(
POTRA( domains( was( investigated.( Thermal(melting( curves( of( POTRA1,( POTRA2( and( POTRA12(
constructs( were( measured( using( circular( dichroism( (CD)( spectroscopy( (Fig.( 2.13b).( Melting(
temperature((!!),(enthalpy(of(denaturation(at(!!(and(Gibbs(free(energy(of(denaturation(were(
obtained(by(nonGlinear( leastGsquared( fit( of( the(measured(data(using(a( twoGstate(model(of( the(
thermal(unfolding(transitions((Eq.(4(and(5(in(Material(and(Methods(section)((Table(2.2).(The(high(
melting( temperature( values( obtained( suggest( stable( POTRA( folds( for( the( three( different(
constructs,( in( agreement( with( previously( published( values[14].( Comparison( of( the( Gibbs( free(
energy(of(the(different(POTRA(constructs(revealed(a(slight(stabilization(of(POTRA1(by(POTRA2,(
indicated( by( a( difference( in(Δ!!"#.!"!of(−0.58!!" ∙ !"#!!.( On( the( other( hand,( the( addition( of(
POTRA1( to( POTRA2( induces( a( strong( destabilization( of( the( second( domain( indicated( by( a(
difference(in(Δ!!"#.!"(of(4.6!!" ∙ !"#!!.((
(
$ Tm$(K)$ !!!!(!" ∙ !"#!!)$ !!!"#.!"!(!" ∙ !"#!!)$ !!!!"#.!"(!" ∙ !"#!!)$
POTRA12$ 343( 331.4( 13.66( 0(
POTRA1$ 346.5( 218( 13.08( G0.58(
POTRA2$ 343.5( 291( 18.28( 4.6(
$
Table$2.2.(Stability(data(for(the(different(POTRA(constructs.(The(stability(parameters(were(obtained(from(
twoGstate(analysis(of(the(thermal(unfolding(transitions((Eq.(4(and(5(in(Material(and(Methods(section).(For(
all(constructs,(the(melting(temperature((Tm),(the(enthalpy(of(denaturation(at(!!,(the(Gibbs(free(energy(of(
denaturation( at( 37°C( (Δ!!"#.!") (and( the( difference( in( Gibbs( free( energy( to( the( POTRA12( construct(
(ΔΔ!!"#.!")(are(given.(
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These( values( corroborate( the( observation( done(on( the(NMR( spectra( of( POTRA1,( POTRA2( and(
POTRA12( upon( SurA( titration( (Fig.( 2.13a)( where( the( addition( of( SurA( leads( to( “unfolding”( of(
POTRA1(and(POTRA12(but(not(POTRA2.(This(“unfolding”(effect(has(to(be(investigated(further(to(
determine( its( precise( role( but,( together( with( the( possible( chemical( exchange( between( the(
residues( constituting( the( hydrophobic( core( of( POTRA1,( it( could( suggest( a( mechanism( of(
interaction(and(/(or(release(of(the(OMP(between(POTRA(and(SurA(proteins(and(transport(of(the(
OMP(along(the(POTRA(domains.(
(
(
$
Figure$2.13.(Stability(of(the(different(POTRA(domains.(a)(2D([15N,1H]GTROSYGHSQC(spectra(of(270(µM([UG
15N]–POTRA1( in(NMR(buffer( (red)(and(upon(addition(of(8(molar(equivalent(of( [UG2H]–SurAΔP2( (yellow).(
The(random(coil(region(of(the(spectra(is(located(between(the(dashed(lines.(b)(Normalized(melting(curves(
of(POTRA1((red),(POTRA2((purple)(and(POTRA12((orange)(recorded(by(CD(spectroscopy(in(CD(buffer(where(
the(y(axis(corresponds(to(the(fraction(of(native(population.(The(solid(lines(correspond(to(the(fitting(curves,(
using(a(twoGstate(model(of(the(thermal(unfolding(transition((Eq.(4(and(5(in(Material(and(Methods(section).(
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Arginine$64,$located$in$the$α2$helix$of$POTRA1$plays$a$crucial$role$in$the$OMP$delivery$
mechanism$
In#vivo(studies(of(the(interaction(between(POTRA(and(SurA(showed(that(the(deletion(of(arginine(
64,(located(in(the(α2(helix(of(POTRA1,(compromise(the(assembly(of(the(OMP[15,(16].(This(defect(in(
the( OMP( assembly( can( be( due( to( the( crucial( role( of( R64( but(might( as( well( be( caused( by( an(
altered(fold(of(the(α2(helix(upon(R64(deletion.(To(investigate(this(aspect(further,(we(designed(a(
construct(where(arginine(64(of(POTRA1(was(mutated(to(an(alanine((POTRA1R64A).(The(2D([15N,(
1H]GTROSYGHSQC( spectrum( of( [UG15N]–POTRA1R64A( showed( wellGdispersed( resonances(
overlaying(with(the(POTRA1(NMR(spectrum.(Only(residues( in(close(vicinity(of(the(mutated(R64(
experienced(chemicalGshift(changes,(which( indicates(that(the(mutation( is(not(affecting(the(fold(
of( the( domain( (data( not( shown).( 2D( [15N,1H]GTROSYGHSQC( spectra( of( [UG15N]–POTRA1R64A( in(
complex(with(SurAΔP2(at(a(1:0.5(to(1:8(POTRA:SurA(molar(ratio(were(measured((Fig(2.14a)(and(
chemical( shift(perturbations( in( the(presence(SurAΔP2(at(a(1:1(molar( ratio(were(measured(and(
compared( to( the( CSP( observed( for( the( wild( type( POTRA( ( (Fig( 2.14b).( Overall,( the( same(
resonances( of( POTRA( are( affected( upon( interaction( with( SurAΔP2( but( the( CSP( are( smaller(
compared(to(the(values(obtained(for(wild(type.(This(indicates(a(lower(affinity(between(the(two(
proteins,( confirmed( by( the( higher( interaction( constant( (KD),( in( the( high( micromolar( range,(
measured( by( SPR( (Fig.( 2.11( and( Table( 2.1).( Interestingly,( the( resonances( constituting( the(
hydrophobic( core( of( POTRA1,( disappearing( in( the(wild( type( POTRA1( spectra( upon( titration( of(
SurAΔP2,(display(here(the(largest(chemical(shift(change((Fig.(2.14c).(Furthermore,(no(“unfolding”(
effect(was(observed(upon(addition(of(SurA(to(a(maximum(of(8(molar(equivalents,(indicating(that(
the(residues(from(the(hydrophobic(core(are(affected(by(the(presence(of(SurA(but(do(not(undergo(
conformational(exchange(in(the(intermediate(range(of(the(NMR(timescale.(
To( confirm( these( observations,( 2D( [15N,1H]GTROSYGHSQC( spectra( of( [UG15N,2H]–SurAΔP2( in(
complex( with( POTRA1R64A( at( a( 1:0.5( to( 1:2( SurA:POTRA( molar( ratio( were( measured.( As(
observed( on( POTRA( side,( the( same( residues( are( affected( upon( binding,( indicating( that( the(
binding( interface( is( not( affected.( Similarly,( the( chemical( shift( perturbations( measured( are(
smaller(than(the(ones(for(wildGtype(POTRA(indicating(a(lower(affinity(in(the(absence(of(arginine(
64( (data( not( shown).( Altogether,( this( indicates( that( R64( is( not( essential( for( the( interaction(
between(the(two(partners(and(that(its(deletion(does(not(affect(the(binding(interface(but(that(it(
substantially(contributes(to(the(affinity(between(the(two(partners(as(well(as(in(the(mechanism(of(
OMP(delivery(to(the(first(domain(of(POTRA.(
Molecular(Chaperones(and(their(Complexes! Chapter(2(!
72(
(
Figure$2.14.(Role(of(arginine(64(in(the(interaction.(a)(Comparison(of(resonances(of(the(residues(G20((top)(
and(E53((bottom)(from(2D([15N,1H]GTROSYGHSQC(spectra(of(270(µM([U( G15N]–POTRA1((left)(and([U( G15N]–
POTRA1R64A((right)(in(NMR(buffer((purple)(and(upon(addition(of(0.5((dark(red),(1((red),(2((dark(orange),(4(
(orange),(and(8((yellow)(molar(equivalent(of([UG2H]–SurAΔP2.(b)(CSP(values(of(POTRA1(residues((red)(and(
POTRA1R64A( residues( (light( pink),( in( presence(of( 1(molar( equivalent( of( SurAΔP2(plotted(vs.( the( amino(
acid( residue( number( of( POTRA12.( The( secondary( structure( elements( of( the( first( domain( of( POTRA( are(
indicated(above.(c)(Ribbon(representation(of(POTRA1R64A((PDB:(2QDF)(where(changes(upon(addition(of(1(
molar(equivalent(of(SurAΔP2(are(indicated(by(a(pink(gradient(for(CSP(values(between(0(and(0.1(ppm.(The(
position(of(the(mutated(arginine(to(alanine(is(indicated(in(red.((
(
(
Discussion$
It(has(been(shown(that(the(interaction(between(POTRA(and(SurA(in(E.#coli(is(a(crucial(step(of(the(
OMP(refolding(pathway,(transferring(the(unfolded(substrate(from(the(chaperone(to(the(POTRA(
domains(of(BamA(for(its(fold(into(the(outer(membrane[15,(16].(Using(NMR(spectroscopy,(we(could(
reproduce(the(interaction(between(the(two(partners#in#vitro.(The(NG(and(CGterminal(domains(of(
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SurA(are(required(for(the( interaction,(while(the(two(peptidylGprolyl( isomerase(domains(are(not(
directly( contributing.( The( role( of( these( two( domains( is( still( unclear,( the( first( PPIase( domain(
exhibiting(no(PPIase(activity(and(adopting(a(distorted( fold(compared(to(other(PPIase(domains,(
could(be(involved(in(substrate(binding(while(the(second(one,(exhibiting(PPIase(activity,(could(act(
as(a(second(binding(site(for(the(peptide(or(exhibit(PPIase(activity[5,(7].(Preliminary(results(localized(
the(interaction(of(POTRA(on(the(NG(and(CGterminal(βGstrands(of(SurA.(This(βGsheet(was(suggested(
to(act(as(a(structural(support(of(the(protein[21](and(the(interaction(of(POTRA(can(act(as(a(release(
mechanism(for(the(OMP(upon(destabilization,(in(absence(of(external(energy.((Furthermore,(we(
could(show(that(SurA(interacts(with(the(first(POTRA(domain(only.(The(residues(affected(by(this(
interaction(are(located(mainly(on(the(α2(helix(and(the(β1,(2(and(3(strands(of(POTRA1,(consistent(
with(previous(observations(showing(that(SurA( is( interacting(with(the(α2(helix(of(POTRA(1[16].(A(
dynamic(behavior(of(POTRA1(was(also(observed(upon(SurA(interaction,(where(the(hydrophobic(
core(of(the(first(POTRA(domain(formed(between(the(residues(of(the(α2(helix(and(the(β2(strand(
seems( to( undergo( conformational( exchange( between( a( bound( state,( forming( hydrophobic(
interactions(and(a( free(state,(at(an( intermediate( rate( in( the(NMR(time(scale.(Finally,(we(could(
also( show( that( in( the( absence(of( arginine( 64,( located( in( the(α2(helix( of( POTRA(1,( the( affinity(
between( the( two( partners( is( reduced( substantially.( Furthermore,( the( hydrophobic( core( is(
affected(but(did(not(undergo(conformational(exchange.(This( indicates( that( the(arginine,(albeit(
not( the( sole( mediator( of( this( interaction( on( POTRA( side,( plays( an( important( role( in( the(
interaction(and(might(in(addition(be(crucial(for(the(mechanism(of(release(of(the(OMP(from(SurA(
to(POTRA(where(the(conformational(exchange(of(the(hydrophobic(core(could(act(as(a(receptor(
for(the(nascent(OMP.(
Our(findings(led(us(to(propose(a(mechanism,(depicted(in(Figure(2.15,(for(the(delivery(of(the(OMP(
to(the(POTRA(domains(of(BamA(for( its(fold( into(the(outer(membrane.(There,(SurA(carrying(the(
unfolded(OMP(interacts(via( its(NG(and(CGterminal(domains(with(the(α2(helix(of(the(first(POTRA(
domain((i).(Upon(interaction,(SurA(docks(to(arginine(64,(located(in(the(α2(helix(and(this(specific(
binding( induces( a( conformational( exchange( of( the( hydrophobic( core( of( POTRA1,( where( the(
hydrophobic(residues(swap(between(a(favorable(and(stable(bound(state,(and(a(free(state(where(
the(hydrophobic(moieties(are(exposed((ii).(SurA(destabilization,(through(interaction(affecting(its(
terminal(βGsheet,( leads(to(the(release(of(the(Omp(that(interacts(with(the(exposed(hydrophobic(
residues(of(POTRA((iii).(The(βGsignal(sequence(of(the(OMP(necessary(for(its(folding(into(the(outer(
membrane,(consists(of(several(hydrophobic(residues(and(might(be(the(interacting(partner(of(the(
hydrophobic(residues(of(POTRA.(To(reach(the(BamA(barrel,( the(unfolded(OMP(slides(along(the(
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POTRA(domains(where(the(hydrophobic(attraction(between(α2(helix(and(β2(strand(will(“push”(
the( unfolded(Omp( to( the( next( POTRA(domain( (iv).( It(was( proposed( earlier( that( the(OMP(was(
binding(and(subsequently(sliding(along(the(POTRA(via(βGaugmentation[13].(This(mechanism(would(
not(be(in(agreement(with(our(proposed(sliding(mechanism(on(the(hydrophobic(residues,(keeping(
the(OMP(unfolded(until(it(reaches(the(βGbarrel(domain(of(BamA.(To(date,(we(do(not(have(direct(
evidence( to( further( prove( this( proposed( mechanism.( Mutations( in( the( hydrophobic( core( of(
POTRA(need(to(be( introduced(and(the(viability(of(these(different(constructs( in(the(presence(of(
the(OMP(need( to( be( tested.( In( addition,(measurements( of( the( exposition( of( the( hydrophobic(
residues( to( water,( in( presence( of( SurA( could( give( hints( on( the( possibility( of( this(mechanism,(
presumably(crucial(in(the(OMP(biogenesis.(
(
$
$
Figure$ 2.15.( Proposed(mechanism( for( the( delivery( of( the( unfolded(OMP( to( the( first( POTRA( domain( of(
BamA.((The(elements(involved(in(the(mechanism(at(each(steps(are(highlighted(in(red,(SurA(is(depicted(in(
blue(and(POTRA(in(orange.(See(text(for(details.$
(
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Material$and$Methods$
Protein$biochemistry$
SurA( constructs(were( cloned( in( pET28b( vector( (Novagen),( containing( a( thrombinGcleavable(NG
terminal(His6Gtag.(E.#coli(BL21((λ(DE3)(Lemo(cells(were(transformed(with(the(respective(plasmid(
and(grown(at(37°C(in(medium(containing(30(µg/mL(kanamycin(to(an(OD600(~(0.6(and(then(for(an(
additional(30(min(at(25°C.(Expression(was(induced(by(0.4(mM(IPTG.(Cells(were(harvested(18(–(20(
h(after(induction(and(resuspended(in(buffer(containing(25(mM(HEPES,(300(mM(NaCl(and(10(mM(
Imidazol(at(pH(7.5(at(a(4:1(buffer/pellet(weight(ratio(and(lyzed(by(two(passes(through(a(French(
press.(The(lysate(was(centrifuged(for(1(h(at(34,500(g(at(4°C,(subsequently(applied(to(a(5(ml(Ni2+G
HisTrap( (GE(Healthcare)( column( and( eluted( by( an( imidazole( gradient.( SurA( elutes( at( 150(mM(
imidazol( concentration.( The( elution( fractions( containing( SurA(were( dialyzed( overnight( against(
Buffer(A( (25(mM(Hepes,(150(mM(NaCl,(pH(7.5)(at(4°C.(Dialyzed(SurA(was(denatured(with(6(M(
Gdm/HCl,(applied(to(Ni2+(beads(and(eluted(with(200(mM(imidazol.(The(eluted(SurA(was(dialyzed(
overnight( against( Buffer( A( (25( mM( HEPES,( 150( mM( NaCl,( pH( 7.5)( at( 4°C.( Dialyzed( SurA( was(
concentrated( in( a( Vivaspin( concentrator( MWCO( 30,000( (Satorius)( and( applied( to( a( HiLoad(
16/600Superdex( 75( or( 200( pg( (GE( Healthcare).( Afterwards,( eluted( fractions( containing( SurA(
were(concentrated(by(ultrafiltration(and(stored(at(G80°C(until(use.(
POTRA(constructs(were(cloned(in(pET28b(vector((Novagen),(containing(a(thrombinGcleavable(NG
terminal(His6Gtag.(Expression(and(purification(were(done(as(described( for(SurA(above(with( the(
change(of(purification(under(denaturing(condition(step(to(purification(via(anion(exchange(affinity(
with(a(5(ml(Q(HiGTrap(FF((GE(Healthcare)(column(and(eluted(by(NaCl(gradient.(POTRA(constructs(
elute(in(the(flow(through((FT).(
The(quick(change(II(mutagenesis(protocol((Stratagene)(was(used(to(clone(the(SurAGNC(construct(
and(to(introduce(the(mutation(R64A(into(POTRA1.(PCR(primers(were(ordered(from(Microsynth.(
The( expression( and( purification( of( these( two( mutants( were( performed( as( their( respective(
protocols(described(above.((
(
(
Isotope$labeling$
[UG2H],( [UG2H,15N],( and( [UG2H,15N,13C]Glabeled( SurA( constructs( were( obtained( by( growing( the(
expression(cells(in(M9(minimal(media[23](supplemented(with((15NH4)Cl,([2H,13C]Gglucose,([2H,12C]G
glucose,( and(D2O.( [UG15N]Glabeled(POTRA( constructs(were(obtained(by( growing( the( expression(
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cells( in(M9(minimal(media[23]( supplemented(with( (15NH4)Cl.( All( isotopes(were( purchased( from(
SigmaGAldrich(or(Cambridge(Isotope(Labs.(
(
(
NMR$spectroscopy$
NMR( spectra( were( recorded( at( 37°C( for( SurA,( POTRA( and( SurA–POTRA( complexes( on( Bruker(
AscendIIG( 700( and( Bruker( AvanceG900( spectrometer( equipped(with( cryogenic( tripleGresonance(
probes.( The(2D( [15N,1H]GTROSYGHSQC(of( SurA(and(POTRA(were( recorded( in(a( total( experiment(
time(of(2(h.(The(1H(carrier(was(centered(on(the(water(resonance,(the(15N(carrier(at(119(ppm.(The(
interscan(delay(was(set(to(1(s.(In(the(direct(dimension,(1024(complex(points(were(recorded(in(an(
acquisition(time(of(91(ms,(multiplied(with(a(75°Gshifted(sine(bell,(zeroGfilled(to(2048(points(and(
Fourier( transformed.( In( the( indirect( dimension,( 100( complex( points( were( measured( with( a(
maximal( evolution( time( of( 4.44(ms,( multiplied( with( a( 75°Gshifted( sine( bell,( zeroGfilled( to( 256(
points(and(Fourier( transformed.(For( the(SurAGPOTRA(titrations(series,(2D( [15N,1H]GTROSYGHSQC(
spectra(were(recorded(with(0.5,(1,(2,(4(and(8(molar(equivalents(of(the(titrated(protein.(Chemical(
shift(perturbations((CSP)(of(amide(moieties(were(calculated(as:(
!"# = !!!"# − !" ! + !!!"#−!"5 2(((((1)(
For(the(sequenceGspecific(backbone(assignment(of([UG2H,15N,13C]Glabeled(SurAΔP2,(the(following(
NMR( spectra( were( recorded:( 3D( TROSYGHNCA,( 3D( TROSYGHNCACB[17],( 3D( TROSYGHNCO[18],( 3D(
TROSYGHNCACO[19](and(3D([1H,1H]GNOESYG15NGTROSY[20](with(a(NOE(mixing( time(of(200(ms.(The(
3D([1H,1H]GNOESYG15NGTROSY(spectrum(was(recorded(using(nonGuniform(sampling[24]((NUS)(with(
36(%(of(sparse(sampling(and(3456(hypercomplex(points( in(both( indirect(dimensions.(Spectrum(
reconstruction( was( achieved( using( MddNMR( program[25].( For( all( spectra( polynomial( baseline(
correction( was( applied( in( all( dimensions.( NMR( data( were( processed( using( PROSA[26],(
NMRPipe[27],(and(analyzed(with(CARA((cara.nmr.ch)(and(XEASY[28].((
1H( projections( of( 2D( [15N,1H]GTROSYGHSQC( spectra( of( SurAΔP2( were( used( to( derive( the(
dimerization(constant((!!)(of( the(protein,(assuming(a(monomerGdimer(equilibrium,(where( the(
monomeric(molar(fraction(!!(is(given(by(Eq.(2(with(!!"!,(the(total(protein(concentration[29].(
!! = 8 ∙ !!"! ∙ !! + !!! − !! /(4 ∙ !!"!)((((((((((2)(
The(experimental(values(of(!!(were(calculated(as( the( ratio(between(the( integrals(at(8.5( to(10(
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and(7.5(to(8.5(ppm(of(the(1H(projections.((
$
Circular$dichroism$spectroscopy$
Circular( dichroism( (CD)( data( were( recorded( on( a( Chirascan( spectrometer,( using( a( 1( mm(
pathlength( cuvette,( in( CD( buffer( (100( mM( NaPi,( pH( 6.5)( using( the( following( protein(
concentration:( POTRA1( at( 12(µM,( POTRA2( at( 5(µM,( POTRA12( at( 3(µM.(Melting( curves( were(
recorded(form(20(to(98°C(with(an(increase(of(1°C(/(point(and(an(averaging(of(3(second(per(point.(
Data( points( were( collected( at( 222( nm( at( 0.2( °C( interval.( The( measured( ellipticity(! (was(
normalized( into( [!]( (deg.cm2.dmolG1)( using( the( following( equation( where( n( is( the( number( of(
peptide(bonds( in( the(protein,( L( the( cuvette(pathlength( (mm)(and(C( the(protein( concentration(
(µM):(
! = !∙!"!!∙!∙! ((((((((((3)(
Curves( were( fitted( using( the( following( formula( where(Nint( and( Nslope( were( the( slope( and( the(
intersection( a( [!] (=( 0( of( the( native( baseline( and( Dint( and( Dslope( were( the( slope( and( the(
intersection(a([!](=( 0(of( the(denatured(baseline.(∆!!(was(estimated(via( the(accessible( surface(
area((ASA)(where(∆!"! = −907 + 93 ∙ !(and(∆!! = −251 + 0.19 ∙ ∆!"!([30].(
[!] = !!"#!!!"#$%∙! ! !!"#!!!"#$%∙! .!! ∆!!"!!!! ∆!!" (((((((((((4)(∆! = ∆!! 1 − !!! + ∆!! ! − !! − ! ∙ !" !!! (((((((((((5)(
(
(
Surface$plasmon$resonance$
Surface(plasmon(resonance((SPR)(experiments(were(recorded(on(a(Biacore(T100(instrument((GE(
healthcare).(Experiments(were(performed(in(SPR(buffer((25(mM(MES,(150(mM(NaCl,(pH6.5)(at(
25(°C.(The(ligands((POTRA(constructs)((2(mg(/(mL)(were(immobilized(by(amine(coupling(to(a(CM5(
chip(surface((GE(healthcare)(at(a(flow(rate(of(2!µl/min(and(a(contact(time(of(1200(second.(The(
surface(of(the(reference(channel(was(inactivated(by(amine(coupling(of(BSA((2(mg(/(mL).((
The( interaction( of( POTRA( constructs( with( SurAfl( and( SurADP2( were( measured( using(
kinetic/affinity(method(from(Biacore.(SurA(at(increasing(concentrations((0,(0.25,(0.5,(1,(2,(4(and(
10(mg(/(ml)(was(loaded(to(the(chip(at(a(flow(of(10(µL/min(and(a(contact(time(of(600(s(followed(
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by( a( dissociation( step( of( 1200( s.( Regeneration( of( the( chip( was( achieved( with( 4( M( Gdm/HCl(
solution(at( a( flow(of(10! µL/min(and(a( contact( time(of(100( second( followed(by(a( regeneration(
step( of( 600( s( with( SPR( buffer.( SPR( data( were( analyzed( using( the( Biacore( T100( evaluation(
software.(
$
Analytical$ultracentrifugation$
Analytical(ultracentrifugation((AUC)(was(used(to(measure(the(size(of(proteins(in(solution(using(a(
labeling(dye.(SurAfl(was( labeled(using(a(DyLight(488(NHS(Ester( (Thermoscientific).( In(brief,(500(
µL( of( SurAfl( at( a( concentration( of( 50( µM( is( mixed( with( 50( µg( of( DyLight( 488( NHS( Ester( at(
incubated( for(1(hour(protected( from( light.(To(remove(the(excess(of(dye,( the(protein(was( then(
dialyzed(four(times(against(1(L(of(AUC(buffer((25(mM(NaPi,(150(mM(NaCl,(pH(6.5).(The(labeled(
protein( at( a( fixed( concentration( of( 100( nM(was(mixed(with( SurAfl( at( concentrations( of( 15.7,(
31.3,( 62.5,( 125,( 250( and( 500(µM( in( a( 200(µL( volume.( The( samples(were( loaded( in(AUC( rotor(
cuvettes( and(measured( under( vaccum( at( 25°C.( The( sedimentation( coefficient( distribution( c(s)(
was( calculated( for( each( concentration( using( Sedfit( and( the( average( size( of( the( molecules( in(
solution(was(determined(for(each(concentration(using(the(fitted(frictional(ratio((! !!).((
The( weight( averaged( sGvalues( (sW)( were( calculated( from( the( c(s)( distribution( for( each(
concentration(using( the(program(GUSSI(and( its(distribution(was( fitted(using(a(monomerGdimer(
model[29]( (Eq.(6)(where(the(sedimentation(coefficient(of(the(dimer((Sdim)(was(fixed(to(6.2(s(and(
the(sedimentation(coefficient(of(the(monomer((Smono)(was(floating.(
!! = !!"# + !!"#" − !!"# ∙ −!! + !!! + 8 ∙ !!"! ∙ !! / 4 ∙ !!"! (((((((6)( (
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3.1 Introduction$
Cellular( metabolism( is( the( sum( of( all( the( biochemical( reactions( taking( place( within( a( cell,(
including( degradation( of( nutrients,( synthesis( of( macromolecules( or( small( precursors,( such( as(
amino( acids( or( electron( transfer[1].( Metabolism( takes( place( in( sequences( of( biochemical(
reactions(called(pathways(that(can(be(linear,(extensively(branched(or(cyclic.(Pathways(can(have(
as(precursor(an(earlier( reaction[2](and(can(have(different( functions.(The(glycolytic(pathway( is(a(
very(important(metabolic(pathway.(It(provides(energy(to(the(cell(in(the(form(of(ATP((adenosine(
triphosphate)( and( NADH( (reduced( nicotinamide( adenine( dinucleotide)( by( converting( glucose(
into( pyruvate( (Fig.( 3.1).( The( pathway( occurs( in( nearly( all( organisms,( both( aerobic,( consuming(
oxygen,( and( anaerobic,( growing( in( the( absence( of( oxygen.( Pyruvate,( the( end( product( of( the(
glycolytic(pathway,(is(a(branching(point(in(the(cell(metabolism(and(can(undergo(diverse(chemical(
reactions.( In( aerobic( organisms,( it( is( the( precursor( of( acetylNCoA( in( the( citric( acid( cycle(
(tricarboxylic(acid((TCA)(cycle(or(Krebs(cycle),(providing(energy(to(the(cell(in(the(form(of(ATP[3,(4](
while( in( anaerobic( organisms( it( is( converted( into( lactate( and( ethanol[5]( (Fig.( 3.1).( In( both(
organisms(it(is(also(used(to(produce(alanine(via(a(transamination(process.(All(metabolic(reactions(
are(catalyzed(by(enzymes,(up(or(down(regulating(the(different(pathways(through(their(sensitivity(
to( external( factors[6]( and( can( be( classified( in( two( broad( categories,( catabolic( and( anabolic(
reactions,( where( the( energy( produced( in( the( form( of( ATP( during( catabolic( pathways( by(
degrading(molecules(is(used(to(drive(anabolic(processes[2].((
In( the( cells,( changes( in( metabolism( upon( infection( is( a( critical( feature( that( has( to( be(
characterized( for(most( diseases( treatment.( NMR( spectroscopy(was( shown( to( be( a(method( of(
choice(to(study(these(changes(in(the(cell[7].(It(allows(nonNinvasive(monitoring(of(a(wide(range(of(
processes,(without(introducing(any(chemical(or(mechanical(perturbations(into(the(system.(NMR(
Studies(of(cell(metabolism(typically(use(31P,(13C,(1H(and(15N(for(their(abundance(in(the(biological(
compounds.(As(an(example,(the(naturally(abundant(31P(was(used(to(assess(the(energy(status(of(a(
cell(by(monitoring(the(intensity(of(resonances(form(adenosine(triphosphate((ATP)[8](as(well(as(to(
measure(the(precise(intracllular(pH[9].((
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Figure$ 3.1( Metabolic( pathways( in( the( cell( where( the( glycolytic( pathway( and( the( citric( acid( cycle(
(tricarboxylic(acid((TCA)(cycle(or(Krebs(cycle(are(depicted(as(well(as(metabolites(products(from(pyruvate.(
Enzymes,(catalyzing(the(reactions,(are(indicated(in(orange.(
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In( metabolomics( studies,( 13CNNMR( is( broadly( used( to( characterize( various( cell( pathways,( as(
carbons(are( found( in(most(biological(compounds.(However,(since(the(13C(natural(abundance( is(
only( 1.1( percent,( 13C( labeling( is( typically( required.( Thereby,( the( redistribution( of( a( 13CNlabeled(
nutrient( among( cellular( metabolites( is( monitored( using( 13CNNMR( experiments,( providing(
information(on(the(subsequently(labeled(compounds,(their(labeling(position(within(the(molecule(
as(well(as(their(concentration[10,(11].(Due(to(its( low(gyromagnetic(ratio,(detection(of(13C(labels( is(
often( limited( to( highly( abundant( compounds,( but( this( issue( can( be( overcome( by( its( indirect(
observation( via( the( more( sensitive( 1H( nuclei,( recording( 1HN13C( correlation( or( XNfiltered(
experiments[12].( There,( 1D( 12CNfiltered( and( 1D( 13CNfiltered( experiments( allow( the( detection( of(
protons(bound(to(12C(and(13C(nuclei(respectively,(providing(quantitative(information(on(fractional(
labeling( of( molecules.( 2D( correlation( NMR( experiments( were( also( used( to( characterize(
metabolites,( improving( the( spectral( resolution( by( editing( a( second( dimension[13,( 14].( These(
experiments( are( however( timeNconsuming( since( data( acquisition( of( the( second( dimension(
requires( longer( measurement( times.( These( long( times( could( lead( to( modification( of( cell(
metabolism( in( the( NMR( tube( as( well( as( to( the( detection( of( molecules( originating( from( an(
average( metabolism( that( does( not( corresponds( to( a( specific( physiological( state( of( the( cell.(
However,( this( issue( can( be( partially( overcome( by( the( use( of( fast( acquisition( spectroscopy[15],(
which(decreases(the(measurement(time(to(few(seconds[16].(NMRNbased(metabolism(studies(were(
broadly(performed(on( intact(cells[17N20](allowing(observation(of(active(metabolite(processes(and(
intracellular(milieu(but,(due(to(the(relative(insensitivity(of(the(method,(require(a(large(number(of(
cells(for(quantitative(measurements.(Thus,(metabolomics(by(NMR(is(mainly(limited(to(cell( lines(
that(can(be(grown(in(culture(condition,(such(as(cancer(cells(even(though(NMRNbased(metabolic(
studies(of(other(systems(have(been(performed,(including(macrophages[21,(22].(The(technique(thus(
also(suffers(from(cell(packing,(lack(of(oxygen,(accumulation(of(waste(products(or(pH(changes(in(
the( NMR( tube( that( can( modify( the( metabolism.( In( parallel,( metabolite( studies( of( extracted(
intracellular( media[19,( 23,( 24]( and( extracellular( media( (metabolic( footprinting)[25,( 26]( is( a( wellN
established( procedure( taking( advantage( of( better( resolution,( higher( sensitivity( and( possible(
addition( of( reference( compounds( for( unambiguous( assignments.( However,( the( destruction( of(
the( cell( sample( and( the( impossibility( to(monitor( continuous(metabolite( processes( can( lead( to(
erroneous(results(and(imply(the(collection(of(numerous(samples(at(different(time(points(to(cover(
a(complete(metabolic(process.((
Despite( significant( technological( and( biochemical( advancement,( the( application( of( NMR(
spectroscopy(to(measure(metabolic(processes(is(limited(by(the(intrinsically(low(sensitivity(of(the(
method.(To(overcome(this(issue,(various(techniques(have(been(proposed(to(enhance(the(nuclear(
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spin( polarization( among( which( optical( pumping[27]( or( dynamic( nuclear( polarization( (DNP)[28].(
These(hyperpolarization(methods(have(the(potential( to(create(a(polarization(close(to(unity(but(
suffer( form( intrinsic(physical( limitations.(Recently,(dissolution(dynamic(nuclear(polarization( (dN
DNP)(NMR(spectroscopy(has(been(developed(allowing(real(time(observation(of( living(cells(with(
high(sensitivity(by(enabling(close(to(unit(polarization(of(organic(molecules(in(a(liquid(solution[29](
and( was( shown( to( be( a( method( of( choice( to( characterize( metabolic( pathways( in( living( S.#
cerevisiae[30],(E.#coli[31,(32](or(breast(cancer(cells[33].(
In(this(chapter,(standard(NMR(spectroscopy(was(used(to(characterize(changes(in(metabolism(of(
cells( upon( infection( by( the( S.# flexneri( pathogen( (section( 3.2),( providing( new( insights( into( this(
highly(infectious(process.(In(section(3.3,(dNDNP(NMR(spectroscopy(was(applied(for(the(first(time(
to(macrophages,(where(metabolic(pathways(could(be(observed(in(real(time,(demonstrating(the(
possible(application(of(this(technique(to(a(large(range(of(systems(as(well(as(its(major(upcoming(
contribution(to(the(metabolic(field.(
(
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Shigella reroutes host cell central metabolism to
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Shigella flexneri proliferate in infected human epithelial cells at
exceptionally high rates. This vigorous growth has important con-
sequences for rapid progression to life-threatening bloody diar-
rhea, but the underlying metabolic mechanisms remain poorly
understood. Here, we used metabolomics, proteomics, and genetic
experiments to determine host and Shigella metabolism during
infection in a cell culture model. The data suggest that infected
host cells maintain largely normal fluxes through glycolytic path-
ways, but the entire output of these pathways is captured by
Shigella, most likely in the form of pyruvate. This striking strategy
provides Shigella with an abundant favorable energy source,
while preserving host cell ATP generation, energy charge mainte-
nance, and survival, despite ongoing vigorous exploitation. Shi-
gella uses a simple three-step pathway to metabolize pyruvate
at high rates with acetate as an excreted waste product. The crucial
role of this pathway for Shigella intracellular growth suggests tar-
gets for antimicrobial chemotherapy of this devastating disease.
infectious diseases | host–pathogen interactions
Infectious diseases typically arise when pathogens grow to hightissue loads, causing extensive damage and immunopathology.
An outstanding example is Shigella flexneri, which rapidly grow
from a small infectious dose of 10–100 bacteria (1) to intestinal
loads causing life-threatening bloody diarrhea (bacillary dysen-
tery) within a few hours (2, 3). This vigorous Shigella growth
occurs inside human colon epithelial cells and requires an in-
tegrated Shigella pathogenesis program, including a type three
secretion system encoded on the Shigella virulence plasmid.
Using this system, Shigella translocates enzymes into the host cell
cytosol, where they target key cellular functions, allowing Shigella
to enter the host cell and escape bacterial killing by innate im-
mune responses (4). After Shigella reaches the host cell cytosol,
many virulence factors are down-regulated (5), and Shigella starts
rapid proliferation.
Biomass generation at such high rates depends on extensive
exploitation of intracellular host nutrients (6). The host cell cy-
toplasm contains hundreds of metabolites, but it is unclear which
of these potential nutrients Shigella uses, how the host cell can
supply them at sufficiently high rates to support rapid Shigella
growth, and why host cells can sustain viability while being vig-
orously exploited by intracellular Shigella. For related enter-
oinvasive Escherichia coli, previous research has shown that
glucose and other host metabolites, such as diverse amino acids,
can be incorporated into the biomass of these closely related
pathogens (7). However, quantitative data are still lacking, and
energy production, which is usually a major part of nutrient use (8),
could not be analyzed because of technical limitations.
In general, pathogen metabolism has been recognized as a fun-
damentally important aspect of infectious diseases, but available
data are mostly restricted to qualitative presence/absence of enzymes
in pathogen genomes and metabolite or gene expression profiles
in various infection models (9–13). Comprehensive quantitative
studies on pathogen nutrition, metabolism, and growth are largely
lacking. This limited knowledge reflects, in part, the fact that suit-
able methodologies are just becoming available. In this study, we
combined various metabolomics approaches, proteomics, and mi-
crobial genetics to elucidate the metabolic basis of Shigella rapid
growth in infected human host cells.
Results
Shigella Grow Rapidly Inside HeLa Host Cells. We infected HeLa
epithelial cells with S. flexneri 2a 2457T icsA. The icsA mutation
prevents spread between host cells (14, 15), thereby simplifying
analysis of intracellular growth. In this model, Shigella grew
rapidly with a generation time of 37 ± 4 min (Fig. S1 and Movie
S1), close to maximal axenic growth rates in rich broth and faster
than almost all other pathogens in their respective host envi-
ronments. Infected HeLa cells remained intact until around 3.5–
4 h postinfection, when their cytoplasm was packed with more
than 100 Shigella. The HeLa cells subsequently detached and
disintegrated, which was observed previously (16).
Host Central Metabolism Remains Functional During Shigella Infection.
Rapid intracellular Shigella growth likely causes a substantial
Significance
Shigella causes devastating bloody diarrhea. Rapid disease
progression results from exceptionally fast Shigella growth in-
side human gut epithelial cells, but how Shigella can obtain
nutrients at such high rates from its host cell has been unclear.
Here, we show that infected host cells maintain normal central
metabolism for energy production and host cell survival. How-
ever, Shigella captures the entire host metabolism output and
degrades it further to acetate. This striking strategy provides
Shigellawith an abundant supply of a favorable energy source,
while preserving host cell viability for prolonged exploitation.
The crucial role of acetate metabolism for Shigella growth
suggests potential new targets for antimicrobial chemotherapy.
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metabolic burden on the infected host cell. Metabolite quantifica-
tion in infected and uninfected cells identified some metabolites
with differential concentrations (Tables S1 and S2), but surpris-
ingly, the energy charge, a measurement of relative ATP, ADP, and
AMP levels, did not change significantly on infection (uninfected
cells, 0.83 ± 0.03; infected cells, 0.80 ± 0.05). This observation
showed that infected cells largely maintain their energy production,
despite ongoing exploitation by Shigella.
Quantitative metabolite analyses of pathogen-infected host
cells encounter the general technical challenge that pathogen
and host cell contents are not easily separable within the re-
quired time frame. Available separation techniques would in-
evitably cause a time delay of up to minutes, during which rapid
reactions, such as ATP hydrolysis, would substantially alter me-
tabolite concentrations. To avoid such artifacts, we quenched the
cell culture immediately and determined combined metabolite
concentrations from infected cells and Shigella. Because of the
much larger volume of human cells compared with Shigella, most
of these data are probably dominated by host metabolites. As
an example, we experimentally determined Shigella adenosine
phosphate (AXP) contents in various axenic cultures (glucose or
pyruvate as sole energy/carbon source provided at 0.1 or 1 g L−1).
The results showed that 50 Shigella cells contained 0.25–0.69
fmol ATP, 0.19–0.35 fmol ADP, and 0.04–0.05 fmol AMP. Even
when subtracting these potential Shigella contributions from the
combined AXP levels of infected HeLa cells, the HeLa-only
AXP values would still yield an energy charge of 0.79 ± 0.02,
suggesting a very minor impact of Shigella AXP on calculated
host cell energy charge values, which was expected based on the
different cell volumes of HeLa and Shigella.
Various mechanisms could enable infected host cells to
maintain their energy charge, despite Shigella exploitation. In
particular, infected cells might increase nutrient uptake from the
extracellular environment (17). However, under the experimen-
tal conditions used here, uninfected and infected cells consumed
glucose at similar rates (9.0 ± 1.1 vs. 9.3 ± 1.3 fmol/min per cell),
whereas uptake of glutamine, another potentially major nutrient
for mammalian cells, remained below 0.5 fmol/min per cell.
To determine metabolic fluxes involved in host cell ATP
production, we switched unlabeled glucose in the external me-
dium to uniformly labeled (U-) 13C glucose and monitored sub-
sequent 13C incorporation in diverse metabolites using mass
spectrometry (MS) (Fig. 1A and Table S3). Uninfected HeLa
cells showed uptake and catabolism of glucose through Embden–
Meyerhof and pentose phosphate pathways but very little feeding
into tricarboxylic acid (TCA) cycle intermediates, indicating
predominant ATP generation through fermentation, which was
previously shown for HeLa and other cancer cell lines (18, 19).
Interestingly, infected HeLa cells, which contained around 50
rapidly growing Shigella at 2.5 h postinfection, had almost
Fig. 1. (A) 13C-incorporation kinetics for various metabolites in uninfected (blue) or infected (red) HeLa cells after feeding of U-13C glucose. The 13C-labeling
percentage is calculated as the fraction of the labeled species (2-13C for acetyl-CoA and U-13C for others) relative to the total metabolite pool. Data are
represent means and SDs of six independent experiments (Table S3 shows the full dataset). (B) Extracellular metabolites before (black) and 3 h after (red)
infection as detected by 1D 1H NMR (Fig. S3 shows identification of acetate by 2D [13C,1H] NMR). Uninfected HeLa cells are shown for comparison (blue). The
medium contained U-13C glucose. (C) 13C labeling of extracellular acetate in medium containing U-13C–labeled compounds (glc*, glucose; gln*, glutamine) or
unlabeled compounds (glc, glucose; gln, glutamine). Data represent means and SDs of three independent experiments. (D) Overview of 13C labeling of
metabolites from U-13C glucose in infected HeLa cells. Font color and superscripts indicate the percentage of the labeled species (2-13C for acetyl-CoA and
U-13C for others) after 20 min (all intracellular metabolites) or 1 h (acetate) of feeding with 13C glucose. Data represent means from six independent
experiments. PPP, pentose phosphate pathway and related metabolites.
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identical label incorporation kinetics in Embden–Meyerhof and
pentose phosphate pathway intermediates and marginal flux into
the TCA cycle. This flux distribution suggested that host cells
maintained their energy charge during infection by using the
main preexisting energy-producing glycolytic pathways. Pro-
teome comparisons revealed that, in general, host cell enzyme
abundance changed little during infection (Fig. S2), arguing
against a major reorganization of the host metabolic network
during infection. This proteomics result was consistent with
previous data on unaltered host cell amino acid biosynthesis
during infection with related enteroinvasive E. coli (7).
Infection Reroutes Carbon Flux to Acetate Excretion. The apparently
minor impact of infection on central host metabolism was sur-
prising, because Shigella obviously must redirect major metabolic
fluxes and capture abundant metabolites to sustain its rapid
proliferation. Indeed, our 13C glucose isotope-tracking experi-
ments showed one remarkable difference between infected and
uninfected cells: a substantial fraction (56 ± 11%) of the acetyl
moiety in acetyl-CoA was rapidly labeled exclusively in infected
cells (Fig. 1A and Table S3). Interestingly, this 13C was hardly
transferred to TCA cycle intermediates, suggesting metabo-
lization through other pathways. To identify potential end
products, we analyzed metabolites in the cell culture medium by
NMR spectroscopy. Uninfected cells converted glucose to lac-
tate and pyruvate (Figs. 1B and 2A), which was expected for this
cell line (20). Surprisingly, lactate and pyruvate excretion was
completely abolished in Shigella-infected cells (Figs. 1B and 2A).
Instead, these cells excreted acetate at a ratio of 2.1 ± 0.3 acetate
per consumed glucose (Figs. 1B and 2A and Fig. S2, identifica-
tion of acetate by NMR). Experiments using media containing
13C glucose or 13C glutamine showed that most acetate originated
from glucose but not glutamine (Fig. 1C).
Together, these data showed that, in infected cells, the dom-
inant glycolytic pathways were fully functional but that their
entire output was rerouted to acetate (Fig. 1D). This finding was
in marked contrast to Shigella-infected macrophages that be-
come metabolically inactive and rapidly die (21) because of
IpaB-mediated pyroptosis (22).
Shigella Produces Acetate from Pyruvate. Acetate is the dominant
waste product of rapidly growing Enterobacteriaceae, such as
Shigella and E. coli (23). Specifically, Shigella uses phospho-
transacetylase (PTA) to convert acetyl-CoA to acetyl phosphate
and acetate kinase (ACKA) to convert acetyl phosphate and
ADP to acetate and ATP. To test the role of this Shigella acetate-
generating pathway during infection, we constructed Shigella pta
and ackA mutants. Both Shigella mutants had substantial in-
tracellular growth defects (40–60% of parental strain) (Fig. 2B
and Table S4). Complementation of the pta mutant with an
episomal pta allele rescued normal growth, indicating that the
Shigella pta phenotype was caused by the deletion of pta. The
reduced mutant growth rates resulted in strongly diminished
Shigella loads after 3.5 h of infection (13 ± 2 Shigella pta and 8 ±
1 Shigella ackA per HeLa cell vs. 73 ± 9 parental Shigella),
consistent with longer generation times. Over an entire day of
infection, these longer generation times could lead to some
500,000-fold lower Shigella loads for mutants vs. the parental
strain (assuming continuous growth). These data show that the
acetate pathway is active and essential for normal Shigella in-
tracellular growth. Similar data for polarized Caco-2 cells and
human umbilical vein endothelial cells (HUVECs) (Table S4)
suggested analogous Shigella metabolic strategies in a colon ep-
ithelial cell line as well as primary human cells.
HeLa cells infected with Shigella pta or ackA excreted lactate
and pyruvate but very little acetate (Fig. 2A). These data sug-
gested that most of the acetate excreted from HeLa cells that
were infected with the Shigella parental strain was a product of
Shigella pyruvate to acetate conversion, which largely depends on
a functional PTA–ACKA pathway (23). The low residual acetate
production of cells infected with Shigella pta or ackA mutants
could reflect alternative Shigella pathways [such as pyruvate
oxidation mediated by pyruvate oxidase (POXB)] or host cell
activities (23). HeLa cells incubated together with gentamicin-
killed Shigella excreted no acetate, again consistent with acetate
as a product of Shigella metabolism.
Together, these data suggest that infected cells switched from
lactate excretion to acetate excretion as a result of Shigella cap-
turing host metabolites and converting them to acetate primarily
through the PTA–ACKA pathway.
Pyruvate Is Taken Up by Shigella from the Host Cytosol. To de-
termine potential host metabolites that fuel Shigella acetate gen-
eration, we mutated additional metabolic genes. Shigella aceE
deficient for pyruvate dehydrogenase and thus, impaired in con-
version of pyruvate to acetyl-CoA showed a strong growth defect
and largely abolished acetate production, suggesting that pyruvate
was a major source of acetyl-CoA and acetate in Shigella (Fig.
2B and Table S4).
Fig. 2. (A) Net metabolite excretion of uninfected HeLa cells and HeLa cells
infected with various Shigella strains between 2 and 3 h postinfection de-
termined by NMR spectroscopy. Data represent means and SDs of three in-
dependent experiments. (B) Intracellular generation time of Shigellamutant
strains (μmut) relative to the parental strain (μpar; pta/pPTA, Shigella pta
mutant complemented in trans with an episomal pta allele). A value of 1.0
(dashed line) corresponds to unimpaired growth. Data represent means and
SDs of 34–56 replicate wells. Detailed data and statistical analysis are in
Table S4. (C) 13C labeling of extracellular acetate in medium containing
U-13C–labeled compounds (glc*, 25 mM glucose; pyr*, 5 mM pyruvate) or
unlabeled compounds (glc, 25 mM glucose; pyr, 5 mM pyruvate). Data
represent means and SDs of three independent experiments. (D)
13C-incorporation kinetics of acetyl-CoA, phosphoenolpyruvate, and citrate
in infected HeLa cells after feeding U-13C pyruvate in the presence of
a fivefold excess of unlabeled glucose. Labeling percentage refers to the
fraction of 2-13C (acetyl-CoA) or U-13C (PEP and citrate) metabolite relative to
the total metabolite pool. Data represent means and SDs of three in-
dependent experiments (full dataset is in Table S5).
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Shigella could obtain this pyruvate directly from the host cell
cytoplasm or generate it itself from other host cell metabolites
through glycolysis and/or lactate oxidation. A Shigella manXYZ
galP ptsG mglBAC uhpT mutant unable to use glucose and
mannose as well as hexose phosphates exhibited unimpaired
growth (Fig. 2B and Table S4). A pykA pykF ptsI mutant de-
fective for the last step of glycolysis [conversion of phospho-
enolpyruvate (PEP) to pyruvate], which cannot grow on any
glycolysis intermediate upstream of pyruvate in vitro, had
a moderate growth defect (77 ± 10% of the parental strain’s
intracellular growth rate) (Fig. 2B and Table S4). These data
indicated the importance of the PEP–pyruvate conversion but
also showed substantial growth of Shigella, even without the use
of any host glycolysis intermediate. This mutant phenotype was
consistent with unabated 13C-label incorporation in host cell
metabolites from hexose phosphate all of the way down to py-
ruvate, suggesting at most, minor consumption of host cell
intermediates upstream of pyruvate by Shigella. These data are in
agreement with previous studies showing no growth of closely
related E. coli on key glycolysis intermediates 3-phosphoglycerate,
2-phosphoglycerate, and phosphoenolpyruvate (24), and toxic
effects of excessive uptake of organophosphates (25). Finally,
Shigella ldhA lldD incapable of lactate utilization also maintained
normal growth, arguing against lactate as a critical source of py-
ruvate (Fig. 2B and Table S4). Taken together, these data suggested
direct uptake of pyruvate by Shigella from the host cell cytoplasm as
the main supply route. A major role of pyruvate and its apparently
complete conversion into acetate was also consistent with the fact
that pyruvate (oxidation state +2) is a highly acetogenic substrate
compared with nutrients with a lower oxidation state, such as glu-
cose (23).
Initially, it was surprising that just a few Shigella cells could
apparently capture the entire glycolysis output of much larger
HeLa cells. However, Shigella can efficiently use external pyru-
vate as a sole carbon and energy source. Indeed, NMR spec-
troscopy revealed that Shigella consumed pyruvate in vitro at a rate
of 0.35 ± 0.06 fmol min−1 per Shigella in M9 minimal medium
containing 1 mM pyruvate and nicotinic acid and 0.1% tryptic soy
broth as supplements. Based on these data, some 50 Shigella can
indeed consume all pyruvate generated by host metabolism in an
infected HeLa cell (around 20 fmol min−1; see above).
Direct validation of Shigella pyruvate uptake during in-
tracellular growth would require a mutant with blocked pyruvate
uptake. Unfortunately, several yet unidentified high-affinity py-
ruvate transporters exist in Shigella/E. coli (26). We deleted
multiple tentative candidates [yhjE (27); actP, a homolog ofmctC
(28); ycaM and ybaT, putative transporter genes up-regulated in
E. coli on pyruvate-containing media (29)], but the resulting
combination mutant was still able to grow rapidly on pyruvate in
vitro, showing the presence of other yet unidentified pyruvate
import mechanisms.
As an alternative approach, we added 13C pyruvate to the
external medium of infected HeLa cells and tracked the labeled
carbon. NMR analysis of the extracellular medium revealed
efficient conversion of 13C pyruvate to 13C acetate, even in the
presence of an excess of unlabeled glucose (Fig. 2C), consistent
with preferred use of pyruvate over glucose and glycolysis
pathway intermediates. Indeed, the only detectable intracellular
metabolite that rapidly acquired substantial amounts of 13C in
infected cells was acetyl-CoA, whereas directly adjacent metab-
olites PEP and citrate were not labeled or labeled at much lower
rate (Fig. 2D and Table S5). Their poor labeling rules out
Embden–Meyerhof and pentose phosphate pathways or TCA
cycle intermediates as relevant sources of the strongly labeled
excreted acetate and supports a direct conversion of host-derived
pyruvate to acetyl-CoA and acetate by Shigella.
Together, these data suggest major Shigella nutrient use through
a short pathway: pyruvate (host cytoplasm)→ pyruvate (Shigella)→
acetyl-CoA (Shigella) → acetyl-phosphate (Shigella) → acetate
(Shigella)→ acetate (host cytoplasm)→ acetate (medium) (Fig. 3).
For each pyruvate molecule, this pathway yields one ATP in the
conversion of acetyl-phosphate to acetate. Because one molecule of
glucose is essentially fully converted into two excreted acetate
molecules, this pathway predominantly provides energy, but not
carbon, for Shigella growth. The limited role of pyruvate as a car-
bon source might explain why this major pathway escaped de-
tection in previous metabolic studies of related pathogens using
methods focusing on pathogen biomass incorporation (10).
Intracellular Shigella Consume Oxygen by Respiration. Oxidation of
glucose to pyruvate and pyruvate to acetate yields reducing
equivalents that might, in part, be used for Shigella biosynthetic
pathways, such as lipogenesis. In addition, infected cells con-
sumed oxygen at a rate of 0.07 ± 0.02 fmol/min per Shigella,
whereas uninfected cells had undetectable oxygen consumption
in our assay. This oxygen consumption was mostly caused by
Shigella respiration, because cells infected with Shigella ubiC
menA (lacking ubiquinone and menaquinone required for aer-
obic respiration) consumed much less oxygen (0.003 ± 0.001
fmol/min per Shigella). This observation is consistent with com-
monly observed active respiration during acetate production in
Enterobacteriaceae (23). Additional work is required to identify
which of the many potential intermediate electron donors/
acceptors are involved in the various host and Shigella redox
reactions.
Additional Nutrients Support Shigella Growth. In addition to the
major energy source pyruvate, Shigellamight obtain other nutrients
from the host cell cytoplasm to meet its biomass demands. We
analyzed Shigella mutants with utilization defects for 18 diverse
metabolites that are known to be available in human cell cyto-
plasm (30). However, all mutants except one had growth rates
indistinguishable from the parental strain (Tables S6 and S7). The
weak but significant growth defect of fadD fadK suggests a po-
tential small contribution of host fatty acids to Shigella growth. We
also analyzed growth phenotypes of 11 auxotrophic Shigella
mutants that depend on external supplementation of specific
nutrients for growth (Tables S6 and S7). High intracellular
growth rates of these auxotrophs showed Shigella access to di-
verse amino acids in sufficient amounts to fully meet their re-
spective Shigella biomass needs, which was previously observed
for closely related pathogens (10). Asparagine, proline, and
purine nucleosides were also available but only in limiting
amounts, requiring additional Shigella biosynthesis for full
Fig. 3. Metabolic overview of Shigella-infected HeLa cells. Uninfected cells
(blue) convert glucose to lactate. In infected cells (red), Shigella takes up
glucose-derived pyruvate from the host cytoplasm and converts it to acetate,
which is excreted into the environment. In addition, Shigella uses host fatty
acids, amino acids, and purine nucleosides. Thick and thin arrows indicate
major and minor carbon flux routes, respectively. The dashed arrows rep-
resent reactions not supported by available evidence.
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growth. Availability of these (and possibly, additional) diverse
nutrients represented another important contribution to support
vigorous intracellular Shigella growth. However, compared with the
massive throughput of pyruvate use, uptake of additional nutrients
for Shigella biomass production must be rather low: based on ac-
etate excretion, each Shigella consumed, on average, 1.2 pg pyru-
vate but generated total new biomass of only 0.4 pg (31) within one
generation time (37 min).
We incorporated our data for Shigella pyruvate consumption,
respiration, and additional biomass supplementation in an in
silico genome-scale metabolic model of closely related E. coli
(32). According to this model, the measured fluxes would enable
Shigella growth with generation times in the range of 33–54 min
(based on error margins of the underlying experimental data),
which is in good agreement with our experimentally determined
generation time of 37 ± 4 min, showing that nutrients identified
in this study can largely explain the outstandingly rapid in-
tracellular Shigella growth as one precondition for the rapid and
dramatic disease progression in dysentery.
Discussion
Rapid disease progression in bacillary dysentery is the result of
vigorous Shigella growth in gut epithelial cells. In addition to
a large number of virulence factors that interfere with host sig-
naling networks, this fast growth requires massive Shigella ex-
ploitation of host metabolism for high-flux nutrient supply.
However, infected cells remain viable for several hours until they
contain more than 100 bacteria. In this study, we show that Shigella
does not affect the main host cell energy production pathways—
Embden–Meyerhof and pentose phosphate pathways—but in-
stead, consumes their entire output at the level of pyruvate. For
this purpose, Shigella uses a short pyruvate-to-acetate pathway
that Enterobacteriaceae typically use during rapid growth under
nutrient-rich conditions (23). S. flexneri cannot reuse acetate later,
because it lacks acetyl-CoA synthetase that is present in closely
related E. coli (33).
This pathway generates only a single ATP for each pyruvate
molecule (and some additional ATP through oxidation of NADH),
and it is far less efficient in terms of ATP generation compared
with the TCA cycle (up to 14 ATP per pyruvate) that predom-
inates under nutrient-poor conditions. However, the low-yield
acetate pathway has lower enzyme costs and membrane space
requirements and can operate at much faster rates compared with
low-throughput, high-yield TCA cycle/oxidative phosphorylation,
which requires bulky enzymatic machinery in the bacterial inner
membrane. The acetate pathway can, thus, cope with high nutrient
supply rates that would saturate the respiratory chain (overflow
metabolism) (34). Similar switches to low-yield/high-rate pathways
are observed for many microbial cells (Crabtree effect) (23) as well
as cancer cells (Warburg effect) (20) during rapid growth.
The use of abundant pyruvate predominantly through this low-
yield, high-speed acetate pathway represents a typical metabolic
pattern of Enterobacteriaceae in general (23). Interestingly, this
default pathway could offer several additional important benefits
to Shigella during intracellular growth in infected human cells: (i)
use of a favorable abundant energy source, pyruvate, at high
rates; (ii) exploitation of the dominant preexisting host meta-
bolic pathways as high-flux supply lines without requiring major
host cell metabolism alterations that could cause delays and limit
supply; and (iii) preservation of host cell energy charge by gly-
colytic ATP generation, allowing extended host cell survival,
despite vigorous exploitation. Taken together, a short metabolic
pathway that is commonly present in many bacteria enables
Shigella to efficiently exploit major nutrient supply routes in
infected host cells. This preadaptation might explain why Shigella
can thrive as a voracious pathogen with only minor metabolic
adaptations to the host cell intracellular environment compared
with closely related extracellular commensals (33, 35). In addition
to the major energy source pyruvate, Shigella accessed diverse
host metabolites for direct biomass incorporation. Computational
modeling revealed that all these nutrients together were sufficient
to support the experimentally observed rapid Shigella intra-
cellular growth.
An important caveat of our study was the use of cancer cell
lines as host cells that ferment glucose to lactate to satisfy their
energy needs (the Warburg effect). Dysentery is a disease of the
colon, and the epithelial cells in this location, the colonocytes,
have a different metabolism. Some 80% of ATP produced in
colonocytes comes from mitochondrial oxidation of butyrate,
which is derived from gut microbiota. However, experiments with
germ-free mice have shown that, in the absence of microbiota-
derived butyrate, colonocytes switch from burning butyrate to
fermenting glucose to lactate (36). It is possible that the flushing
action of diarrhea during dysentery removes much of the micro-
biota, thereby lowering butyrate levels in the colon and triggering
colonocyte metabolism similar to HeLa cell metabolism in our in
vitro model. Additional studies are required to clarify this issue.
Comprehensive quantitative data on pathogen nutrition, me-
tabolism, and growth in host environments are largely lacking.
However, comparison of the Shigella data with our recent study on
Salmonella enterica metabolism in a mouse typhoid fever model
(37) reveals commonalities and striking differences. Shigella, like
Salmonella and many other pathogens (37), exploits the fact that
most biomass components are readily available in infected host
environments. Uptake of these biomass components can save
substantial biosynthesis costs. However, Shigella has access to
a high-flux supply for pyruvate that provides sufficient energy
to drive fast growth, whereas intracellular Salmonella has access
to many diverse but only scarce energy sources that together just
support slow nutrient-limited growth (37). This striking difference
may reflect the fact that Shigella reside directly in the host cyto-
plasm, whereas intracellular Salmonella are surrounded by
a phagosomal membrane with apparently poor permeability in
macrophages (their main target cell type during systemic infec-
tions). Additional studies with other pathogens might clarify the
general relevance of these distinct metabolic patterns.
Although host pyruvate supply enables vigorous Shigella pro-
liferation, the heavy dependence on pyruvate metabolism makes
Shigella also vulnerable to metabolic perturbation. Indeed, our
mutant data for the corresponding enzymes show dramatically
reduced Shigella loads compared with the parental strain, even
within short infection times. The residual slow growth of these
mutants and their altered waste product spectrum show that
Shigella can use alternative pathways, such as pyruvate oxidase,
but these pathways are far less efficient for supporting growth
as expected (23). Importantly, the key enzymes phospho-
transacetylase (PTA) and acetate kinase (ACKA) have no
human homologs, suggesting that specific inhibition of Shigella
enzymes without adverse effects on human metabolism might be
possible. Shigella acetate metabolism enzymes could, thus, rep-
resent promising targets to control bacillary dysentery.
Materials and Methods
Strains and Plasmids. HeLa Kyoto cells (38) and HUVECs were provided by
Cécile Arrieumerlou and Claudia Mistl (Biozentrum, University of Basel).
Caco-2 cells (ATCC-HTB-37) were obtained from the American Type Culture
Collection. S. flexneri 2a 2457T icsA was provided by M. B. Goldberg (Mas-
sachusetts General Hospital, Boston). All mutants in this work were derived
from this icsA strain (referred to as the parental strain). Mutants were
constructed as described (39) using a λ-red recombinase-mediated allelic
replacement system introducing a flippase recognition target sites-flanked
chloramphenicol resistance marker (40) followed by purification using
phage P1 transduction. Combinations of multiple deletions were made by P1
transduction into mutants, in which the chloramphenicol resistance was
removed using flippase. For complementation of the pta mutant, we cloned
pta together with its native promoter (intergenic region upstream of the
ackA-pta operon) on a medium copy number plasmid (pA15 ori). All strains
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carried plasmid pNF106 (SC101 ori) for doxycycline/anhydrotetracycline-
inducible expression of gfp (39).
Labeled Nutrients. [U-99% 13C]-labeled glucose, [U-99% 13C;U-99% 15N]-labeled
glutamine, and [U-99% 13C]-labeled pyruvate were purchased from Cambridge
Isotopes Laboratories.
Shigella Infections. HeLa cells, CaCo-2 cells, and HUVECs were infected with
polylysine-treated Shigella. After 30 min, cells were washed and treated
with gentamicin. Intracellular growth of GFP-expressing Shigella was de-
termined using flow cytometry and plating. Protocols for infections and
growth determination are described in detail in SI Materials and Methods.
Proteomics of Infected Cells. Cells were harvested, digested with trypsin/
chymotrypsin, and analyzed by MS as described in SI Materials and Methods.
Measurement of Intracellular Metabolites by MS. Uninfected and infected cells
were quenched with acetonitrile/methanol/formic acid. Samples were ana-
lyzed by MS. Detailed protocols are described in SI Materials and Methods.
Measurement of Glucose Uptake Rates. Glucose consumption was determined
using the EnzyChrom Glucose Assay Kit (Bioassay Systems) as described in SI
Materials and Methods.
Measurement of Excreted Extracellular Metabolites. Supernatants of un-
infected and infected cells were analyzed by 1D 1H NMR spectroscopy as
described in SI Materials and Methods.
Oxygen Consumption Measurements. Oxygen consumption of infected and
uninfected cells was determined using Oxoplates (OP96C; PreSens) and a
fluorescent plate reader as described in SI Materials and Methods.
Modeling of Intracellular Shigella Metabolism. Experimental metabolite up-
take rates and mutant phenotypes were combined with a modified E. coli
metabolism reconstruction (32) to model intracellular Shigella metabolism
using Flux-Balance Analysis as described in SI Materials and Methods.
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SI Materials and Methods
HeLa Infections. HeLa cells were cultivated in DMEM (Sigma)
containing 10 mM Hepes, 25 mM glucose, and 4 mM glutamine.
HeLa cells were initially seeded in DMEM supplemented with
10% (vol/vol) fetal calf serum and penicillin/streptomycin solu-
tion (100 units/mL; Invitrogen). At 16 and 3.5 h before infection,
medium was exchanged for serum-free DMEM containing glu-
cose and glutamine (5 mM pyruvate was also included in some
experiments). Shigella was grown to exponential phase in tryptic
soy broth, coated with poly-L-lysine, and added at a multiplicity
of infection (MOI) of 75 (metabolomics and proteomics) or 10
(growth rate assays). Shigella was centrifuged onto HeLa cells
(600 × g for 5 min). At 30 min postinfection, we added genta-
micin (gent; 100 μg/mL) to kill extracellular bacteria and
1 μg/mL anhydrotetracycline (aTc) to induce gfp expression in
live intracellular bacteria. In metabolomics experiments, we used
200 ng/mL doxycycline instead of aTc to avoid addition of the
aTc solvent ethanol. At an MOI of 75, typically around 90% of
the HeLa cells became infected and reached a Shigella load of
∼50 in infected cells at 2.5 h postinfection, which was determined
by comparing GFP amounts of infected cells and individual
Shigella released by shear stress using flow cytometry.
Infections of Caco-2 Cells and Human Umbilical Vein Endothelial Cells.
We infected Caco-2 and human umbilical vein endothelial cells
and analyzed them for intracellular Shigella growth as described
for HeLa cells with the following differences: human umbilical
vein endothelial cells were cultivated in Gibco Medium 199
(product no. 22340020; Life Technologies) and infected with an
MOI of 200. Caco-2 cells were grown in DMEM on 3-μm cell
culture filter inserts (product no. 353492; Becton Dickinson) to
facilitate infection from the basal side of this polarized cell line,
mimicking the natural route of Shigella infection of gut epithelial
cells. Differentiation of Caco-2 cells was achieved using the
BioCoat Intestinal Epithelium Differentiation Environment Kit
(product no. 355057; Becton Dickinson). To infect Caco-2 cells,
we flipped inserts upside-down, placed custom-made plastic caps
on the inserts, and added poly-L-lysine–coated Shigella (MOI of
100 or more). After centrifugation (1 min at 600 × g), inserts
were flipped back and filled with 0.5 mL DMEM.
Intracellular Growth Rate Determination. HeLa cells were infected
with Shigella at an MOI of 10 (to minimize multiple infections of
the same host cell). Gent and aTc were added at 30 min post-
infection. Cells were trypsinized and fixed at 2.5 or 3.5 h post-
infection. Shigella loads of infected cells were determined by
comparing GFP amounts in infected cells and individual Shigella
liberated by shear stress using flow cytometry. These GFP-based
data closely agree with the colony-forming units (CFUs) as de-
termined by plating, and both methods also yield similar values
for the fold increase between two time points postinfection (Fig.
S1). Furthermore, live cell imaging shows that almost all GFP-
Shigella rapidly replicate during intracellular infections (Movie
S1). These data suggest that GFP particles represent viable
Shigella, similar to previous observations for Salmonella (1).
Our infection cultures might also contain some dead Shigella,
because we killed extracellular Shigella with gent after 30 min to
synchronize the infection. Importantly, we induced gfp ex-
pression only after this addition of gent. Extracellular Shigella is
immediately inhibited in its protein synthesis and thus, remains
GFP-negative and dies (we confirmed blocked GFP synthesis
in control experiments). In contrast, intracellular Shigella is
protected from extracellular gent, starts to express GFP, and
stays alive.
Taken together, all GFP-Shigella seems to be alive, whereas
potentially present dead Shigella remains GFP-negative. These
data support the use of flow cytometry high-throughput mea-
surements for assessing intracellular Shigella growth. We de-
termined growth rates by calculating the increase in Shigella
loads between 2.5 and 3.5 h postinfection. HeLa cells infected
with the parental strain contained 24 ± 4 and 73 ± 9 Shigella
at 2.5 and 3.5 h postinfection, respectively, corresponding to
a generation time of 37 ± 4 min. Data for Shigella mutants are
represented as relative rates compared with the parental strain.
Proteomics of Infected Cells.HeLa cells were infected at an MOI of
75 and sampled at 3 h postinfection together with uninfected
controls (six biological replicates each). Cells were washed two
times with PBS, treated with a 4 °C quenching solution [EDTA-
free protease inhibitor mixture (Roche), 6 M urea, 0.1 M
NH4HCO3], and harvested by scraping. Samples were sonicated
three times for 45 s and stored at −80 °C. For each sample, 500 μg
protein was digested with trypsin/chymotrypsin (2), desalted, dried,
and reconstituted in 3% (vol/vol) acetonitrile and 0.2% (vol/vol)
formic acid for a final peptide concentration of 0.25 μg/μL. MS
analyses were carried out on an LTQ-Orbitrap Velos Mass Spec-
trometer (Thermo Scientific) coupled to an Eksigent-Nano-HPLC
System (Eksigent Technologies). For each run, 1 μg peptides were
loaded on a self-made C18 column (75 μm × 150 mm, 3 μm, 200 Å)
and eluted with a gradient from 3% to 35% (vol/vol) acetonitrile in
142 min (flow rate = 250 nL/min). The acquisition method con-
sisted of one survey scan (MS) followed by 20 dependent scans
(MS/MS) looped throughout the run. All samples were run two
times. Proteins were identified using the Mascot 2.3.02 Search
Engine (Matrix Science) against an in-house database containing
human (Swissprot), S. flexneri 2457T, Escherichia coli MG1655, and
reversed decoy sequences as well as the common contaminants.
Peptides identified with a Mascot ion score higher than 40 were
accepted, resulting in a protein false discovery rate of 1.65%. Label-
free quantification was performed using Progenesis LC-MS v.4.0
(Nonlinear Dynamics), normalizing on all human features.
Measurement of Intracellular Metabolites by MS. For each condition,
we prepared three (six for isotope tracking with 13C glucose) in-
dependent biological replicates on different days. HeLa cells were
grown on 28-mm coverslips to allow quick washing and quenching
of cells. Samples were taken at 2.5 h postinfection. For quantifi-
cation of metabolite concentrations, coverslips were briefly
washed in rapidly stirred ddH2O at 37 °C and dropped into 8 mL
quenching solution (40% acetonitrile, 40% methanol, 20% 0.5 M
formic acid, all vol/vol) at −20 °C together with a 13C standard
prepared from Methylobacterium extorquens and Saccharomyces
cerevisiae containing 13C-labeled metabolites of known concen-
tration. Total time for washing and quenching was 2 s. Quenched
samples were sonicated, freeze-dried, and dissolved in ddH2O. To
remove debris, samples were centrifuged, and the supernatant was
transferred to new tubes and centrifuged a second time.
To determine Shigella adenosine phosphates content, Shigella
cultures were grown until an OD600 of 0.1 in M9 minimal me-
dium containing 0.1 or 1 g L−1 glucose or 0.1 or 1 g L−1 pyruvate.
Shigella cells were sampled during exponential growth by fast
filtration without washing (3, 4). For quenching and metabolite
extraction, filters were transferred into −20 °C cold quenching
solution (acetonitrile:methanol:0.5 M formic acid at 60:20:20).
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For analysis of 13C incorporation kinetics using 13C glucose or
13C pyruvate, coverslips were washed in DMEM lacking glucose
or pyruvate, transferred to DMEM containing 13C glucose or 13C
pyruvate, and incubated for 30 s, 1 min, 2 min, 5 min, or 20 min
before washing in ddH2O and quenching (which was always done
at 2.5 h postinfection). Unquenched control samples were tryp-
sinized, fixed, and analyzed by flow cytometry to estimate in-
fection efficiency and Shigella load. Additional control samples
were used to count the number of HeLa cells per coverslip.
All metabolites except pyruvate were measured by liquid
chromatography–mass spectrometry (MS). Samples were diluted
1:4 (vol:vol) with a tributylamine solution (1.7 mM acetic acid,
3.28 mM tributylamine adjusted to pH 9.2 with ammonium hy-
droxide). Analytical measurements were performed using a
nanoliquid chromatography system (nano-2D Ultra LC; Eksi-
gent Technologies Inc.) coupled to a tandem mass spectrometer
(LTQ Orbitrap; Thermo Fisher Scientific) as described pre-
viously (5) with slight modifications. The stationary phase was
replaced by HaLo C18 particles (2.7 μm; New Objective Inc.), and
the tributylamine solution had a slightly lower pH of 9.2. Xcalibur,
version 2.1 (Thermo Fisher Scientific) and eMZed (6), version 1.3
were used for data acquisition and analysis, respectively.
Pyruvate was measured by gas chromatography-MS. Samples
were derivatized with trimethylsilane and analyzed on a Waters
GCT Premier Spectrometer (Waters) equipped with Restek GC
Column Rxi-5Sil MS (Restek Corporation). Acquisition and data
analysis were performed with MassLinx software (Waters) as
described previously (7).
Measurement of Glucose Uptake Rates. Three independent bi-
ological replicates of infected or uninfected HeLa cells were
prepared on different days. Supernatant samples were taken at
2 and 3 h postinfection, and glucose was quantified using the
EnzyChrom Glucose Assay Kit (Bioassay Systems). The culture
medium contained 2.5 mM (instead of 25 mM) glucose to
achieve a measureable decrease in concentration between 2 and
3 h postinfection. Lowering the glucose concentration did not
affect lactate or acetate excretion in uninfected or infected cells,
and for uninfected cells, uptake rates at 2.5 and 25 mM deter-
mined over 10 h were similar. Uptake of glutamine, measured
with the EnzyChrom Glutamine Assay Kit (Bioassay Systems),
was below the detection threshold of 0.5 fmol/min per cell for
both uninfected and infected HeLa cells.
Measurement of Excreted Extracellular Metabolites. Three inde-
pendent biological replicates of infected or uninfected HeLa cells
were prepared on different days. At 20 min postinfection, cells
were switched to DMEM containing gent, doxycyclin, and un-
labeled or uniformly labeled 13C glucose, glutamine, and/or py-
ruvate. Supernatant samples were taken at 20 min, 2 h, and 3 h
postinfection. After medium sampling, infection efficiency and
Shigella load were determined by flow cytometry, and HeLa cells
were counted for each sample.
All NMR samples were prepared by diluting 100 μL super-
natant medium to a total volume of 500 μL with 5% (vol/vol)
D2O, 20 μM trimethylsilylproprionate, and 0.05% (wt/vol) so-
dium azide in the final sample. All experiments were recorded at
30 °C on Bruker Avance III Spectrometers with field strengths
of 600, 700, or 800 MHz. The spectra were calibrated using
trimethylsilylproprionate as chemical shift reference (8). To
quantify the amounts of unlabeled and labeled metabolites, 1D
1H NMR experiments with 12C and 13C filtering were recorded
(9). NMR data were processed and analyzed using Topspin. For
concentration determination, the PULCON method (10) was
used combined with interactive intensity scaling relative to ref-
erence spectra of pure compound samples with uniformly labeled
13C or natural abundance labeling.
Oxygen Consumption Measurements. Infections were done as for
growth rate assays, except that 96-well plates containing an
oxygen-sensitive fluorescence sensor (Oxoplates OP96C; PreSens)
were used. After addition of gent/aTc at 20 min postinfection, the
medium in each well was overlaid with 100 μLmineral oil, and the
plate was sealed with VIEWseal Transparent Film (Greiner Bio-
One) to prevent oxygen exchange between medium and ambient
air. Fluorescence was continuously recorded in a plate reader for
4 h, and oxygen concentrations were calculated according to the
manufacturer’s protocol.
Modeling of Intracellular Shigella Metabolism. We started with a
genome-scale in silico reconstruction for closely related E. coli
(11) and removed genes present in E. coli but absent in S. flex-
neri, including cadA, nadB, and acs. The resulting reconstruction
was used as an approximation for Shigella. Shigella growth was
modeled by Flux-Balance Analysis using the COBRA 2.0 Tool-
box (12) in a MATLAB environment. Uptake rates for pyruvate
and oxygen as well as acetate excretion rates were derived from
our experimental data. Uptake rates for amino acids, nucleo-
sides, and nicotinic acid were estimated based on intracellular
growth rates of Shigella auxotrophs as recently described for
Salmonella (13).
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Fig. S1. Comparison of flow cytometry and plating for analysis of Shigella infections. (A) Number of GFP particles as detected by flow cytometry and colony-
forming units (CFUs) as determined by plating per well of infected HeLa cells. The data represent means and SDs of 10 wells each for two time points (2.5 and
3.5 h postinfection) from three independent experiments. (B) Fold increase in CFUs or GFP particles between 2.5 and 3.5 h postinfection as calculated from data
shown in A.
Fig. S2. Changes in protein levels of HeLa cells on Shigella infection. The levels of 1,848 host proteins were measured in infected and uninfected HeLa by MS-
based shot gun proteomics; 58 proteins (3.1%) had at least twofold abundance differences (27 less abundant in infected cells and 31 more abundant in infected
cells) and q values < 0.05. These differentially abundant proteins included six metabolic enzymes (red circles). Data represent geometric means (abundance
ratios) and q values calculated from six independent experiments. AKR1A1, Aldo-keto reductase family 1 member A1 (oxidoreductase with broad specificity);
ATP5F1, mitochondrial ATP synthase subunit 8 (involved in energy production); MT-ATP8, mitochondrial ATP synthase subunit 8 (involved in energy pro-
duction); NDUFB4, mitochondrial NADH dehydrogenase (ubiquinone) 1 β-subcomplex, subunit 4 (involved in energy production through aerobic respiration);
NUDT5, Nudix type 5 motif hydrolase (degrades toxic ADP ribose, a potential NAD+ degradation product, and other toxic nucleoside derivatives); UQCRH,
mitochondrial cytochrome b-c1 complex subunit 6 (involved in energy production through aerobic respiration).
Fig. S3. Identification of extracellular metabolites from infected HeLa cells by 2D [13C,1H] heteronuclear multiple quantum coherence NMR. The subspectrum
with 13C-enriched acetate (red square) is plotted at higher-contour base level to account for the increased signal intensity relative to the other natural
abundance cross-peaks. gln, Glutamine.
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Table S1. Intracellular metabolite levels of infected and uninfected HeLa cells: metabolites with absolute
quantification
Metabolite
Concentration (x × mol/cell)
Log10 (infected/uninfected;
range; P value)x Uninfected Infected
Hexose 1-phosphate 10−17 33 ± 7 12 ± 3 −0.42 (−0.58 to −0.30; 0.00)
UTP 10−16 39 ± 11 15 ± 5 −0.41 (−0.66 to −0.25; 0.02)
Pantothenic acid 10−17 143 ± 50 62 ± 24 −0.36 (−0.68 to −0.18; 0.05)
cADP ribose 10−18 186 ± 56 91 ± 32 −0.31 (−0.58 to −0.15; 0.00)
Fumarate 10−17 110 ± 32 55 ± 10 −0.30 (−0.48 to −0.17; 0.01)
CTP 10−17 153 ± 44 78 ± 32 −0.29 (−0.59 to −0.12; 0.08)
UDP 10−17 141 ± 58 75 ± 40 −0.27 (−0.76 to −0.05; 0.01)
Malate 10−16 28 ± 7 15 ± 4 −0.25 (−0.43 to −0.13; 0.03)
ATP 10−16 88 ± 23 51 ± 22 −0.23 (−0.54 to −0.06; 0.01)
Hexose 6-phosphate 10−17 121 ± 28 72 ± 3 −0.23 (−0.34 to −0.14; 0.01)
Mesaconic acid 10−18 44 ± 24 27 ± 5 −0.21 (−0.58 to −0.01; 0.12)
Sedoheptulose 7-phosphate 10−17 26 ± 13 16 ± 4 −0.20 (−0.55 to −0.01; 0.02)
2-Deoxy-ATP 10−18 88 ± 22 56 ± 19 −0.20 (−0.44 to −0.04; 0.00)
ADP 10−16 26 ± 10 17 ± 9 −0.20 (−0.66–0.02; 0.03)
ADP-pentose 10−20 129 ± 66 85 ± 72 −0.18 (−2.50–0.12; 0.95)
Glycerate bisphosphate 10−18 112 ± 27 76 ± 40 −0.16 (−0.54–0.03; 0.05)
GTP 10−16 19 ± 4 13 ± 6 −0.14 (−0.43–0.03; 0.02)
CDP 10−17 21 ± 9 16 ± 8 −0.14 (−0.64–0.09; 0.23)
GDP 10−17 65 ± 27 48 ± 24 −0.13 (−0.60–0.09; 0.68)
AMP 10−17 84 ± 30 67 ± 31 −0.10 (−0.49–0.10; 0.11)
Glutathione oxidized 10−16 104 ± 18 83 ± 26 −0.10 (−0.29–0.04; 0.69)
Triose phosphate (DHAP, GAP) 10−17 58 ± 24 48 ± 26 −0.09 (−0.59–0.14; 0.09)
Ethylmalonic acid 10−17 14 ± 5 13 ± 3 −0.05 (−0.29–0.10; 0.66)
UMP 10−17 13 ± 5 12 ± 5 −0.04 (−0.42–0.15; 0.39)
Aconitate 10−18 36 ± 13 33 ± 7 −0.04 (−0.27–0.12; 0.82)
Gluconate phosphate 10−17 43 ± 14 41 ± 7 −0.02 (−0.22–0.12; 0.01)
GMP 10−17 12 ± 4 12 ± 6 0.00 (−0.39–0.20; 0.12)
Citrate 10−16 11 ± 4 12 ± 1 0.01 (−0.17–0.14; 0.65)
TDP 10−19 70 ± 31 73 ± 34 0.02 (−0.43–0.23; 0.13)
CMP 10−18 45 ± 16 64 ± 20 0.16 (−0.12–0.33; 0.01)
α-Ketoglutarate 10−17 70 ± 19 133 ± 23 0.28 (0.11–0.40; 0.01)
Hexose 1,6-bisphosphate 10−16 11 ± 3 23 ± 11 0.32 (−0.02–0.51; 0.01)
Sedoheptulose bisphosphate 10−18 82 ± 16 246 ± 62 0.48 (0.31–0.60; 0.00)
Glycerate phosphate 10−17 24 ± 5 136 ± 8 0.75 (0.65–0.84; 0.00)
Glyceric acid 10−17 23 ± 6 159 ± 20 0.85 (0.70–0.95; 0.03)
PEP 10−18 50 ± 11 437 ± 3 0.94 (0.84–1.02; 0.00)
Pentose 5-phosphate 10−17 21 ± 5 285 ± 25 1.14 (1.01–1.23; 0.00)
Ribose 5-phosphate 10−17 34 ± 10 891 ± 186 1.42 (1.22–1.56; 0.00)
Data represent means and SDs of three independent replicates. DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde-3-phos-
phate; PEP, phosphoenolpyruvate.
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Table S2. Intracellular metabolite levels of infected and uninfected HeLa cells: metabolites
with relative quantification
Metabolite
Signal (a.u.)
Log10 (infected/uninfected;
range; P value)Uninfected Infected
Serine phosphate 1,160 ± 232 29 ± 5 −1.6 (−1.73 to −1.5; 0.00)
AICAR 253 ± 50 54 ± 44 −0.67 (−1.44 to −0.41; 0.01)
Propionyl-CoA 139 ± 41 46 ± 21 −0.48 (−0.82 to −0.29; 0.90)
UDP-N-acetylglucosamine 28 ± 9 11 ± 5 −0.42 (−0.75 to −0.23; 0.03)
dTTP 139 ± 46 56 ± 24 −0.4 (−0.74 to −0.21; 0.00)
Glyceryl-phosphate 28 ± 8 11 ± 4 −0.4 (−0.66 to −0.24; 0.03)
UDP-diphosphoglucurate 23 ± 8 12 ± 6 −0.29 (−0.75 to −0.08; 0.45)
NAD 153 ± 43 83 ± 28 −0.26 (−0.51 to −0.11; 0.00)
FAD 31 ± 9 19 ± 8 −0.22 (−0.51 to −0.04; 0.08)
UDP-Hexose 25 ± 7 15 ± 6 −0.22 (−0.52 to −0.04; 0.03)
Succinyl-CoA 36 ± 11 28 ± 7 −0.12 (−0.34–0.02; 0.12)
NADH 36 ± 14 27 ± 11 −0.12 (−0.48–0.07; 0.51)
Sedoheptulose phosphate 15 ± 3 16 ± 5 0.04 (−0.17–0.17; 0.98)
Acetyl-CoA 10 ± 3 18 ± 3 0.23 (0.03–0.37; 0.00)
N-acetyl-glutamate 67 ± 21 125 ± 10 0.27 (0.1–0.39; 0.00)
Succinate 36 ± 6 119 ± 22 0.51 (0.39–0.61; 0.00)
Pentose 1,5-bisphosphate 57 ± 35 461 ± 271 0.9 (0.1–1.17; 0.00)
MECDP — 12 ± 2 —
dTDP-D-fucose/rhamnose — 17 ± 6 —
Data represent means and SDs of three independent replicates. AICAR, 5-aminoimidazole-4-carboxamide
ribonucleotide; dTDP, thymidine diphosphate; dTTP, thymidine triphosphate; FAD, flavin adenine dinucleotide;
MECDP, 2-C-methyl-D-erythritol-2.4-cyclodiphosphate (Shigella metabolite not present in uninfected cells).
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Table S4. Intracellular growth of Shigella mutants with deficiencies around the pyruvate node
Shigella strain
μmut/μpar (n) P value q ValueName Genotype* Defective step
HeLa
SHP236 ΔmanXYZ ΔgalP ΔptsG ΔmglBAC uhpT::kan Glucose, mannose, hexose-P uptake 0.97 ± 0.11 (33) 0.16 n.s.
SHM10 ΔptsI ΔpykA pykF::kan PEP ↔ pyruvate 0.77 ± 0.10 (32) 0.0001 <0.001
SHP550 ppsA::cam Pyruvate → PEP 1.07 ± 0.10 (21) 0.007 0.009
SHP555 aceE::kan Pyruvate ↔ acetyl-CoA 0.39 ± 0.19 (43) 0.0002 <0.001
SHP578 pflB pflD tdcE ybiYW yfiD Pyruvate ↔ acetyl-CoA 1.02 ± 0.07 (16) 0.21 n.s.
SHP437 ldhA::kan lldD::cam Lactate ↔ acetyl-CoA 1.01 ± 0.14 (47) 0.78 n.s.
SHP374 pta:kan Acetyl-CoA ↔ acetyl-P 0.62 ± 0.14 (56) 0.0001 <0.001
SHP410 ackA::kan Acetyl-P ↔ acetate 0.41 ± 0.11 (34) 0.0001 <0.001
Caco-2
SHP555 aceE::kan Pyruvate ↔ acetyl-CoA 0.66 ± 0.30 (18) 0.0002 <0.001
SHP374 pta:kan Acetyl-CoA ↔ acetyl-P 0.64 ± 0.24 (13) 0.0002 <0.001
HUVEC
SHP555 aceE::kan Pyruvate ↔ acetyl-CoA 0.21 ± 0.22 (6) 0.0003 <0.001
SHP374 pta:kan Acetyl-CoA ↔ acetyl-P 0.51 ± 0.19 (8) 0.0001 <0.001
HUVEC, human umbilical vein endothelial cell; n.s., q value > 0.05; PEP, phosphoenolpyruvate.
*All mutants were derivatives of the icsA parental strain; μmut/μpar is the growth rate of the mutant (μmut) relative to the parental strain (μpar). Data represent means
and SDs of n replicate culture wells. Statistical differences were analyzed by a two-tailed t test followed by Benjamini–Hochberg correction for multiple testing.
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Table S6. Intracellular growth of Shigella nutrient utilization mutants
Strain name Genotype*
Utilization defect
(defective for use of. . .) μmut/μpar (n) P value q Value
SHP078 amtB::kan Ammonium 1.03 ± 0.04 (10) 0.08 n.s.
SHP079 lldP::kan yghK::cam Lactate 0.95 ± 0.05 (9) 0.01 n.s.
SHP084 glnHPQ::kan Glutamine 1.00 ± 0.05 (8) 0.82 n.s.
SHP126 uhpT::kan Hexose phosphate 1.03 ± 0.13 (21) 0.31 n.s.
SHP127 ΔrbsC ΔrbsD xylFGH::kan D-RIBOSE 1.02 ± 0.06 (9) 0.31 n.s.
SHP128 sdaC::kan Serine 0.97 ± 0.08 (7) 0.36 n.s.
SHP129 kgtP::kan α-Ketoglutarate 1.04 ± 0.08 (4) 0.38 n.s.
SHP130 ΔytfRT ΔgalP fucP::cam mglBAC::kan Galactose 1.01 ± 0.11 (18) 0.61 n.s.
SHP155 ΔgltJKL gltS::kan gltP::cam Glutamate 0.94 ± 0.08 (10) 0.04 n.s.
SHP168 ΔmanXYZ ΔgalP ptsG::cam mglBAC::kan Glucose and mannose 1.02 ± 0.09 (21) 0.41 n.s.
SHP169 ptsI:kan PTS carbohydrates 1.03 ± 0.07 (12) 0.17 n.s.
SHP171 ΔfucP ΔmanXYZ fruBKA::kan Fructose 1.05 ± 0.10 (4) 0.42 n.s.
SHP196 ΔyhcL ΔdctA ΔdcuC ΔdcuA dcuB::kan C4 dicarboxylates 0.96 ± 0.08 (9) 0.19 n.s.
SHP240 ΔgntU ΔgntP kdgT::cam gntT::kan Gluconate 1.01 ± 0.05 (11) 0.72 n.s.
SHP263 nupG::kan nupC::cam Nucleosides 0.96 ± 0.09 (7) 0.26 n.s.
SHP384 ΔglpT ugpBAEQ::kan Glycerol-phosphate 0.95 ± 0.12 (31) 0.02 n.s.
SHP280 Δggt gsiABCD::kan Glutathione 0.94 ± 0.11 (9) 0.13 n.s.
SHP492 fadK::cam fadD::kan Fatty acid 0.90 ± 0.05 (12) 0.0001 0.002
SHP408 citE::kan Citrate 1.01 ± 0.07 (24) 0.63 n.s.
n.s., q value > 0.05.
*All mutants were derivatives of the icsA parental strain; μmut/μpar is the growth rate of the mutant (μmut) relative to the parental strain (μpar). Data represent means
and SDs of n replicate culture wells. Statistical differences were analyzed by two-tailed t test followed by Benjamini–Hochberg correction for multiple testing. PTS,
phosphotransferase system.
Table S7. Intracellular growth of auxotrophic mutants
Strain name Genotype*
Biosynthesis defect
(auxotrophic for. . .) μmut/μpar (n) P value q Value
SHP300 glnA::cam Glutamine 1.06 ± 0.11 (10) 0.12 n.s.
SHP239 hisG::kan Histidine 0.93 ± 0.10 (10) 0.051 n.s.
SHP259 serA::kan Serine 1.02 ± 0.10 (6) 0.58 n.s.
SHP260 asnB::kan asnA::cam Asparagine 0.49 ± 0.11 (32) <0.0001 <0.001
SHP261 thrC::kan Threonine 0.99 ± 0.12 (4) 0.91 n.s.
SHP270 argH::kan lysA::cam Arginine, lysine 1.03 ± 0.12 (4) 0.68 n.s.
SHP305 metA::cam Methionine 1.01 ± 0.03 (10) 0.51 n.s.
SHP336 ilvE::kan leuB::cam Leucine, valine, isoleucine 1.03 ± 0.08 (10) 0.27 n.s.
SHP375 ΔtyrA trpA::kan pheA::cam Phenylalanine, tyrosine, tryptophan 0.97 ± 0.12 (10) 0.34 n.s.
SHP475 proC::kan Proline 0.56 ± 0.14 (10) <0.0001 <0.001
SHP198 purH::kan Purines 0.86 ± 0.06 (9) <0.0001 <0.001
n.s., q value > 0.05.
*All mutants were derivatives of the icsA parental strain; μmut/μpar is the growth rate of the mutant (μmut) relative to the parental strain
(μpar). Data represent means and SDs of n replicate culture wells. Statistical differences were analyzed by two-tailed t test followed by
Benjamini–Hochberg correction for multiple testing.
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Movie S1. Intracellular growth of GFP-expressing Shigella (green) in HeLa cells stained with Wheat Germ Agglutination-Texas Red (red).
Movie S1
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3.3 Direct$Observation$of$Metabolic$Events$in$
Living$Macrophages$by$Dissolution$Dynamic$
Nuclear$Polarization$NMR$Spectroscopy*
$
!
$
Abstract$
Within(the(last(ten(years,(the(development(of(dissolution(dynamic(nuclear(polarization((dNDNP)(
NMR(spectroscopy(provided(the(sensitivity(to(follow(real(time(metabolic(processes(in(the(cell.(So(
far,( it(was( successfully( applied( to( several( systems( such( as(E.# coil( or(S.# cerevisiae,( allowing( the(
characterization( of(metabolic( pathways( such( as( glycolysis( or( the( TCA( cycle.( Here,( for( the( first(
time,( dissolutionNDNP( NMR( spectroscopy( was( applied( to( macrophages.( We( show( that(
hyperpolarized( [UN2H,N13C]Nglucose( and( 13C1Npyruvate( metabolisation( can( be( followed( in( real(
time.( The( end(products( of(metabolic( pathways( are(detected,( at( increasing( concentration(with(
time,( in( the( NMR( spectra.( Our( findings( show( that( dissolutionNDNP( NMR( spectroscopy( can( be(
applied( to( a( broad( range(of( cellular( systems,( and( can(become( routinely( applied( for(metabolic(
studies( in( the(cell.( In( the(case(of(macrophages,(we(aim( to(characterize( the(metabolic( changes(
induced(by(activation(from(a(basal(state(to(the(M1(phenotype.(
$
$
$
$
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Introduction$
Standard(NMR(spectroscopy(is(a(powerful(tool(to(characterize(metabolites(and(metabolic(flux(in(
the( cell,( allowing( nonNinvasive( measurement( of( cellular( compounds[1N9].( However,( the(
intrinsically( low(sensitivity(of( the(method(generally( limits( its(use( to( specific( cell( lines(or(highly(
concentrated(cell(media.(To(overcome(this(issue,(a(range(of(methods(was(proposed(to(increase(
the(nuclear(spin(polarization,(called(hyperpolarization(methods.(In(particular(optical(pumping[10],(
paraNhydrogenNinduced( polarization[11]( and( dynamic( nuclear( polarization[12]( were( shown( to(
increase(polarization(close(to(unit(but(are(still(limited(to(specific(samples(and(applications.(In(the(
last( ten( years,( dissolution( dynamic( nuclear( polarization( (dNDNP)( NMR( spectroscopy( was(
developed,( enabling( close( to( unit( polarization( of( organic( molecules( in( a( liquid( solution[13]( by(
hyperpolarization( of( the( nuclear( spins( in( the( solid( state,( transferring( the( high( electron(
polarization(to(other(nuclei(using(microwave( irradiation(at( low(temperature,( followed(by(rapid(
dissolution.(This(method(enables(to(bring(the(polarized(cold(sample(into(a(liquid(state(preserving(
its(nuclear(polarization[14],(enhancing(the(singleNscan(liquidNstate(13C(NMR(signalNtoNnoise(ratio(by(
factors( of( 10,000( or( more[13].( DissolutionNDNP( NMR( spectroscopy( has( high( potential( in( the(
metabolomics(filed,(where(administration(of(hyperpolarized(metabolites(with(13C(enrichment(to(
cell( suspensions( has( been( used( to( characterize( metabolism( associated( with( glycolysis( of( S.#
cerevisiae[15],(E.#coli[16,(17],(breast(cancer(cells[18](or(perfused(rat(heart[19].(Recent(developments,(as(
the(use(of(deuterated(molecules(or(cross(polarization(transfer(to(increase(polarization(levels(and(
lifetime[20],(extends(its(use(to(a(large(range(of(molecular(processes(in(the(cell.(
Here( we( applied( for( the( first( time( dissolutionNDNP( NMR( spectroscopy( to( living(macrophages.(
Macrophages( are( the( “big( eaters”( of( the( immune( system( that( engulf( apoptotic( cells( and(
pathogens( and( produce( immune( effector(molecules( in( a( process( called( phagocytosis[21].( Upon(
infection,( they( undergo( specific( activation( profiles( from( a( basal( to( a( classical( state( (M1)(
encouraging( inflammation( and( stimulating( the( immune( system( or( an( alternative( state( (M2)(
decreasing( inflammation( and( encouraging( tissue( repair,( modifying( their( metabolism[22,( 23].(
Metabolic( changes( associated( to( the( activation( to( a(M1( phenotype( (Fig.( 3.2)( are( induced( by(
bacterial(derived(products(such(as( lipopolysaccharides[24]( (LPS),(as(well(as(by(signals(associated(
with(infection(from(which(interferon(gamma((IFNNγ)( is(among(the(most(important[25].(Mainly,( it(
downNregulates(mitochondrial(oxidation[22](while(glycolysis(is(upNregulated(resulting(in(high(rates(
of( glucose( consumption( and( conversion( of( pyruvate( to( lactate[26,( 27].( As( well,( the( proN
inflammatory(cytokine(production(is(up(regulated[28].(Altogether,(these(metabolic(events(provide(
rapid( energy( and( reducing( equivalents( to( the( cell,(which( are( required( for( bactericidal( activity.(
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Here,(we(show,(for(the(first(time,(that(dNDNP(NMR(could(be(used(to(study(realNtime(metabolism(
of(living(macrophages,(using([UN2H,N13C]Nglucose(and(13C1Npyruvate(as(hyperpolarized(nutrients.(
(
(
$
$
Figure$ 3.2.(Overview(of( the(macrophages(metabolism.(a)( Simplified( view(of(macrophage(metabolism( in(
the(basal(state.(b)(Simplified(view(of(macrophage(metabolism( in(the(M1(state.(The(upNregulation(of( the(
glycolytic(pathway(is(indicated(by(bold(arrows.((
$
Results$
The$short$T1$of$[UL13C]Lglucose$limits$its$use$as$a$hyperpolarized$nutrient$
In(an(attempt(to(visualize(the(different(metabolites(of(the(glycolytic(pathway(in(macrophages,(a(
similar( procedure( than( previously( developed( by( Meier( et# al.( was( applied[15].( Hyperpolarized(
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glucose,( efficiently( incorporated( and(metabolized( by( the( cell( at( a( rate( of( 1( –( 3( nmol( /(min( /(
million(cell,(was(used(as(a(nutrient.((
(
(
(
Figure$3.3.(Zoom(of(time(series(of(1D(13C(spectra(of( living(macrophages(fed(with(hyperpolarized([Ua13C]N
glucose,( recorded( every( 6( seconds.( The( lower( spectrum( is( recorded( 4( seconds( after( injection( of(
hyperpolarized([UN13C]Nglucose.(Glycerol,(as(an(excreted(product,(is(highlighted(in(red.(
(
(
867(mM(UN13C(glucose(was(hyperpolarized(in(the(solid(state(and(subsequently(quickly(dissolved(
by( superheated( D2O.( After( dissolution,( the( hyperpolarized( sample( was( automatically( injected(
into( a( suspension( of( 80( million( macrophages( in( the( basal( state,( residing( in( a( 500(MHz( NMR(
spectrometer( in( order( to( detect( chemical( transformation( of( the( substrate( by( the( cells.(
Subsequently,( a( series( of( 1D( 13C( spectra( was( recorded( every( second( for( a( total( time( of( 256(
seconds.( The( spectra( displayed( glycerol( resonances( only,( used( as( a( glassing( agent( during( the(
hyperpolarized(sample(preparation( (Fig.(3.3).(The(absence(of(detectable(hyperpolarized(signal,(
besides( glycerol,( was( attributed( to( the( fast( T1( of( the( protonated( UN13C( glucose,( of( about( 6(
seconds,(leading(to(a(rapid(loss(of(the(hyperpolarization(by(crossNrelaxation(via(protons,(before(
reaching( the( cell( suspension.( In( comparison,( the( perdeuterated( glycerol( displayed( a( longer(T1(
allowing(its(detection(in(the(NMR(spectra.(
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Hyperpolarized$ [UL2H,L13C]$ glucose$ as$ a$ nutrient$ to$ follow$ glycolysis$ cycle$ in$
macrophages$
In( order( to( provide( a( sufficiently( long( T1( for( dNDNP( NMR( measurement,( [UN2H,N13C]Nglucose,(
displaying( a( T1( two( times( longer( than( the( protonated( version,( was( used( as( hyperpolarized(
nutrient( for( macrophages.( The( same( experiment( was( performed,( where( 867(mM( [UN2H,N13C]N
glucose(was(hyperpolarized( in(the(solid(state,(dissolved(by(superheated(D2O(and(automatically(
injected( into(a(suspension(of(80(million(macrophages( in(the(basal(state,( residing( in(a(500(MHz(
NMR(spectrometer.( Subsequently,( a( series(of(1D( 13C( spectra(was( recorded(at(37°C(during(256(
seconds(after(dissolution((Fig(3.4a).(
(
(
Figure$ 3.4.(Macrophages( fed(with( hyperpolarized( [UN2H,N13C]Nglucose.( a)( Zoom( of( time( series( of( 1D( 13C(
spectra( of( living( macrophages( fed( with( hyperpolarized( [UN2H,N13C]Nglucose,( recorded( every( 6( seconds,(
normalized( to( the( signal( of( glucose.( The( lower( spectrum( is( recorded( 4( seconds( after( injection( of(
hyperpolarized([UN2H,N13C]Nglucose.(Glucose(resonances(are(highlighted(in(green(and(excreted(products(in(
red.( b)( Zoom( of( 1D( 13C( spectra( of( living( macrophages( fed( with( hyperpolarized( [UN2H,N13C]Nglucose,(
recorded(at(thermal(equilibrium(30(min(after(injection(of(hyperpolarized([UN2H,N13C]Nglucose.(Resonances(
labeled(with(*(correspond(to(impurities.(
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There( the( resonances(of( the(hyperpolarized(glucose(were(detected(as(well( as(glycerol(derived(
from( glucose,( possibly( through( the( conversion( of( the( glycolysis( metabolite( dihydroxyacetone(
phosphate(via(glycerolN3Nphosphate.(The(increase(of(the(glycerol(resonances(over(time(indicated(
its(accumulation(in(the(sample.(Weak(resonances,(undergoing(intensity(increase(over(time(were(
detected(as(well(at(67.8,(69.5,(81,(83.5,(101.2,(105.5(and(106.5(ppm((data(not(shown)(but(could(
not( be( assigned( to( any( of( the( metabolites( that( are( part( of( the( glycolytic( pathway.( 1D( 13C(
spectrum(recorded(on(the(macrophages(suspension(at(“thermal(equilibrium”,(in(the(absence(of(
hyperpolarization,( 30( minutes( after( dissolution( (Fig.( 3.4b),( displayed( resonances( from( lactate(
and(alanine.((
Intermediate(metabolites(of(the(glycolytic(pathway(are(not(detected(in(this(experiment(because(
of(their(low(concentration,(as(they(are(constantly(produced(and(metabolized(by(the(cells,(while(
the(end(product(glycerol(is(accumulating(over(time.(Surprisingly,(lactate(was(not(detected(during(
the(first(90(seconds(of(measurement(whereas( it(appeared(as(an(end(product.(This(observation(
indicates( a( longer( and( /( or( less( efficient( conversion( of( glucose( to( pyruvate( /( lactate( than( to(
glycerol.( Comparison( to( different( cell( systems( indicates( that( the( glycolytic( pathway( in(
macrophages(is(longer(than(in(E.coli(or(S.#cerevisiae(where(pyruvate(and(lactate(production(were(
observed(during(the(first(seconds(of(measurements[15,(16].((
$
Hyperpolarized$13C1Lpyruvate$used$as$a$nutrient$by$macrophages$$
In(an(attempt(to(visualize(the(downstream(metabolites(of(the(glycolytic(pathway,(13C1Npyruvate(
was( used( as( a( hyperpolarized( nutrient.( Its( T1( of( 70( seconds,( 6( times( longer( than( [UN2H,N13C]N
glucose,( enables( long( measurement( times( of( the( hyperpolarized( compounds.( 1.5( M( 13C1N
pyruvate(was( hyperpolarized( to( 28(%( in( the( solid( state( and( subsequently( quickly( dissolved(by(
superheated(D2O.(After(dissolution,(the(hyperpolarized(sample(was(automatically(injected(into(a(
suspension( of( 80( million( macrophages( in( the( basal( state,( residing( in( a( 500( MHz( NMR(
spectrometer( in( order( to( detect( chemical( transformation( of( the( substrate( by( the( cells.(
Subsequently,( a( series( of( 1D( 13C( spectra(was( recorded( every( second( for( a( total( time( of( 1280(
second.( Figure( 3.5( displays( the( sum( of( the( initial( 30( 1D( 13C( spectra( recorded( on(macrophage(
suspension( fed(with( hyperpolarized(pyruvate.( Resonances( of( pyruvate(C1( (172.9( ppm)( and( 13C(
natural( abundant( pyruvate( C2( (207.9( ppm)(were( detected( as( well( as( pyruvate( hydrate( (181.2(
ppm)(produced(from(pyruvate(in(our(setup(condition[29].(Resonances(of( lactate(C1((185.1(ppm),(
alanine(C1((178.5(ppm),(bicarbonate((HCO3N,(160.6(ppm)(and(CO2((125.2(ppm)(were(visible(in(the(
NMR(spectra.(The(conversion(of(pyruvate(signal(into(several(products(was(detected(in(real(time(
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and(occurred(within(few(seconds((Fig.(3.6a).(Metabolites(that(were(quickly(formed(and(yielded(
signals(were( lactate(C1,(alanine(C1,(bicarbonate(and(CO2(directly(produced(from(pyruvate.(They(
were( detected( only( 10( seconds( after( 13C1Npyruvate( injection,( indicating( its( conversion( to(
downstream(products(of(about(that(time.(Lactate(approached(its(maximum(signal(level(within(80(
seconds(after(pyruvate(injection((Fig.(3.6b).(As(an(end(product,(it(should(accumulate(inside(and(
outside(the(cell,(and(its(decrease(in(concentration(observed(in(the(NMR(spectra(after(80(seconds(
could(indicates(a(metabolic(change(in(the(NMR(tube(leading(to(a(consumption(of(lactate(by(the(
cells.(Alanine,(bicarbonate(and(CO2(were(formed(considerably(slower(and(in(fewer(amounts(than(
lactate(and(their(production(was(observed(during(all(the(measurement(time(frame.$(
$
$
$
$
$
$
Figure$3.5.(Metabolism(of(macrophages(suspension(fed(with(hyperpolarized(pyruvate.(Sum(of( the( initial(
30(1D(13C(spectra(recorded(on(living(macrophage(fed(with(hyperpolarized(13C1Npyruvate.(Excreted(products(
are(highlighted(in(red(and(resonances(of(the(hyperpolarized(nutrient(in(green.(Resonances(labeled(with(*(
correspond(to(impurities.(
(
(
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$
Figure$ 3.6.( Metabolism( of( living( macrophages( fed( with( hyperpolarized( 13C1Npyruvate.( a)( Zoom( of( time(
series(of(1D(13C(spectra(of!living!macrophages!fed!with!hyperpolarized(13C1Npyruvate,(recorded(every(30(
seconds,( normalized( to( the( signal( of( pyruvate( C1.( The( lower( spectrum( is( recorded( 15( seconds( after(
injection(of(hyperpolarized(13C1Npyruvate.(Excreted(products(are(highlighted(in(red(and(resonances(of(the(
hyperpolarized( nutrient( in( green.( b)( Evolution( of$ the(metabolites( produced( from( 13C1Npyruvate( in( living(
macrophages(over(time(normalized(to(the(signal(of(pyruvate(C1.(The(evolution(of(CO2(is(not(shown(due(to(
its(low(intensity,(close(to(the(noise(level.(The(red(lines(correspond(to(the(fitting(curve.(
(
(
Discussion$
Within( the( last( ten(years,(hyperpolarization(NMR(allows( to(monitor( real( time(metabolites( in(a(
large( range( of( cell( systems[15N19].( Compared( to( standard( NMR( measurements,( it( enables( the(
observation(of(fast(metabolite(processes(and(increases(the(sensitivity(of(the(NMR(experiments(
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of( at( least( a( factor( 10,000( compared( to( standard( 13C( measurements[13].( Recently,( the(
development(of(new(polarization(techniques(and(the(use(of(specifically( labeled(nutrients(to(be(
hyperpolarized(extended(its(use(to(a(broad(range(of(metabolic(processes(in(living(cells[20].(Here(
dissolutionNDNP(NMR( spectroscopy(was( applied( for( the( first( time( to( study( the(metabolism( of(
living(macrophages(in(real(time.(The(use(of(deuterated(nutrients,(necessary(for(measurement(of(
hyperpolarized( metabolites( signal( was( demonstrated,( where( [UN2H,N13C]Nglucose( and( 13C1N
pyruvate( allowed( the( detection( of( downstream( metabolite( products( in( real( time( in( the( cell(
suspension.(Mainly,( the( resonances(observed( in( the(1D( 13C(NMR(spectra(corresponded( to(end(
products( of( metabolic( pathways,( where( their( accumulation( at( high( amounts( in( the( cell(
suspension( allowed( their( detection.( The( choice( of( nutrient( was( related( to( the( metabolite(
pathway(to(be(characterized(due(to(the(time(limitation(of(the(hyperpolarization(compared(to(the(
length( of( the( compounds(metabolisation.( Indeed,(whether( this( technique( allows( studying( fast(
metabolic(processes(and( low(concentrated(products( compared( to( standard(NMR(experiments,(
its(use(is(restricted(to(the(observation(of(events(happening(in(the(second(range(due(to(the(fast(
decay(of(the(hyperpolarized(signal(through(crossNrelaxation.(Recently,(Carravetta(et#al.(described(
longNlived( states( (LLS),( involving( pairs( of( inequivalent( spins( that( can( be( used( to( store( the(
hyperpolarized(magnetization,(exhibiting(lifetimes(up(to(37(times(T1[30],(possibly(extending(the(dN
DNP(NMR(measurement(window(to(the(minute(range.(Several(improvements,(among(which(LLS(
could( be( tested( and( included( in( our( proposed( setup,( may( lead( further( to( the( possible(
characterization(of(metabolic(changes(in(macrophages(upon(activation(to(a(M1(phenotype.(
$
Material$and$Methods$
Macrophages$biochemistry$
Macrophages( were( grown( in( 175( cm2( flask( containing( 100(mL( growing(medium( (DMEM,( FCS(
10%,(Glutamine,(bicarbonate,(25(mM(Glucose)(at(37°C(under(5(%(CO2.(The(growing(medium(was(
exchanged( every( 24( hours( following( the( hereinafterNdescribed( protocol.( The( macrophages(
growing(medium(was( remove(by(pipetting( and(25(mL(of( PBS( (phosphate(buffered( saline)(was(
added( to( the( flask.(PBS(was( then(exchanged( to(25(mL(PBS/EDTA( solution(and( incubated( for(5(
minutes( at( room( temperature( (RT).( Macrophages( were( detached( form( the( flask( wall( and(
centrifuged( for( 5(minutes( at( 200( g( at( RT.( The( cell( pellet( was( resuspended( in( 10(mL( growing(
medium(containing(5(mM(glucose.(In(order(to(count(the(cells,(a(macrophage(sample(was(diluted(
20(times(in(trypan(blue(solution(and(placed(in(a(counting(plate.(The(total(number(of(cells((Ntot)(
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was(calculated(from(the(average(number(of(cells(on(each(counting(plate(quadrant((Naverage)(using(
the(following(formula(where(d(is(the(dilution(factor(of(the(cells(in(trypan(blue(and(V(the(volume(
of(the(cell(sample.(
!!"! = !!"#$!%# ∙ ! ∙ ! ∙ 10!!
A(sample(volume(corresponding(to(80 ∙ 10!(macrophages(was(centrifuged(5(min(at(200(g(at(RT,(
resuspended(in(100(mL(growing(medium(containing(5(mM(glucose,(placed(in(a(175(cm2(flask(and(
incubated(for(24(hours(at(37°C(under(5%(CO2.(NMR(sample(preparation(was(achieved(following(
the( aboveNdescribed( protocol( containing( the( following( changes:( after( cell( count,( a( sample(
volume( corresponding( to(80 ∙ 10! (macrophages( was( centrifuged( 5( min( at( 200( g( at( RT( and(
resuspended(in(250(mL(of(growing(medium(without(glucose(containing(30(µL(D2O.!(
$
$
Dissolution$DNP$NMR$methods$
1.5(M(13C1Npyruvate((Cambridge(Isotope(Labs)(was(dissolved(in(a(D2O:UN2HNglycerol( (solution(at(
1:1( ratio( containing( 25(mM( TEMPOL( (SigmaNAldrich).( 867(mM( [UN2H,N13C]Nglucose( (Cambridge(
Isotope(Labs)(was(dissolved( in(an(H2O:D2O:UN2HNglycerol(solution(at(a(1:4:5(ratio(containing(50(
mM(TEMPOL( (SigmaNAldrich).( 10( and( 5( 10(µL( flashNfrozen( sample( beads(were(mixed(with( the(
same(number(of(10(µL(flashNfrozen(beads(of(3(M(ascorbate(in(D2O(for(the([UN2H,N13C]Nglucose(and(
13C1Npyruvate( sample( respectively( and( placed( inside( the( sample( holder.(Microwave( frequency(
modulation( was( set( at( Δ!!"# = 10 (kHz( and(Δ!!" = 50 (MHz( with( a( negative( microwave(
irradiation(of(the(ESR(line(of(TEMPOL(at(188.3(GHz.(13C(direct(polarization(was(performed(on(the(
[UN2H,N13C]Nglucose(sample(at(1.2(K(and(Hartmann(Hahn(CrossNpolarization( (CP)(was(performed(
on( the( 13C1Npyruvate( sample(with( a( CP( every( 5(minutes( and( 2(ms( contact( pulse( at( 1.2( K.( The(
sample(was(then(quickly(dissolved(by(superheated(D2O(at(a(temperature(of(400(K(and(a(pressure(
of( 10( bars.( 400( µL( of( the( dissolved( sample( were( transferred,( via( a( magnetic( tunnel,( in( 4.5(
seconds( to( a( Bruker( 500( MHz( spectrometer( preNheated( at( 37°C( containing( a( 400( µL(
macrophages( suspension(with(D2O( to(allow( fieldNfrequency( locking(prior( to( injection.( 13C(NMR(
spectra(were(recorded(as(an(array(of(256(oneNdimensional(spectra(using(10°(flip(angle.(Each(oneN
dimensional( spectrum(was( recorded(every(1(and(5( seconds(and(46080(and(65536(data(points(
were(recorded(in(the(time(domain(with(a(13C(carrier(centered(at(113(and(130(ppm(for(the([UN2H,N
13C]Nglucose(and(13C1Npyruvate(sample(respectively.(Spectra(were(processed(with(an(exponential(
line(broadening(of(3(Hz,(zeroNfilled(to(65536(points(and(Fourier(transformed(in(Topspin(3.2.(Data(
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analysis(was(performed(in(Topspin(3.2.(Spectra(were(normalized(using(the(glucose(and(pyruvate(
signal.(
1D(13C(NMR(spectra(at(thermal(equilibrium(were(recorded(30(minutes(after(dissolution(in(a(total(
experiment(time(of(30(minutes.(The(13C(carrier(was(centered(at(113(and(130(ppm(for(the([UN2H,N
13C]Nglucose(and(13C1Npyruvate(sample(respectively.(The(interscan(delay(was(set(to(200(ms.(In(the(
direct( dimension,( 65536( complex( points( were( recorded( in( an( acquisition( time( of( 1.33( s,(
multiplied(with(an(exponential( line(broadening(of(3(Hz,(zeroNfilled(to(65536(points(and(Fourier(
transformed(in(Topspin(3.2.(Data(analysis(was(performed(in(Topspin(3.2.(
(
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Abbreviations$and$Symbols$$
Å( (angstrom(
α, β (lower,(higher(energy(state(for(spin(½((
ASA( (accessible(surface(area(
ATP( (adenosine(triphosphate(
AUC( (analytical(ultracentrifugation(
B( (magnetic(field(
Bam( (βNbarrel(assembly(machinery(
BSA(( (Bovine(Serum(Albumin(
CD( (circular(dichroism(
CP( (cross(polarization(
Cp( (heat(capacity(
CSA( (chemical(shift(anisotropy(
CSP( ( chemical(shift(perturbation(
δ( (chemical(shift(
d1( (interscan(delay(
Dis( ( dipolarNcoupling(between(residues(i(and(s(
Da( (Dalton,(g.molN1 
DMEM( (Dulbecco's(Modified(Eagle's(medium(
DNP( (dynamic(nuclear(polarization(
DSS( (2NdimethylN2NsilapentaneN5Nsulfonic(acid(
E.#coli# # Escherichia#coli# # #
EDTA( ( ethyleneNdiamineNtetraacetic(acid(
ESR( ( electron(spin(resonance(
FCS( ( fetal(calf(serum(
FID( ( free(induction(decay(
FT( (Fourier(transformation(
γ( (gyromagnetic(ratio(
G( (Gibbs(free(energy(
Gdm/HCl( guanidine(hydrochloride(
ΔH( (enthalpy(of(transition(
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ħ( (Planck(constant,(1.054571726 ∙ 10!!"!! ∙ !(
HMQC( (heteronuclear(multiple(quantum(coherence(
Hsp( (heat(shock(protein(
HSQC( (heteronuclear(single(quantum(coherence(
I,(S( (nuclear(spin(
IM( (inner(membrane(
INEPT( (insensitive(nuclei(enhancement(by(polarization(transfer(
IFNNγ  interferon(gamma(
IPTG( (isopropyl(βNDN1Nthiogalactopyranoside 
n!!"( (scalar(coupling(constant(between(I(and(S(separated(by(n(covalent(bonds(! ! ( (spectral(density(
k( (chemical(exchange(rate(
kB( (Boltzmann(constant,(1.381 ∙ 10!!"!! ∙ !!! 
KD( dissociation(constant(
kex( (kinetic(exchange(rate(constant(
LLS( (longNlived(states((
LPS( (lipopolysaccharides(
µ( (magnetic(moment(
m( (spin(quantum(number(
M( (molar((mol(/(L)(!! ,!! ,!!( (x,(y,(z(component(of(the(magnetization(M(
MRI( (magnetic(resonance(imaging(
MWCO( (molecular(weight(cutNoff((
NADH( (reduced(nicotinamide(adenine(dinucleotide(
NMR( (nuclear(magnetic(resonance(!! , !! ((((((((((((( (population(of(the(α(and(β(state((
NOE( ( nuclear(Overhauser(effect(
NOESY( (nuclear(Overhauser(enhancement(spectroscopy(
NUS( (nonNuniform(sampling(
OD( (optical(density(
OM( (outer(membrane(
OMP( (outer(membrane(protein(
PBS( (phosphate(buffered(saline(
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PDB( ( RCSB(Protein(Data(Bank,(www.rcsb.org/pdb(
PHIP( (paraNhydrogen(induced(polarization(
POTRA( (polypeptide(transport(associated(
PPIase( ( peptidylNprolyl(isomerase 
ppm( (parts(per(million(
PRE( ( paramagnetic(relaxation(enhancement(!( (ellipticity(
R( (gas(constant,(8.314!! ∙ !!! ∙ !"#!!(
R1,(R2(( (longitudinal(and(transversal(relaxation(time(!! ,!!((( (selfNrelaxation(constant(of(spin(I,(spin(S(
RT( (room(temperature(
σ( (shield(!!"( (cross(relaxation(rate(constant(between(spins(I(and(S(
SAXS( (smallNangle(XNray(scattering(
S.#cerevisiae# #Saccharomyces#cerevisiae(
Sec( (secretoryNtranslocase(
SF( (scaling(factor(
S.#flexneri# Shigella#flexneri(
Skp( ( seventeenNkilodalton(protein(
SPR( (surface(plasmon(resonance(
SurA( (survival(factor(A(
t1,(t2(( (chemical(shift(evolution(times(
T1,(T2( (longitudinal(and(transversal(relaxation(
τc( (molecular(rotational(correlation(time(
τm( (mixing(time(
Tm( (melting(temperature(
TamA( (translocation(and(assembly(module(A(
TCA( (tricarboxylic(acid(
TEMPOL( 4NhydroxyN2,2,6,6NtetramethylpiperidinN1Noxyl(
TROSY( (transverse(relaxationNoptimized(spectroscopy(
ω( (resonance(frequency(
W( (transition(rate(constant(
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